data_2kio_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kio _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.552 ' C ' ' H ' ' A' ' 9' ' ' VAL . 80.6 mt-10 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 120.633 0.254 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -50.26 -12.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.638 -1.289 . . . . 0.0 108.542 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.552 ' H ' ' C ' ' A' ' 7' ' ' GLU . 3.2 t -79.14 -65.5 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -44.51 -45.58 9.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.634 -0.666 . . . . 0.0 109.325 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -62.29 -50.04 73.26 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -55.94 -55.1 36.77 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -50.22 -59.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -50.58 -27.86 7.59 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 108.981 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -99.78 -0.64 39.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.58 -0.7 . . . . 0.0 109.768 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -72.71 -10.71 60.11 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.367 -0.833 . . . . 0.0 110.132 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -50.11 -21.12 1.16 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -91.47 -68.31 0.8 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.492 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 95.1 mt -40.99 -28.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.731 0.777 . . . . 0.0 109.639 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 18' ' ' SER . 23.3 mt-10 -75.82 -47.72 24.53 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' SER . 5.4 mmt180 -60.2 -29.96 69.06 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -65.87 -67.89 0.41 Allowed 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.284 -0.885 . . . . 0.0 110.424 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.8 OUTLIER -54.83 -63.88 1.01 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.035 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.621 ' NE2' ' N ' ' A' ' 24' ' ' GLN . 0.7 OUTLIER -43.96 -32.52 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -0.877 . . . . 0.0 110.455 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -95.65 -70.16 0.72 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.91 -1.119 . . . . 0.0 110.924 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 22' ' ' LEU . 48.1 m-85 -63.46 -69.77 0.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 111.101 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.407 ' H ' HD11 ' A' ' 27' ' ' ILE . 3.9 mp -92.26 -80.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.138 -0.976 . . . . 0.0 110.982 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 123.01 38.44 0.56 Allowed Glycine 0 N--CA 1.501 3.018 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.16 91.4 2.62 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.441 -1.035 . . . . 0.0 109.107 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.1 m -139.43 69.7 39.35 Favored Pre-proline 0 N--CA 1.498 1.933 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.536 ' C ' ' H ' ' A' ' 33' ' ' TRP . 79.8 Cg_endo -86.84 -21.69 2.07 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.099 2.533 . . . . 0.0 112.662 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -53.73 -7.27 0.11 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 0.0 109.038 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.536 ' H ' ' C ' ' A' ' 31' ' ' PRO . 8.4 m-90 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.552 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 9' ' ' VAL . 2.3 pm0 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.056 -0.021 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.437 ' H ' ' CD ' ' A' ' 8' ' ' GLN . 4.2 mp0 -48.1 -16.64 0.1 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.611 -1.306 . . . . 0.0 108.264 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.525 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.2 t -73.08 -60.1 2.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -45.43 -45.28 12.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 0.0 109.127 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 15' ' ' GLN . 1.2 mptp? -61.64 -50.55 72.08 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -55.78 -55.5 31.6 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -48.55 -57.64 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -53.42 -36.72 61.83 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 11' ' ' LYS . 18.7 mt-30 -87.27 -3.49 59.04 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -78.33 -7.58 57.42 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.486 -0.759 . . . . 0.0 109.84 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 16' ' ' ALA . 3.3 p -37.97 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.9 0.857 . . . . 0.0 109.549 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 m -83.56 -70.38 0.57 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mt -42.81 -34.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.709 0.766 . . . . 0.0 109.299 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.506 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 2.3 pt-20 -75.94 -38.02 58.04 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' SER . 2.5 mmp_? -66.62 -33.91 76.71 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 24' ' ' GLN . 8.9 mp -62.67 -61.6 2.31 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.843 0.83 . . . . 0.0 110.212 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 14.4 p -43.43 -16.4 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.59 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' LEU . 73.2 mt-30 -91.57 -37.71 12.93 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.993 -1.067 . . . . 0.0 109.873 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -92.75 -70.16 0.71 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.161 -0.962 . . . . 0.0 110.258 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -44.56 -63.98 0.79 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.89 . . . . 0.0 110.356 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.13 -80.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.278 -0.889 . . . . 0.0 110.061 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 145.6 -54.55 0.55 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.514 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -73.01 165.01 25.85 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.335 -1.097 . . . . 0.0 108.571 179.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 70.7 m -155.63 118.6 2.37 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 108.383 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -39.48 -84.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.486 1.457 . . . . 0.0 112.908 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -172.65 66.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.414 -1.429 . . . . 0.0 110.164 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 120.528 -1.358 . . . . 0.0 108.845 178.661 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.519 ' C ' ' H ' ' A' ' 9' ' ' VAL . 64.3 mm-40 . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -57.85 -9.36 1.26 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 7' ' ' GLU . 44.4 t -84.43 -68.79 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.59 -37.9 8.78 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -68.0 -48.02 66.9 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -56.91 -56.39 22.28 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.1 mt -47.4 -58.71 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.45 ' O ' ' OG1' ' A' ' 17' ' ' THR . 39.0 mt-30 -50.06 -31.86 14.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.527 ' C ' ' H ' ' A' ' 17' ' ' THR . 14.8 mm-40 -87.43 -66.55 0.9 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.236 -0.915 . . . . 0.0 109.267 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -48.96 -9.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.793 . . . . 0.0 109.867 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.527 ' H ' ' C ' ' A' ' 15' ' ' GLN . 0.8 OUTLIER -76.25 -45.25 33.66 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.833 -1.167 . . . . 0.0 108.213 179.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.624 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.8 m -51.93 -28.93 18.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.355 -0.84 . . . . 0.0 109.316 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 18' ' ' SER . 79.7 mt -45.92 -23.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 120.761 -1.212 . . . . 0.0 107.925 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.476 ' N ' ' C ' ' A' ' 18' ' ' SER . 42.1 mt-10 -77.1 -41.88 40.29 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.624 ' N ' ' O ' ' A' ' 18' ' ' SER . 2.2 mtm180 -66.46 -33.32 75.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -70.45 -69.72 0.34 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.358 -0.838 . . . . 0.0 110.439 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' A' ' 28' ' ' GLY . 21.7 p -46.76 -61.46 1.83 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.738 -0.601 . . . . 0.0 110.118 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.491 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 75.8 mt-30 -47.9 -29.94 3.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 109.776 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -95.48 -67.92 0.83 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.238 -0.914 . . . . 0.0 110.554 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.492 ' N ' ' O ' ' A' ' 22' ' ' LEU . 61.0 m-85 -68.42 -65.97 0.63 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 111.213 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -98.9 -81.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.147 -0.97 . . . . 0.0 111.511 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 137.59 -5.13 3.43 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -86.14 118.51 25.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.203 -1.175 . . . . 0.0 109.613 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 m -160.21 101.36 1.4 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.477 -0.764 . . . . 0.0 108.957 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -41.81 -86.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.647 2.231 . . . . 0.0 113.864 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.407 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 53.2 t80 -178.5 74.21 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.854 -1.154 . . . . 0.0 109.327 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.403 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.481 ' C ' ' N ' ' A' ' 9' ' ' VAL . 33.9 tt0 . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -49.3 -19.67 0.53 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.674 -1.266 . . . . 0.0 108.004 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.481 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.7 t -71.76 -63.95 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 14' ' ' GLN . 23.2 t70 -46.52 -48.25 19.36 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -55.21 -50.82 68.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.42 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -59.54 -56.62 19.69 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 16' ' ' ALA . 8.2 mt -51.84 -56.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 10' ' ' ASP . 32.4 mm-40 -48.93 -41.34 33.52 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.605 0.717 . . . . 0.0 109.187 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -67.26 -11.14 56.71 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -76.48 -9.85 58.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.49 -0.756 . . . . 0.0 108.994 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 p -52.99 -32.38 46.02 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -64.89 -70.05 0.25 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' SER . 96.8 mt -43.46 -29.1 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.841 0.829 . . . . 0.0 109.149 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.572 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 34.9 mt-10 -75.79 -46.31 31.37 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -61.77 -38.23 87.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.85 -64.9 0.79 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.069 0.938 . . . . 0.0 109.051 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.506 ' O ' ' N ' ' A' ' 28' ' ' GLY . 13.7 p -55.51 -23.65 27.4 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.054 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -95.41 -29.54 14.37 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.981 -1.074 . . . . 0.0 110.588 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 21' ' ' ARG . 23.8 t60 -91.66 -70.38 0.69 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.008 -1.058 . . . . 0.0 111.246 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -66.46 -45.92 78.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.128 -0.982 . . . . 0.0 110.783 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.5 mm -85.75 -72.0 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.017 -1.052 . . . . 0.0 109.79 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 103.58 42.94 1.91 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.45 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -170.04 120.2 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.221 -1.164 . . . . 0.0 108.941 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.45 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.8 m -147.7 72.58 11.56 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 120.982 -1.074 . . . . 0.0 109.889 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -83.36 29.91 0.54 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.666 2.244 . . . . 0.0 112.338 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -127.79 17.17 6.85 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.402 -0.811 . . . . 0.0 109.041 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.572 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 2.9 m-90 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.976 -1.012 . . . . 0.0 108.747 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.631 ' OE2' ' OE1' ' A' ' 8' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 119.97 -0.062 . . . . 0.0 111.135 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.631 ' OE1' ' OE2' ' A' ' 7' ' ' GLU . 1.0 OUTLIER -57.35 -9.97 1.2 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 119.88 -1.763 . . . . 0.0 107.455 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.53 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -84.25 -65.93 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -46.34 -43.67 16.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.633 -0.667 . . . . 0.0 109.21 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -62.51 -49.26 76.07 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -57.43 -57.06 14.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 17' ' ' THR . 9.7 mt -48.98 -61.26 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.418 ' O ' ' OG1' ' A' ' 17' ' ' THR . 51.9 mt-30 -46.71 -38.26 9.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -79.15 -25.88 42.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.584 -0.698 . . . . 0.0 109.264 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -95.62 -9.65 31.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.323 -0.86 . . . . 0.0 110.227 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 13' ' ' ILE . 1.6 p -48.11 -40.77 24.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.088 -1.007 . . . . 0.0 108.874 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 20' ' ' GLU . 1.7 m -65.52 -67.72 0.42 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.619 -0.676 . . . . 0.0 109.27 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.497 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 98.0 mt -41.35 -28.43 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.891 0.853 . . . . 0.0 109.516 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.574 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 27.3 mt-10 -78.08 -57.99 3.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -51.85 -27.09 11.49 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.4 mp -70.11 -67.44 0.49 Allowed 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.341 -0.849 . . . . 0.0 110.983 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.6 p -64.04 -57.14 10.54 Favored 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.564 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.489 ' OE1' ' SG ' ' A' ' 23' ' ' CYS . 7.5 mp0 -46.4 -33.62 4.03 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.872 -1.143 . . . . 0.0 109.348 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -95.53 -61.58 1.44 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -0.923 . . . . 0.0 110.279 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' LEU . 6.2 m-85 -81.66 -73.89 0.36 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 111.558 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.9 mm -76.56 -79.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.535 -1.353 . . . . 0.0 110.616 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 122.26 -9.23 9.54 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.479 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 75.2 t90 -84.86 100.16 11.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.628 -0.925 . . . . 0.0 109.459 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.479 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 10.3 m -160.17 73.3 3.03 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 109.059 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.544 ' C ' ' H ' ' A' ' 33' ' ' TRP . 94.7 Cg_endo -85.38 -22.73 2.53 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 123.115 2.544 . . . . 0.0 112.892 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -56.61 -3.2 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.055 -1.028 . . . . 0.0 109.239 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.574 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 8.4 m-90 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.655 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.571 ' C ' ' H ' ' A' ' 9' ' ' VAL . 4.4 mp0 . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.488 ' OE1' ' N ' ' A' ' 8' ' ' GLN . 19.9 mp0 -49.77 -12.93 0.08 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.677 -1.264 . . . . 0.0 108.315 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.571 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.3 t -82.22 -67.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' VAL . 26.3 t0 -46.92 -40.43 14.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 108.876 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' GLN . 38.7 mttt -63.94 -50.68 67.7 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.403 HD21 ' N ' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -53.46 -54.74 32.69 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.0 mt -51.2 -58.95 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -55.78 -35.52 66.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.627 -0.671 . . . . 0.0 109.804 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 11' ' ' LYS . 45.1 mt-30 -76.0 -23.72 55.25 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 108.926 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -50.04 -12.93 0.09 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 109.42 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 15' ' ' GLN . 32.3 p -52.65 -32.87 44.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 108.44 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -63.02 -70.1 0.23 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.482 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 84.1 mt -42.91 -27.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 121.943 0.878 . . . . 0.0 109.313 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.532 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 36.1 mt-10 -81.28 -47.91 12.71 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 18' ' ' SER . 13.1 mmm-85 -63.68 -28.81 70.15 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.9 mp -61.77 -66.21 0.57 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.867 0.841 . . . . 0.0 109.919 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.535 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.8 OUTLIER -58.04 -60.97 2.91 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.841 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -45.28 -33.49 2.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.267 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -95.32 -65.58 0.97 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.073 -1.017 . . . . 0.0 110.58 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' A' ' 22' ' ' LEU . 45.5 m-85 -68.14 -68.18 0.41 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.157 -0.965 . . . . 0.0 110.843 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.22 -80.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.198 -0.939 . . . . 0.0 111.269 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 131.93 6.8 3.12 Favored Glycine 0 N--CA 1.502 3.089 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -98.12 99.46 10.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.271 -1.135 . . . . 0.0 109.804 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.4 m -155.11 69.48 5.57 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.934 . . . . 0.0 108.898 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.549 ' C ' ' H ' ' A' ' 33' ' ' TRP . 70.5 Cg_endo -86.54 -19.57 2.83 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.016 2.477 . . . . 0.0 112.651 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -60.02 1.01 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 109.663 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.549 ' H ' ' C ' ' A' ' 31' ' ' PRO . 7.1 m-90 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.504 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.567 ' C ' ' H ' ' A' ' 9' ' ' VAL . 31.1 mp0 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -50.98 -10.11 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.835 -1.166 . . . . 0.0 108.669 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 7' ' ' GLU . 28.2 t -82.32 -68.42 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.539 ' CG ' HE21 ' A' ' 14' ' ' GLN . 2.7 t70 -43.63 -40.35 4.06 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.22 -50.11 62.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -56.08 -54.17 48.23 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -49.37 -57.21 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.539 HE21 ' CG ' ' A' ' 10' ' ' ASP . 2.8 mp0 -53.41 -42.71 67.28 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -77.26 -9.73 58.98 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.313 -0.867 . . . . 0.0 109.048 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -90.33 -9.04 49.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.6 p -76.61 -29.99 56.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.453 -0.779 . . . . 0.0 110.649 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 21' ' ' ARG . 4.0 m -92.51 -14.87 27.78 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.967 -1.083 . . . . 0.0 110.627 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.491 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 43.1 mt -49.36 -23.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 120.446 -1.409 . . . . 0.0 107.399 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.524 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 16.2 pt-20 -78.08 -38.14 44.89 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' SER . 7.2 mmt-85 -69.83 -32.94 71.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.5 mp -66.48 -68.63 0.36 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.951 0.881 . . . . 0.0 110.499 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.524 ' SG ' ' NE2' ' A' ' 24' ' ' GLN . 2.5 p -48.57 -62.25 1.6 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.738 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.529 ' N ' ' OE1' ' A' ' 24' ' ' GLN . 1.2 mp0 -43.28 -33.54 1.0 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.404 -0.81 . . . . 0.0 110.041 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.473 ' CD2' ' CE1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -95.79 -52.33 4.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.416 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.473 ' CE1' ' CD2' ' A' ' 25' ' ' HIS . 13.8 m-85 -92.94 -68.52 0.8 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 111.85 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.1 mm -82.07 -80.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.432 -1.418 . . . . 0.0 110.301 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.433 ' H ' ' CB ' ' A' ' 23' ' ' CYS . . . 130.5 -14.31 5.59 Favored Glycine 0 N--CA 1.501 2.997 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -90.12 115.81 27.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.189 -1.183 . . . . 0.0 109.168 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 31' ' ' PRO . 1.7 m -160.7 109.0 1.32 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 109.129 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.542 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 35.7 Cg_exo -38.31 -102.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.175 1.917 . . . . 0.0 113.493 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.542 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 51.8 m-85 -159.6 65.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.415 -1.428 . . . . 0.0 110.015 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.411 ' C ' ' O ' ' A' ' 32' ' ' PHE . 3.1 m-90 . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.644 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 9' ' ' VAL . 15.7 tt0 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.47 ' CD ' ' N ' ' A' ' 8' ' ' GLN . 4.0 mp0 -56.4 -9.44 0.7 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 7' ' ' GLU . 37.4 t -82.05 -66.73 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -46.1 -43.88 15.12 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.51 -49.55 74.9 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -56.01 -56.17 24.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' THR . 9.1 mt -49.78 -60.7 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -48.62 -33.0 9.06 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -82.0 -49.56 10.11 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.354 -0.841 . . . . 0.0 109.878 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.69 -16.25 62.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.975 . . . . 0.0 109.665 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 20' ' ' GLU . 1.1 p -66.53 -48.03 71.01 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -39.33 -57.6 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.692 0.758 . . . . 0.0 110.005 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.495 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 79.6 mt -45.18 -25.9 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.5 0.667 . . . . 0.0 109.337 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -84.83 -34.16 22.76 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' SER . 34.7 mtm180 -73.33 -36.44 66.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.9 mp -51.9 -61.07 2.49 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.025 0.917 . . . . 0.0 109.713 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -63.45 -62.24 1.81 Allowed 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.383 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.514 ' NE2' ' OE1' ' A' ' 20' ' ' GLU . 73.9 mt-30 -48.48 -29.7 4.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.176 -0.953 . . . . 0.0 110.036 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.426 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 50.4 t60 -95.1 -62.24 1.34 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.05 -1.031 . . . . 0.0 110.367 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 22' ' ' LEU . 38.3 m-85 -75.64 -65.14 0.94 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.13 -0.981 . . . . 0.0 110.936 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.49 -81.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.101 -0.999 . . . . 0.0 111.58 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 126.95 32.96 0.66 Allowed Glycine 0 N--CA 1.505 3.238 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -116.33 78.19 1.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.55 -0.971 . . . . 0.0 109.176 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.4 m -150.51 69.21 8.7 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.143 -0.973 . . . . 0.0 109.766 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.19 60.04 7.64 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.634 2.222 . . . . 0.0 111.698 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 32' ' ' PHE . 71.2 t80 -162.2 29.36 0.11 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.029 -1.044 . . . . 0.0 110.336 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.018 -0.991 . . . . 0.0 108.766 179.34 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.545 ' C ' ' H ' ' A' ' 9' ' ' VAL . 65.5 tt0 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -52.8 -12.02 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.545 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -77.6 -70.04 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -44.81 -42.25 7.69 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -60.88 -52.51 64.76 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.104 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.65 -55.4 32.54 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.8 mt -52.21 -56.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -54.61 -38.67 67.07 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.395 0.617 . . . . 0.0 109.812 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 11' ' ' LYS . 17.9 mt-30 -65.05 -24.64 67.53 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.465 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.41 -15.84 1.91 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.293 -0.879 . . . . 0.0 109.125 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 p -55.51 -32.92 63.3 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -62.63 -70.25 0.21 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 18' ' ' SER . 72.8 mt -40.32 -33.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 122.063 0.935 . . . . 0.0 109.051 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.408 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 19.2 mt-10 -73.21 -54.14 9.19 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 18' ' ' SER . 31.6 mmt-85 -52.52 -39.13 60.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 24' ' ' GLN . 9.5 mp -63.52 -66.06 0.59 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.975 0.893 . . . . 0.0 109.299 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 6.9 p -46.06 -18.83 0.05 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.319 0.58 . . . . 0.0 109.937 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 22' ' ' LEU . 70.6 mt-30 -95.27 -27.18 15.62 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -96.07 -69.66 0.75 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.049 -1.032 . . . . 0.0 110.827 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -58.85 -58.92 6.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.459 -0.776 . . . . 0.0 111.66 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.425 ' H ' HD11 ' A' ' 27' ' ' ILE . 3.3 mp -94.12 -27.47 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.234 -0.916 . . . . 0.0 111.114 -177.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.31 -45.17 2.78 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.499 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 4.1 m95 -69.8 151.6 45.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -1.121 . . . . 0.0 109.127 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 82.4 m -156.04 108.41 2.1 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -36.78 -92.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.919 1.746 . . . . 0.0 113.093 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 65.4 t80 -174.26 69.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.518 -1.364 . . . . 0.0 109.76 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.36 179.274 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.519 ' C ' ' H ' ' A' ' 9' ' ' VAL . 8.7 pt-20 . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.488 ' N ' ' CG ' ' A' ' 7' ' ' GLU . 1.0 OUTLIER -56.72 -9.83 0.87 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.414 -1.429 . . . . 0.0 107.596 179.269 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -82.22 -65.85 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -46.02 -43.29 14.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.472 -0.767 . . . . 0.0 109.123 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -62.17 -50.22 72.69 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -57.1 -56.15 25.46 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.8 mt -49.49 -57.04 2.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -48.81 -34.63 12.77 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -87.66 -11.12 49.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -75.33 -11.91 60.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.088 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.3 p -77.05 -9.47 58.74 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -94.36 -70.72 0.69 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.78 -0.575 . . . . 0.0 110.007 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.1 mt -38.79 -31.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.602 0.715 . . . . 0.0 109.921 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.48 ' CG ' ' N ' ' A' ' 21' ' ' ARG . 11.9 pt-20 -75.83 -46.4 30.69 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' SER . 1.5 mmm180 -58.91 -40.85 85.75 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.12 -60.6 3.26 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.964 0.888 . . . . 0.0 109.93 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.653 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 7.0 p -51.25 -52.32 45.86 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.428 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.653 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 79.4 mt-30 -62.02 -24.52 67.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.783 -1.198 . . . . 0.0 110.09 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -95.49 -49.02 5.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -0.944 . . . . 0.0 110.538 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -97.81 -76.84 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 111.672 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.6 mm -59.19 -80.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.834 -1.166 . . . . 0.0 110.323 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 135.53 -60.24 0.64 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.472 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 8.5 t90 -64.42 142.03 58.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.371 -1.076 . . . . 0.0 108.901 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.472 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 3.1 m -155.01 120.61 2.63 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.546 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 60.9 Cg_exo -37.66 -94.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.567 1.512 . . . . 0.0 113.039 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 86.2 m-85 -158.2 59.21 0.46 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.325 -1.485 . . . . 0.0 110.723 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 120.693 -1.254 . . . . 0.0 108.84 179.078 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 9' ' ' VAL . 28.2 mm-40 . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.463 ' CD ' ' N ' ' A' ' 8' ' ' GLN . 17.3 mp0 -54.23 -9.9 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.885 -1.134 . . . . 0.0 108.081 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.534 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -82.54 -67.36 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.84 -33.86 2.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.616 -0.677 . . . . 0.0 109.614 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 15' ' ' GLN . 14.8 tttt -73.76 -49.14 26.89 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -54.23 -53.44 53.59 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.344 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 mt -50.01 -58.32 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -56.95 -27.42 61.1 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.415 0.626 . . . . 0.0 109.714 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' LYS . 75.8 mt-30 -99.73 0.09 41.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.193 -0.942 . . . . 0.0 110.176 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -67.59 -9.81 46.24 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.29 -0.881 . . . . 0.0 110.189 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.0 p -70.6 -15.15 62.72 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -93.28 -58.4 2.32 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.506 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 77.5 mt -39.59 -26.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 121.866 0.841 . . . . 0.0 109.346 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 18' ' ' SER . 3.5 mm-40 -74.49 -50.26 18.91 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -55.74 -31.86 62.89 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -69.81 -69.45 0.35 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.463 -0.773 . . . . 0.0 110.724 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.5 p -54.58 -57.03 13.03 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.192 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -46.33 -33.11 3.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.082 -1.011 . . . . 0.0 109.779 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -95.62 -65.6 0.96 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.159 -0.963 . . . . 0.0 110.153 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 22' ' ' LEU . 50.2 m-85 -67.25 -72.02 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 110.912 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.14 -81.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.054 -1.029 . . . . 0.0 111.16 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 129.53 0.82 5.7 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -92.51 98.92 11.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.271 -1.135 . . . . 0.0 109.258 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.8 m -153.44 77.22 6.03 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 109.068 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' A' ' 33' ' ' TRP . 65.6 Cg_endo -87.98 -26.05 0.75 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.015 2.477 . . . . 0.0 112.572 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.424 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 86.9 t80 -55.86 -3.9 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.659 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.523 ' H ' ' C ' ' A' ' 31' ' ' PRO . 13.8 m-90 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.607 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' A' ' 9' ' ' VAL . 49.1 mt-10 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -54.71 -9.24 0.31 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.956 -1.09 . . . . 0.0 108.347 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.533 ' H ' ' C ' ' A' ' 7' ' ' GLU . 54.2 t -85.7 -70.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.426 ' OD1' ' OE1' ' A' ' 14' ' ' GLN . 4.7 t70 -45.85 -31.77 2.27 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.618 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -74.53 -48.63 25.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -57.66 -55.89 29.0 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.635 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.5 mt -49.32 -54.56 5.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.426 ' OE1' ' OD1' ' A' ' 10' ' ' ASP . 8.2 mt-30 -50.29 -42.64 52.72 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -77.14 -6.57 53.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -95.26 -43.41 8.07 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 110.192 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.424 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 10.5 p -34.5 -30.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.975 0.417 . . . . 0.0 111.521 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 m -89.32 -71.37 0.61 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.007 -1.058 . . . . 0.0 109.572 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.9 mt -47.58 -29.11 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.809 ' OE2' ' CG ' ' A' ' 33' ' ' TRP . 17.9 mm-40 -75.49 -53.16 9.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 17' ' ' THR . 13.4 mmm-85 -49.63 -32.17 12.42 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.38 -68.19 0.41 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.719 0.771 . . . . 0.0 110.351 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' GLY . 28.0 p -60.29 -16.14 31.65 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.652 -0.655 . . . . 0.0 109.584 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -93.13 -31.08 14.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.298 -0.876 . . . . 0.0 109.442 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -95.55 -56.85 2.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.298 -0.876 . . . . 0.0 110.527 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -63.52 -57.41 10.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 110.853 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.8 mp -100.51 -80.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.017 -1.052 . . . . 0.0 110.764 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 131.34 39.9 0.24 Allowed Glycine 0 N--CA 1.502 3.084 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.423 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 2.0 t90 -162.67 124.46 2.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.054 -1.262 . . . . 0.0 108.849 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.423 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.6 m -144.93 94.13 5.44 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.146 -0.971 . . . . 0.0 109.448 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 33' ' ' TRP . 94.3 Cg_endo -84.51 -27.8 1.27 Allowed 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.097 1.865 . . . . 0.0 112.437 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -62.54 -0.16 0.57 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.051 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.809 ' CG ' ' OE2' ' A' ' 20' ' ' GLU . 21.2 m-90 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.282 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 9' ' ' VAL . 39.4 tt0 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -50.14 -12.47 0.08 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.631 -1.293 . . . . 0.0 108.465 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -78.68 -64.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.535 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 6.0 t70 -43.93 -47.58 8.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 4.4 mptp? -59.49 -52.58 64.96 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -54.17 -50.97 65.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.567 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 16' ' ' ALA . 8.0 mt -56.79 -62.02 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 10' ' ' ASP . 2.4 mp0 -47.51 -20.08 0.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 109.024 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.443 ' N ' ' C ' ' A' ' 13' ' ' ILE . 46.7 mt-30 -102.08 -16.42 16.42 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.556 0.694 . . . . 0.0 109.347 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -52.98 -9.55 0.13 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.406 -0.809 . . . . 0.0 110.295 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 15' ' ' GLN . 14.3 p -78.89 -21.66 47.11 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.829 -1.17 . . . . 0.0 109.195 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -95.8 -71.88 0.65 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -0.832 . . . . 0.0 110.969 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 18' ' ' SER . 97.8 mt -42.92 -30.66 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.643 0.735 . . . . 0.0 110.073 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -73.85 -48.42 31.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 18' ' ' SER . 6.0 mmm180 -53.91 -35.27 61.46 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.6 mp -67.8 -67.51 0.45 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.718 0.771 . . . . 0.0 109.975 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 14.3 p -51.05 -58.58 5.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.295 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.639 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 78.8 mt-30 -47.88 -31.49 5.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.783 -1.198 . . . . 0.0 109.797 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -95.9 -59.09 1.93 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.259 -0.901 . . . . 0.0 111.304 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 22' ' ' LEU . 22.9 m-85 -87.34 -80.32 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.986 -1.071 . . . . 0.0 112.245 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 mm -56.16 -65.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.805 -1.184 . . . . 0.0 110.412 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 107.28 -20.37 32.94 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -96.53 122.08 39.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.504 -0.998 . . . . 0.0 108.728 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.7 m -135.22 94.15 16.1 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -34.24 -98.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.444 2.096 . . . . 0.0 113.819 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.43 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 62.0 t80 -172.08 70.29 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.502 -1.374 . . . . 0.0 109.597 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.77 179.447 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 9' ' ' VAL . 1.4 tm-20 . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.457 ' CD ' ' N ' ' A' ' 8' ' ' GLN . 2.9 mp0 -51.55 -13.04 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.786 -1.196 . . . . 0.0 108.232 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 7' ' ' GLU . 18.0 t -76.22 -65.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.544 ' CG ' HE21 ' A' ' 14' ' ' GLN . 3.1 t70 -43.4 -45.81 6.36 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -61.41 -51.26 69.49 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -56.51 -55.22 36.53 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 16' ' ' ALA . 10.3 mt -49.77 -55.53 4.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.544 HE21 ' CG ' ' A' ' 10' ' ' ASP . 2.8 mp0 -50.93 -41.18 58.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -75.1 -13.3 60.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -88.27 -25.92 22.58 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 14' ' ' GLN . 47.8 p -61.7 -31.76 71.93 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -69.05 -70.9 0.24 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.436 -0.79 . . . . 0.0 109.474 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 79.3 mt -46.41 -28.45 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -78.28 -54.24 6.43 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -51.27 -37.2 45.93 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 22' ' ' LEU . 3.7 mp -65.79 -69.93 0.27 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.877 0.846 . . . . 0.0 109.438 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' GLY . 9.0 p -52.64 -38.58 60.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.208 0.528 . . . . 0.0 109.638 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.505 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 37.3 mm-40 -67.15 -36.71 82.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.814 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -90.05 -38.85 13.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.201 -0.937 . . . . 0.0 110.076 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -75.95 -65.56 0.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.905 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.77 -68.64 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 119.68 -2.48 13.63 Favored Glycine 0 N--CA 1.501 3.029 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.451 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -131.97 123.39 27.25 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.539 -0.977 . . . . 0.0 108.496 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.451 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.3 m -147.59 69.63 11.33 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 108.943 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.67 8.96 3.12 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.385 2.056 . . . . 0.0 112.59 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -84.87 -1.21 56.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.035 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.049 179.852 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.563 ' C ' ' H ' ' A' ' 9' ' ' VAL . 31.8 tt0 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -48.84 -14.08 0.06 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.706 -1.246 . . . . 0.0 108.249 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.563 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.2 t -77.92 -63.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.548 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 5.5 t70 -46.82 -47.6 21.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 108.833 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.42 -50.5 72.8 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.41 ' N ' HD21 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -57.7 -55.44 34.77 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.8 mt -51.33 -53.49 15.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.053 -1.03 . . . . 0.0 108.353 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.548 ' NE2' ' O ' ' A' ' 10' ' ' ASP . 2.3 mp0 -52.98 -37.74 61.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -72.39 -15.63 61.85 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -95.6 -13.37 24.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 14' ' ' GLN . 30.7 p -71.03 -31.64 68.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.116 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -65.75 -71.0 0.2 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.414 -0.804 . . . . 0.0 109.802 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 77.7 mt -46.79 -28.88 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.465 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 32.0 mt-10 -77.93 -49.29 14.45 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 25' ' ' HIS . 11.5 mmm180 -55.93 -34.32 65.52 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.69 -65.84 0.63 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.982 0.896 . . . . 0.0 109.815 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 28' ' ' GLY . 20.2 p -60.87 -18.4 55.96 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.87 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -95.2 -28.31 15.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 0.0 109.76 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 21' ' ' ARG . 46.9 t60 -95.24 -69.09 0.77 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.168 -0.958 . . . . 0.0 110.395 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -52.71 -54.76 29.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 110.784 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.9 mp -98.84 -80.84 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.154 -0.966 . . . . 0.0 110.798 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.47 42.57 0.24 Allowed Glycine 0 N--CA 1.501 2.988 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.442 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -170.29 130.37 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -1.195 . . . . 0.0 109.089 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.442 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.6 m -146.74 89.52 5.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.208 -0.932 . . . . 0.0 109.523 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 96.6 Cg_endo -84.83 51.73 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.196 1.93 . . . . 0.0 112.364 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 63.8 m-85 -158.52 28.11 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.974 -1.079 . . . . 0.0 109.74 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.465 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 2.9 m-90 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.017 -0.992 . . . . 0.0 108.767 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 9' ' ' VAL . 28.5 tt0 . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.526 ' CD ' ' H ' ' A' ' 8' ' ' GLN . 3.8 mp0 -56.78 -10.17 0.97 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.506 ' H ' ' C ' ' A' ' 7' ' ' GLU . 3.4 t -82.39 -64.88 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -46.27 -43.93 16.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -60.62 -50.2 74.47 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -58.48 -56.5 21.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 16' ' ' ALA . 10.1 mt -49.29 -52.28 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -51.2 -42.35 60.84 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -71.83 -13.91 61.81 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -86.42 -24.24 25.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.444 -0.785 . . . . 0.0 109.23 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -94.49 -12.55 27.45 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -95.54 -67.83 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 18' ' ' SER . 95.5 mt -38.11 -28.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.836 0.826 . . . . 0.0 109.876 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.531 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 15.7 pt-20 -82.55 -46.56 13.21 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' SER . 11.9 mtt85 -69.6 -30.18 67.88 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' A' ' 26' ' ' TYR . 4.3 mp -65.28 -68.74 0.34 Allowed 'General case' 0 C--O 1.204 -1.309 0 O-C-N 121.224 -0.923 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.58 ' O ' ' N ' ' A' ' 28' ' ' GLY . 3.2 p -41.56 -54.52 3.16 Favored 'General case' 0 N--CA 1.504 2.248 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.673 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.535 ' N ' ' OE1' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -45.99 -42.88 13.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 109.56 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -95.44 -54.86 3.24 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.119 -0.988 . . . . 0.0 109.682 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 22' ' ' LEU . 13.8 m-85 -61.68 -77.46 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.452 -0.78 . . . . 0.0 109.826 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.15 -80.78 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.584 -0.697 . . . . 0.0 110.512 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 139.98 -7.89 2.97 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -88.17 115.25 25.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.319 -1.106 . . . . 0.0 109.494 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.6 m -160.3 108.55 1.38 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 108.923 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -40.12 -83.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.305 2.003 . . . . 0.0 113.642 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.49 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 53.3 t80 -176.23 71.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.798 -1.189 . . . . 0.0 110.093 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.091 -1.005 . . . . 0.0 109.553 178.85 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 9' ' ' VAL . 42.7 mm-40 . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.699 ' NE2' ' H ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.65 -9.62 0.35 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.867 -1.133 . . . . 0.0 107.95 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.539 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -88.07 -67.44 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -49.62 -39.63 36.46 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.949 -1.094 . . . . 0.0 108.819 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 15' ' ' GLN . 37.2 mttp -63.46 -49.42 73.74 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.52 -54.37 41.97 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 mt -54.04 -56.51 9.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -56.74 -32.74 65.86 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.49 -0.756 . . . . 0.0 109.505 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 11' ' ' LYS . 49.3 mt-30 -69.32 -26.33 64.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.193 -0.942 . . . . 0.0 109.048 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.15 -13.09 0.74 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.298 -0.876 . . . . 0.0 109.131 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.413 ' N ' ' C ' ' A' ' 15' ' ' GLN . 8.6 p -51.56 -36.68 46.26 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -60.17 -69.27 0.23 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.447 -0.783 . . . . 0.0 109.105 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.3 mt -42.73 -29.6 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 121.883 0.849 . . . . 0.0 109.334 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.568 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 29.6 mt-10 -79.52 -48.88 13.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 18' ' ' SER . 16.6 mmt85 -60.61 -33.32 72.59 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.8 mp -63.99 -66.97 0.47 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 122.022 0.915 . . . . 0.0 109.699 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 28' ' ' GLY . 18.7 p -57.37 -16.69 9.72 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.767 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -95.48 -29.58 14.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.174 -0.954 . . . . 0.0 109.844 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -95.3 -68.53 0.8 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.208 -0.933 . . . . 0.0 110.635 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -52.49 -54.29 34.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.179 -0.951 . . . . 0.0 110.966 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.01 -80.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.078 -1.014 . . . . 0.0 111.192 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.95 37.91 0.37 Allowed Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -163.69 128.97 2.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -1.189 . . . . 0.0 109.246 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.6 m -144.12 105.19 4.79 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.14 -0.975 . . . . 0.0 109.022 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.52 ' C ' ' H ' ' A' ' 33' ' ' TRP . 89.6 Cg_endo -82.56 -29.22 1.49 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.836 1.69 . . . . 0.0 112.992 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.08 11.15 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 109.159 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.568 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 16.8 m-90 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.627 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 9' ' ' VAL . 64.7 tt0 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -54.89 -9.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.537 ' H ' ' C ' ' A' ' 7' ' ' GLU . 3.9 t -84.74 -68.03 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -46.37 -33.81 4.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.595 -0.691 . . . . 0.0 109.569 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -73.03 -48.12 38.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -56.23 -55.13 36.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -49.16 -56.81 2.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -53.37 -42.76 67.19 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.46 -18.78 61.66 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.312 -0.868 . . . . 0.0 108.885 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -72.38 -9.36 58.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.321 -0.862 . . . . 0.0 109.078 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 20' ' ' GLU . 6.5 p -46.16 -65.54 0.54 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.785 . . . . 0.0 109.423 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -36.21 -66.59 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.618 0.723 . . . . 0.0 110.763 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -45.01 -27.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 109.914 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.518 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 0.3 OUTLIER -83.85 -35.78 23.93 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' SER . 10.7 mmt180 -72.21 -25.53 61.69 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.7 mp -64.21 -65.63 0.65 Allowed 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.636 0.731 . . . . 0.0 110.009 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 28' ' ' GLY . 5.0 p -47.09 -58.15 4.32 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -47.36 -34.56 7.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.968 . . . . 0.0 109.99 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -95.49 -70.4 0.71 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.044 . . . . 0.0 111.294 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 22' ' ' LEU . 52.5 m-85 -53.21 -67.68 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.74 -81.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.118 -0.989 . . . . 0.0 110.697 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 134.32 42.56 0.14 Allowed Glycine 0 N--CA 1.498 2.833 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -165.95 116.74 1.03 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -1.15 . . . . 0.0 109.201 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 m -130.24 90.04 43.02 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.76 41.09 0.99 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.974 1.783 . . . . 0.0 112.89 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.494 ' CG ' ' O ' ' A' ' 32' ' ' PHE . 71.9 t80 -160.19 27.8 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.709 -1.245 . . . . 0.0 110.121 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.163 179.639 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 9' ' ' VAL . 52.0 mt-10 . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -55.62 -9.73 0.57 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.856 -1.152 . . . . 0.0 108.041 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 7' ' ' GLU . 42.1 t -81.3 -67.04 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 14' ' ' GLN . 2.2 t0 -45.09 -44.17 10.2 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -62.64 -50.24 72.01 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.329 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.09 -54.99 36.13 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -50.26 -58.04 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -56.39 -36.6 69.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.557 -0.714 . . . . 0.0 109.812 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.525 ' C ' ' H ' ' A' ' 17' ' ' THR . 13.3 mt-30 -76.89 -49.9 14.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.947 -1.095 . . . . 0.0 109.42 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -53.02 -9.05 0.12 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 108.949 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.525 ' H ' ' C ' ' A' ' 15' ' ' GLN . 6.5 p -42.98 -23.88 0.05 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.072 0.939 . . . . 0.0 108.864 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.5 m -79.32 -70.81 0.48 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.9 mt -43.74 -37.57 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-O 122.027 0.918 . . . . 0.0 109.298 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.507 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 1.6 pt-20 -73.63 -45.51 52.4 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.542 ' NE ' ' OE1' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -58.0 -41.24 82.63 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mp -55.9 -59.25 5.15 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.154 0.978 . . . . 0.0 109.132 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 5.3 p -55.75 -32.6 63.54 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.19 -178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.542 ' OE1' ' NE ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -95.5 -25.42 16.22 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.763 -1.211 . . . . 0.0 110.968 -178.098 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 21' ' ' ARG . 3.6 t60 -87.82 -68.68 0.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.042 -1.036 . . . . 0.0 110.971 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -76.91 -47.92 19.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.149 -0.969 . . . . 0.0 111.408 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mm -76.34 -76.05 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.89 -1.131 . . . . 0.0 109.898 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.41 -36.95 2.36 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.508 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 4.1 t90 -90.84 151.36 21.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.4 -1.059 . . . . 0.0 109.4 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 60.1 m -156.99 150.47 19.0 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 56.2 Cg_endo -70.28 -89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 121.353 1.369 . . . . 0.0 111.949 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 31' ' ' PRO . 19.8 m-85 -155.4 47.12 0.51 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.844 -1.16 . . . . 0.0 111.164 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 O-C-N 120.563 -1.336 . . . . 0.0 108.718 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.548 ' C ' ' H ' ' A' ' 9' ' ' VAL . 69.1 tt0 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.56 ' H ' ' NE2' ' A' ' 8' ' ' GLN . 4.1 mp0 -51.43 -12.28 0.15 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.425 -1.422 . . . . 0.0 108.329 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.548 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.3 t -81.35 -64.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.506 ' OD1' ' NE2' ' A' ' 14' ' ' GLN . 5.6 t70 -46.05 -45.63 16.21 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' NZ ' ' CG ' ' A' ' 7' ' ' GLU . 27.2 mttp -59.28 -51.96 67.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.417 ' N ' HD21 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -54.34 -53.45 53.67 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.0 mt -54.42 -59.75 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.506 ' NE2' ' OD1' ' A' ' 10' ' ' ASP . 37.0 mt-30 -51.47 -38.09 52.1 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.329 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 17' ' ' THR . 42.9 mt-30 -64.19 -28.25 69.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -0.91 . . . . 0.0 108.683 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.33 -13.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.592 -0.693 . . . . 0.0 109.702 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' GLN . 5.9 p -52.17 -31.93 33.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 108.472 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -65.02 -70.63 0.22 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.051 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' SER . 94.6 mt -38.38 -30.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.864 0.84 . . . . 0.0 109.591 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' SER . 16.1 mt-10 -75.47 -53.01 9.37 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' SER . 5.3 mmt-85 -52.57 -43.74 65.46 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 25' ' ' HIS . 7.8 mp -59.9 -62.39 1.91 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.029 0.919 . . . . 0.0 109.443 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 1.7 p -44.13 -49.29 9.04 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.456 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.612 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 58.9 mt-30 -62.86 -24.19 67.67 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.887 -1.133 . . . . 0.0 108.71 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 22' ' ' LEU . 46.8 t-80 -96.13 -58.78 1.99 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.458 -0.776 . . . . 0.0 111.193 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.471 ' N ' ' O ' ' A' ' 22' ' ' LEU . 73.6 m-85 -88.93 -80.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 0.0 112.037 -177.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 29' ' ' TRP . 3.8 mm -48.62 -19.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.03 -1.044 . . . . 0.0 109.74 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 68.07 -55.44 0.41 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.471 ' N ' ' O ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -76.68 159.08 30.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -1.191 . . . . 0.0 108.856 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 31' ' ' PRO . 52.8 m -154.55 106.22 2.37 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 24.6 Cg_exo -37.08 -105.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.346 2.03 . . . . 0.0 113.58 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 68.5 m-85 -158.99 63.43 0.41 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.352 -1.468 . . . . 0.0 110.069 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.395 179.169 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 3' ' ' LEU . 34.4 p-10 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 4' ' ' ASP . 56.2 mt-10 -63.89 77.36 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.208 -0.932 . . . . 0.0 109.523 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 1' ' ' ASN . 31.6 tp -50.19 -13.33 0.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 0.0 108.903 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 2' ' ' GLU . 1.7 p30 -77.96 52.95 1.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.775 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.627 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.2 t -72.8 -35.77 3.15 Favored Pre-proline 0 C--N 1.306 -1.289 0 O-C-N 121.106 -0.996 . . . . 0.0 110.199 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 84.0 Cg_exo -48.82 117.68 2.91 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.407 2.071 . . . . 0.0 112.271 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.552 ' C ' ' H ' ' A' ' 9' ' ' VAL . 80.6 mt-10 -93.94 -70.53 0.7 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.39 -0.819 . . . . 0.0 111.067 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -50.26 -12.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.638 -1.289 . . . . 0.0 108.542 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.552 ' H ' ' C ' ' A' ' 7' ' ' GLU . 3.2 t -79.14 -65.5 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -44.51 -45.58 9.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.634 -0.666 . . . . 0.0 109.325 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -62.29 -50.04 73.26 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -55.94 -55.1 36.77 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -50.22 -59.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -50.58 -27.86 7.59 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 108.981 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -99.78 -0.64 39.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.58 -0.7 . . . . 0.0 109.768 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -72.71 -10.71 60.11 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.367 -0.833 . . . . 0.0 110.132 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -50.11 -21.12 1.16 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -91.47 -68.31 0.8 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.492 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 95.1 mt -40.99 -28.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.731 0.777 . . . . 0.0 109.639 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 18' ' ' SER . 23.3 mt-10 -75.82 -47.72 24.53 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' SER . 5.4 mmt180 -60.2 -29.96 69.06 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -65.87 -67.89 0.41 Allowed 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.284 -0.885 . . . . 0.0 110.424 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.8 OUTLIER -54.83 -63.88 1.01 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.035 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.621 ' NE2' ' N ' ' A' ' 24' ' ' GLN . 0.7 OUTLIER -43.96 -32.52 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -0.877 . . . . 0.0 110.455 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -95.65 -70.16 0.72 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.91 -1.119 . . . . 0.0 110.924 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.46 ' N ' ' O ' ' A' ' 22' ' ' LEU . 48.1 m-85 -63.46 -69.77 0.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 111.101 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.407 ' H ' HD11 ' A' ' 27' ' ' ILE . 3.9 mp -92.26 -80.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.138 -0.976 . . . . 0.0 110.982 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 123.01 38.44 0.56 Allowed Glycine 0 N--CA 1.501 3.018 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.16 91.4 2.62 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.441 -1.035 . . . . 0.0 109.107 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.1 m -139.43 69.7 39.35 Favored Pre-proline 0 N--CA 1.498 1.933 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.536 ' C ' ' H ' ' A' ' 33' ' ' TRP . 79.8 Cg_endo -86.84 -21.69 2.07 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.099 2.533 . . . . 0.0 112.662 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -53.73 -7.27 0.11 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 0.0 109.038 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.536 ' H ' ' C ' ' A' ' 31' ' ' PRO . 8.4 m-90 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.552 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.523 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 56.5 t30 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.523 ' H ' ' CG ' ' A' ' 1' ' ' ASN . 18.6 mt-10 -84.07 93.33 8.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 109.83 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 5' ' ' VAL . 10.1 mp -75.2 19.91 0.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 108.689 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 2' ' ' GLU . 19.5 p-10 -65.98 40.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 110.167 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.622 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.7 t -76.43 -35.25 1.51 Allowed Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.242 -0.912 . . . . 0.0 110.281 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 41.2 Cg_exo -44.63 113.2 0.43 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.395 2.063 . . . . 0.0 112.816 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' A' ' 9' ' ' VAL . 2.3 pm0 -88.99 -68.41 0.77 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.737 -0.602 . . . . 0.0 110.979 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.437 ' CD ' ' H ' ' A' ' 8' ' ' GLN . 4.2 mp0 -48.1 -16.64 0.1 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.611 -1.306 . . . . 0.0 108.264 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.525 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.2 t -73.08 -60.1 2.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -45.43 -45.28 12.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 0.0 109.127 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 15' ' ' GLN . 1.2 mptp? -61.64 -50.55 72.08 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -55.78 -55.5 31.6 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -48.55 -57.64 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -53.42 -36.72 61.83 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 11' ' ' LYS . 18.7 mt-30 -87.27 -3.49 59.04 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -78.33 -7.58 57.42 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.486 -0.759 . . . . 0.0 109.84 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 16' ' ' ALA . 3.3 p -37.97 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.9 0.857 . . . . 0.0 109.549 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 m -83.56 -70.38 0.57 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mt -42.81 -34.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.709 0.766 . . . . 0.0 109.299 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.506 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 2.3 pt-20 -75.94 -38.02 58.04 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' SER . 2.5 mmp_? -66.62 -33.91 76.71 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 24' ' ' GLN . 8.9 mp -62.67 -61.6 2.31 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.843 0.83 . . . . 0.0 110.212 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 14.4 p -43.43 -16.4 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.59 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' LEU . 73.2 mt-30 -91.57 -37.71 12.93 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.993 -1.067 . . . . 0.0 109.873 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -92.75 -70.16 0.71 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.161 -0.962 . . . . 0.0 110.258 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -44.56 -63.98 0.79 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.89 . . . . 0.0 110.356 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.13 -80.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.278 -0.889 . . . . 0.0 110.061 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 145.6 -54.55 0.55 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.514 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -73.01 165.01 25.85 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.335 -1.097 . . . . 0.0 108.571 179.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 70.7 m -155.63 118.6 2.37 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 108.383 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -39.48 -84.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.486 1.457 . . . . 0.0 112.908 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -172.65 66.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.414 -1.429 . . . . 0.0 110.164 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 120.528 -1.358 . . . . 0.0 108.845 178.661 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 4' ' ' ASP . 4.3 pt-20 -48.25 103.91 0.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 109.701 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.3 mp -52.59 -12.38 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 2' ' ' GLU . 4.6 p-10 -95.49 78.6 3.39 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.592 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 9.8 t -71.86 -35.22 3.45 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.332 -0.855 . . . . 0.0 110.599 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 72.8 Cg_exo -52.38 84.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.627 1.551 . . . . 0.0 112.493 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.519 ' C ' ' H ' ' A' ' 9' ' ' VAL . 64.3 mm-40 -94.59 -52.78 4.15 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -57.85 -9.36 1.26 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 7' ' ' GLU . 44.4 t -84.43 -68.79 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.59 -37.9 8.78 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -68.0 -48.02 66.9 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -56.91 -56.39 22.28 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.1 mt -47.4 -58.71 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.45 ' O ' ' OG1' ' A' ' 17' ' ' THR . 39.0 mt-30 -50.06 -31.86 14.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.527 ' C ' ' H ' ' A' ' 17' ' ' THR . 14.8 mm-40 -87.43 -66.55 0.9 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.236 -0.915 . . . . 0.0 109.267 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -48.96 -9.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.793 . . . . 0.0 109.867 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.527 ' H ' ' C ' ' A' ' 15' ' ' GLN . 0.8 OUTLIER -76.25 -45.25 33.66 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.833 -1.167 . . . . 0.0 108.213 179.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.624 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.8 m -51.93 -28.93 18.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.355 -0.84 . . . . 0.0 109.316 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 18' ' ' SER . 79.7 mt -45.92 -23.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 120.761 -1.212 . . . . 0.0 107.925 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.476 ' N ' ' C ' ' A' ' 18' ' ' SER . 42.1 mt-10 -77.1 -41.88 40.29 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.624 ' N ' ' O ' ' A' ' 18' ' ' SER . 2.2 mtm180 -66.46 -33.32 75.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -70.45 -69.72 0.34 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.358 -0.838 . . . . 0.0 110.439 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' A' ' 28' ' ' GLY . 21.7 p -46.76 -61.46 1.83 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.738 -0.601 . . . . 0.0 110.118 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.491 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 75.8 mt-30 -47.9 -29.94 3.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 109.776 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -95.48 -67.92 0.83 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.238 -0.914 . . . . 0.0 110.554 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.492 ' N ' ' O ' ' A' ' 22' ' ' LEU . 61.0 m-85 -68.42 -65.97 0.63 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 111.213 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.2 mp -98.9 -81.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.147 -0.97 . . . . 0.0 111.511 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 137.59 -5.13 3.43 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -86.14 118.51 25.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.203 -1.175 . . . . 0.0 109.613 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 m -160.21 101.36 1.4 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.477 -0.764 . . . . 0.0 108.957 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -41.81 -86.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.647 2.231 . . . . 0.0 113.864 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.407 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 53.2 t80 -178.5 74.21 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.854 -1.154 . . . . 0.0 109.327 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.403 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.458 ' C ' HD21 ' A' ' 1' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' A' ' 4' ' ' ASP . 7.9 tp10 -76.63 113.01 13.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.001 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 5' ' ' VAL . 9.2 mp -69.7 12.9 0.16 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.168 -0.958 . . . . 0.0 109.203 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.555 ' H ' ' C ' ' A' ' 2' ' ' GLU . 55.2 p30 -71.53 38.0 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.489 -0.757 . . . . 0.0 110.095 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.636 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.8 t -78.78 -34.85 1.02 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 110.351 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 78.0 Cg_exo -48.79 122.03 7.49 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.447 2.098 . . . . 0.0 112.08 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' C ' ' N ' ' A' ' 9' ' ' VAL . 33.9 tt0 -93.98 -71.24 0.67 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.286 -0.883 . . . . 0.0 111.665 -177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -49.3 -19.67 0.53 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.674 -1.266 . . . . 0.0 108.004 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.7 t -71.76 -63.95 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 14' ' ' GLN . 23.2 t70 -46.52 -48.25 19.36 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -55.21 -50.82 68.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.42 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -59.54 -56.62 19.69 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 16' ' ' ALA . 8.2 mt -51.84 -56.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 10' ' ' ASP . 32.4 mm-40 -48.93 -41.34 33.52 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.605 0.717 . . . . 0.0 109.187 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -67.26 -11.14 56.71 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -76.48 -9.85 58.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.49 -0.756 . . . . 0.0 108.994 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 p -52.99 -32.38 46.02 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -64.89 -70.05 0.25 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' SER . 96.8 mt -43.46 -29.1 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.841 0.829 . . . . 0.0 109.149 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.572 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 34.9 mt-10 -75.79 -46.31 31.37 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -61.77 -38.23 87.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.85 -64.9 0.79 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.069 0.938 . . . . 0.0 109.051 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.506 ' O ' ' N ' ' A' ' 28' ' ' GLY . 13.7 p -55.51 -23.65 27.4 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.054 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -95.41 -29.54 14.37 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.981 -1.074 . . . . 0.0 110.588 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 21' ' ' ARG . 23.8 t60 -91.66 -70.38 0.69 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.008 -1.058 . . . . 0.0 111.246 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -66.46 -45.92 78.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.128 -0.982 . . . . 0.0 110.783 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.5 mm -85.75 -72.0 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.017 -1.052 . . . . 0.0 109.79 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 103.58 42.94 1.91 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.45 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -170.04 120.2 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.221 -1.164 . . . . 0.0 108.941 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.45 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.8 m -147.7 72.58 11.56 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 120.982 -1.074 . . . . 0.0 109.889 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -83.36 29.91 0.54 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.666 2.244 . . . . 0.0 112.338 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -127.79 17.17 6.85 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.402 -0.811 . . . . 0.0 109.041 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.572 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 2.9 m-90 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.976 -1.012 . . . . 0.0 108.747 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.527 ' N ' HD21 ' A' ' 1' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 4' ' ' ASP . 27.1 mm-40 -69.35 104.5 2.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 109.43 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.9 12.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.343 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 2' ' ' GLU . 46.7 p-10 -85.55 96.47 9.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.242 -0.911 . . . . 0.0 109.907 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.0 t -70.59 -36.86 5.99 Favored Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 120.962 -1.086 . . . . 0.0 110.024 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 79.8 Cg_exo -49.5 113.44 0.95 Allowed 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.327 2.018 . . . . 0.0 112.096 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.631 ' OE2' ' OE1' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -95.42 -56.04 2.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.413 -0.804 . . . . 0.0 111.135 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.631 ' OE1' ' OE2' ' A' ' 7' ' ' GLU . 1.0 OUTLIER -57.35 -9.97 1.2 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 119.88 -1.763 . . . . 0.0 107.455 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.53 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -84.25 -65.93 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -46.34 -43.67 16.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.633 -0.667 . . . . 0.0 109.21 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -62.51 -49.26 76.07 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -57.43 -57.06 14.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 17' ' ' THR . 9.7 mt -48.98 -61.26 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.418 ' O ' ' OG1' ' A' ' 17' ' ' THR . 51.9 mt-30 -46.71 -38.26 9.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -79.15 -25.88 42.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.584 -0.698 . . . . 0.0 109.264 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -95.62 -9.65 31.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.323 -0.86 . . . . 0.0 110.227 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 13' ' ' ILE . 1.6 p -48.11 -40.77 24.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.088 -1.007 . . . . 0.0 108.874 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 20' ' ' GLU . 1.7 m -65.52 -67.72 0.42 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.619 -0.676 . . . . 0.0 109.27 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.497 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 98.0 mt -41.35 -28.43 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.891 0.853 . . . . 0.0 109.516 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.574 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 27.3 mt-10 -78.08 -57.99 3.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -51.85 -27.09 11.49 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.4 mp -70.11 -67.44 0.49 Allowed 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.341 -0.849 . . . . 0.0 110.983 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.527 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.6 p -64.04 -57.14 10.54 Favored 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.564 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.489 ' OE1' ' SG ' ' A' ' 23' ' ' CYS . 7.5 mp0 -46.4 -33.62 4.03 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.872 -1.143 . . . . 0.0 109.348 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -95.53 -61.58 1.44 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -0.923 . . . . 0.0 110.279 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' LEU . 6.2 m-85 -81.66 -73.89 0.36 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 111.558 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.9 mm -76.56 -79.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.535 -1.353 . . . . 0.0 110.616 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 122.26 -9.23 9.54 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.479 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 75.2 t90 -84.86 100.16 11.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.628 -0.925 . . . . 0.0 109.459 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.479 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 10.3 m -160.17 73.3 3.03 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 109.059 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.544 ' C ' ' H ' ' A' ' 33' ' ' TRP . 94.7 Cg_endo -85.38 -22.73 2.53 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 123.115 2.544 . . . . 0.0 112.892 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -56.61 -3.2 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.055 -1.028 . . . . 0.0 109.239 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.574 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 8.4 m-90 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.655 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 24.0 t30 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.568 ' C ' ' H ' ' A' ' 4' ' ' ASP . 43.8 tt0 -97.9 146.37 25.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.296 -0.878 . . . . 0.0 109.387 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.1 tp -66.04 12.02 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.296 -0.877 . . . . 0.0 109.976 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.568 ' H ' ' C ' ' A' ' 2' ' ' GLU . 50.0 p-10 -80.18 83.93 5.96 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.221 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 45.3 t -75.92 -33.08 1.23 Allowed Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.153 -0.967 . . . . 0.0 111.425 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 10.0 Cg_endo -89.53 116.49 0.7 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.464 2.109 . . . . 0.0 111.41 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.571 ' C ' ' H ' ' A' ' 9' ' ' VAL . 4.4 mp0 -81.41 -62.92 1.51 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.513 -176.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.488 ' OE1' ' N ' ' A' ' 8' ' ' GLN . 19.9 mp0 -49.77 -12.93 0.08 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.677 -1.264 . . . . 0.0 108.315 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.571 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.3 t -82.22 -67.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' VAL . 26.3 t0 -46.92 -40.43 14.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 108.876 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' GLN . 38.7 mttt -63.94 -50.68 67.7 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.403 HD21 ' N ' ' A' ' 12' ' ' LEU . 0.4 OUTLIER -53.46 -54.74 32.69 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.0 mt -51.2 -58.95 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -55.78 -35.52 66.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.627 -0.671 . . . . 0.0 109.804 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 11' ' ' LYS . 45.1 mt-30 -76.0 -23.72 55.25 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 108.926 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -50.04 -12.93 0.09 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 109.42 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 15' ' ' GLN . 32.3 p -52.65 -32.87 44.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 108.44 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -63.02 -70.1 0.23 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.482 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 84.1 mt -42.91 -27.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 121.943 0.878 . . . . 0.0 109.313 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.532 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 36.1 mt-10 -81.28 -47.91 12.71 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 18' ' ' SER . 13.1 mmm-85 -63.68 -28.81 70.15 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.9 mp -61.77 -66.21 0.57 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.867 0.841 . . . . 0.0 109.919 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.535 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.8 OUTLIER -58.04 -60.97 2.91 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.841 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -45.28 -33.49 2.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.267 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -95.32 -65.58 0.97 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.073 -1.017 . . . . 0.0 110.58 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' A' ' 22' ' ' LEU . 45.5 m-85 -68.14 -68.18 0.41 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.157 -0.965 . . . . 0.0 110.843 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.22 -80.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.198 -0.939 . . . . 0.0 111.269 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 131.93 6.8 3.12 Favored Glycine 0 N--CA 1.502 3.089 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -98.12 99.46 10.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.271 -1.135 . . . . 0.0 109.804 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.4 m -155.11 69.48 5.57 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.934 . . . . 0.0 108.898 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.549 ' C ' ' H ' ' A' ' 33' ' ' TRP . 70.5 Cg_endo -86.54 -19.57 2.83 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.016 2.477 . . . . 0.0 112.651 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -60.02 1.01 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 109.663 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.549 ' H ' ' C ' ' A' ' 31' ' ' PRO . 7.1 m-90 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.504 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 4' ' ' ASP . 80.3 mt-10 -49.92 120.43 4.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.587 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.6 tp -51.99 -12.99 0.25 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 2' ' ' GLU . 7.3 p-10 -115.5 69.61 0.73 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 6' ' ' PRO . 8.0 t -51.48 -60.81 5.09 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 0.0 110.654 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.431 ' C ' ' O ' ' A' ' 5' ' ' VAL . 56.6 Cg_exo -28.46 106.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 122.972 2.448 . . . . 0.0 113.208 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.567 ' C ' ' H ' ' A' ' 9' ' ' VAL . 31.1 mp0 -95.43 -70.2 0.72 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.576 -0.702 . . . . 0.0 109.949 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -50.98 -10.11 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.835 -1.166 . . . . 0.0 108.669 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 7' ' ' GLU . 28.2 t -82.32 -68.42 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.539 ' CG ' HE21 ' A' ' 14' ' ' GLN . 2.7 t70 -43.63 -40.35 4.06 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.22 -50.11 62.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -56.08 -54.17 48.23 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -49.37 -57.21 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.539 HE21 ' CG ' ' A' ' 10' ' ' ASP . 2.8 mp0 -53.41 -42.71 67.28 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -77.26 -9.73 58.98 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.313 -0.867 . . . . 0.0 109.048 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -90.33 -9.04 49.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.6 p -76.61 -29.99 56.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.453 -0.779 . . . . 0.0 110.649 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 21' ' ' ARG . 4.0 m -92.51 -14.87 27.78 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.967 -1.083 . . . . 0.0 110.627 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.491 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 43.1 mt -49.36 -23.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 120.446 -1.409 . . . . 0.0 107.399 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.524 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 16.2 pt-20 -78.08 -38.14 44.89 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' SER . 7.2 mmt-85 -69.83 -32.94 71.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.5 mp -66.48 -68.63 0.36 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.951 0.881 . . . . 0.0 110.499 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.524 ' SG ' ' NE2' ' A' ' 24' ' ' GLN . 2.5 p -48.57 -62.25 1.6 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.738 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' N ' ' OE1' ' A' ' 24' ' ' GLN . 1.2 mp0 -43.28 -33.54 1.0 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.404 -0.81 . . . . 0.0 110.041 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.473 ' CD2' ' CE1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -95.79 -52.33 4.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.416 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.473 ' CE1' ' CD2' ' A' ' 25' ' ' HIS . 13.8 m-85 -92.94 -68.52 0.8 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 111.85 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.1 mm -82.07 -80.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.432 -1.418 . . . . 0.0 110.301 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.433 ' H ' ' CB ' ' A' ' 23' ' ' CYS . . . 130.5 -14.31 5.59 Favored Glycine 0 N--CA 1.501 2.997 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -90.12 115.81 27.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.189 -1.183 . . . . 0.0 109.168 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 31' ' ' PRO . 1.7 m -160.7 109.0 1.32 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 109.129 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.542 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 35.7 Cg_exo -38.31 -102.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.175 1.917 . . . . 0.0 113.493 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.542 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 51.8 m-85 -159.6 65.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.415 -1.428 . . . . 0.0 110.015 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.411 ' C ' ' O ' ' A' ' 32' ' ' PHE . 3.1 m-90 . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.644 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.556 ' C ' ' H ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -53.31 124.51 14.85 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.522 ' N ' ' OE1' ' A' ' 2' ' ' GLU . 1.4 tp -50.33 -9.62 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.432 -0.792 . . . . 0.0 109.144 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 2' ' ' GLU . 0.8 OUTLIER -94.14 124.75 38.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.617 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.2 t -91.5 -33.65 0.35 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.155 -0.966 . . . . 0.0 111.566 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 72.7 Cg_exo -50.74 82.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.89 1.726 . . . . 0.0 112.946 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 9' ' ' VAL . 15.7 tt0 -95.47 -54.08 3.52 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.47 ' N ' ' CD ' ' A' ' 8' ' ' GLN . 4.0 mp0 -56.4 -9.44 0.7 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 7' ' ' GLU . 37.4 t -82.05 -66.73 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -46.1 -43.88 15.12 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.51 -49.55 74.9 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 12' ' ' LEU . 0.5 OUTLIER -56.01 -56.17 24.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' THR . 9.1 mt -49.78 -60.7 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -48.62 -33.0 9.06 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -82.0 -49.56 10.11 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.354 -0.841 . . . . 0.0 109.878 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.69 -16.25 62.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.975 . . . . 0.0 109.665 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.528 ' O ' ' N ' ' A' ' 20' ' ' GLU . 1.1 p -66.53 -48.03 71.01 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -39.33 -57.6 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.692 0.758 . . . . 0.0 110.005 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.495 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 79.6 mt -45.18 -25.9 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.5 0.667 . . . . 0.0 109.337 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.528 ' N ' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -84.83 -34.16 22.76 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' SER . 34.7 mtm180 -73.33 -36.44 66.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.9 mp -51.9 -61.07 2.49 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.025 0.917 . . . . 0.0 109.713 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -63.45 -62.24 1.81 Allowed 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.383 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.514 ' NE2' ' OE1' ' A' ' 20' ' ' GLU . 73.9 mt-30 -48.48 -29.7 4.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.176 -0.953 . . . . 0.0 110.036 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.426 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 50.4 t60 -95.1 -62.24 1.34 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.05 -1.031 . . . . 0.0 110.367 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 22' ' ' LEU . 38.3 m-85 -75.64 -65.14 0.94 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.13 -0.981 . . . . 0.0 110.936 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.49 -81.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.101 -0.999 . . . . 0.0 111.58 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 126.95 32.96 0.66 Allowed Glycine 0 N--CA 1.505 3.238 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -116.33 78.19 1.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.55 -0.971 . . . . 0.0 109.176 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.4 m -150.51 69.21 8.7 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.143 -0.973 . . . . 0.0 109.766 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.19 60.04 7.64 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.634 2.222 . . . . 0.0 111.698 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.53 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 71.2 t80 -162.2 29.36 0.11 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.029 -1.044 . . . . 0.0 110.336 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.018 -0.991 . . . . 0.0 108.766 179.34 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.564 0.697 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' A' ' 4' ' ' ASP . 29.6 tt0 -48.71 167.8 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.419 -0.801 . . . . 0.0 109.358 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.2 tp -71.99 16.25 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.48 -0.762 . . . . 0.0 109.63 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 2' ' ' GLU . 37.2 p-10 -83.64 105.36 14.5 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.561 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 1.7 t -72.21 -39.12 6.19 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 120.954 -1.092 . . . . 0.0 110.009 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 11.9 Cg_exo -71.78 92.6 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 121.983 1.789 . . . . 0.0 111.521 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.545 ' C ' ' H ' ' A' ' 9' ' ' VAL . 65.5 tt0 -94.87 -55.4 3.12 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -52.8 -12.02 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.545 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -77.6 -70.04 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -44.81 -42.25 7.69 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -60.88 -52.51 64.76 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.104 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.65 -55.4 32.54 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.8 mt -52.21 -56.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -54.61 -38.67 67.07 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.395 0.617 . . . . 0.0 109.812 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 11' ' ' LYS . 17.9 mt-30 -65.05 -24.64 67.53 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.465 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.41 -15.84 1.91 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.293 -0.879 . . . . 0.0 109.125 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 p -55.51 -32.92 63.3 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -62.63 -70.25 0.21 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 18' ' ' SER . 72.8 mt -40.32 -33.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 122.063 0.935 . . . . 0.0 109.051 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.408 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 19.2 mt-10 -73.21 -54.14 9.19 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 18' ' ' SER . 31.6 mmt-85 -52.52 -39.13 60.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 24' ' ' GLN . 9.5 mp -63.52 -66.06 0.59 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.975 0.893 . . . . 0.0 109.299 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 6.9 p -46.06 -18.83 0.05 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.319 0.58 . . . . 0.0 109.937 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 22' ' ' LEU . 70.6 mt-30 -95.27 -27.18 15.62 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -96.07 -69.66 0.75 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.049 -1.032 . . . . 0.0 110.827 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -58.85 -58.92 6.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.459 -0.776 . . . . 0.0 111.66 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.425 ' H ' HD11 ' A' ' 27' ' ' ILE . 3.3 mp -94.12 -27.47 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.234 -0.916 . . . . 0.0 111.114 -177.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.31 -45.17 2.78 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.499 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 4.1 m95 -69.8 151.6 45.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -1.121 . . . . 0.0 109.127 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 82.4 m -156.04 108.41 2.1 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -36.78 -92.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.919 1.746 . . . . 0.0 113.093 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 65.4 t80 -174.26 69.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.518 -1.364 . . . . 0.0 109.76 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.36 179.274 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.577 ' ND2' ' N ' ' A' ' 2' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.577 ' N ' ' ND2' ' A' ' 1' ' ' ASN . 2.8 pt-20 -47.27 107.24 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.865 . . . . 0.0 109.696 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.7 tp -59.23 -4.45 0.54 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.07 -1.019 . . . . 0.0 108.4 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 2' ' ' GLU . 4.5 p-10 -108.35 118.59 37.18 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.0 t -78.66 -35.17 1.08 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.232 -0.918 . . . . 0.0 111.071 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 80.9 Cg_exo -47.67 110.54 0.32 Allowed 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.384 2.056 . . . . 0.0 113.088 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.519 ' C ' ' H ' ' A' ' 9' ' ' VAL . 8.7 pt-20 -95.54 -55.92 2.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.573 -0.704 . . . . 0.0 110.338 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.488 ' N ' ' CG ' ' A' ' 7' ' ' GLU . 1.0 OUTLIER -56.72 -9.83 0.87 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.414 -1.429 . . . . 0.0 107.596 179.269 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -82.22 -65.85 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -46.02 -43.29 14.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.472 -0.767 . . . . 0.0 109.123 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -62.17 -50.22 72.69 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -57.1 -56.15 25.46 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.8 mt -49.49 -57.04 2.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -48.81 -34.63 12.77 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -87.66 -11.12 49.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -75.33 -11.91 60.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.088 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.3 p -77.05 -9.47 58.74 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -94.36 -70.72 0.69 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.78 -0.575 . . . . 0.0 110.007 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.1 mt -38.79 -31.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.602 0.715 . . . . 0.0 109.921 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.48 ' CG ' ' N ' ' A' ' 21' ' ' ARG . 11.9 pt-20 -75.83 -46.4 30.69 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' SER . 1.5 mmm180 -58.91 -40.85 85.75 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.12 -60.6 3.26 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.964 0.888 . . . . 0.0 109.93 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.653 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 7.0 p -51.25 -52.32 45.86 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.428 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.653 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 79.4 mt-30 -62.02 -24.52 67.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.783 -1.198 . . . . 0.0 110.09 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -95.49 -49.02 5.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -0.944 . . . . 0.0 110.538 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -97.81 -76.84 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 111.672 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.6 mm -59.19 -80.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.834 -1.166 . . . . 0.0 110.323 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 135.53 -60.24 0.64 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.472 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 8.5 t90 -64.42 142.03 58.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.371 -1.076 . . . . 0.0 108.901 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.472 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 3.1 m -155.01 120.61 2.63 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.546 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 60.9 Cg_exo -37.66 -94.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.567 1.512 . . . . 0.0 113.039 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 86.2 m-85 -158.2 59.21 0.46 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.325 -1.485 . . . . 0.0 110.723 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 120.693 -1.254 . . . . 0.0 108.84 179.078 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.541 ' C ' ' H ' ' A' ' 4' ' ' ASP . 3.9 pt-20 -61.66 98.06 0.09 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.134 -0.979 . . . . 0.0 109.474 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -73.17 13.92 0.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.196 -0.94 . . . . 0.0 108.662 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 2' ' ' GLU . 38.5 p-10 -44.3 91.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.603 -0.686 . . . . 0.0 110.141 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.626 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.2 t -76.15 -35.23 1.58 Allowed Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.248 -0.908 . . . . 0.0 110.479 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 81.4 Cg_exo -49.97 108.0 0.19 Allowed 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.472 2.115 . . . . 0.0 113.113 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 9' ' ' VAL . 28.2 mm-40 -95.63 -59.48 1.86 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.747 -0.595 . . . . 0.0 109.449 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.463 ' CD ' ' N ' ' A' ' 8' ' ' GLN . 17.3 mp0 -54.23 -9.9 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.885 -1.134 . . . . 0.0 108.081 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.534 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -82.54 -67.36 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.84 -33.86 2.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.616 -0.677 . . . . 0.0 109.614 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 15' ' ' GLN . 14.8 tttt -73.76 -49.14 26.89 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -54.23 -53.44 53.59 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.344 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 mt -50.01 -58.32 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -56.95 -27.42 61.1 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.415 0.626 . . . . 0.0 109.714 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' LYS . 75.8 mt-30 -99.73 0.09 41.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.193 -0.942 . . . . 0.0 110.176 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -67.59 -9.81 46.24 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.29 -0.881 . . . . 0.0 110.189 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.0 p -70.6 -15.15 62.72 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -93.28 -58.4 2.32 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.506 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 77.5 mt -39.59 -26.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 121.866 0.841 . . . . 0.0 109.346 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 18' ' ' SER . 3.5 mm-40 -74.49 -50.26 18.91 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -55.74 -31.86 62.89 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -69.81 -69.45 0.35 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.463 -0.773 . . . . 0.0 110.724 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.5 p -54.58 -57.03 13.03 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.192 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -46.33 -33.11 3.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.082 -1.011 . . . . 0.0 109.779 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -95.62 -65.6 0.96 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.159 -0.963 . . . . 0.0 110.153 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 22' ' ' LEU . 50.2 m-85 -67.25 -72.02 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 110.912 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.14 -81.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.054 -1.029 . . . . 0.0 111.16 -178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 129.53 0.82 5.7 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -92.51 98.92 11.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.271 -1.135 . . . . 0.0 109.258 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.8 m -153.44 77.22 6.03 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 109.068 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' A' ' 33' ' ' TRP . 65.6 Cg_endo -87.98 -26.05 0.75 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.015 2.477 . . . . 0.0 112.572 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.424 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 86.9 t80 -55.86 -3.9 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.659 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.523 ' H ' ' C ' ' A' ' 31' ' ' PRO . 13.8 m-90 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.607 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.487 ' ND2' ' OE2' ' A' ' 7' ' ' GLU . 1.1 m120 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.339 0.59 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 4' ' ' ASP . 6.0 tt0 -154.34 -165.42 2.08 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.404 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 8.1 mt -75.98 16.84 0.38 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.103 -0.998 . . . . 0.0 108.751 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 2' ' ' GLU . 28.4 p-10 -114.4 109.7 18.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.624 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.1 t -71.62 -36.32 4.44 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 120.944 -1.098 . . . . 0.0 110.27 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 32.3 Cg_exo -60.06 100.16 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.21 1.94 . . . . 0.0 112.413 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' A' ' 9' ' ' VAL . 49.1 mt-10 -95.68 -63.4 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.501 -0.749 . . . . 0.0 109.357 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -54.71 -9.24 0.31 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.956 -1.09 . . . . 0.0 108.347 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.533 ' H ' ' C ' ' A' ' 7' ' ' GLU . 54.2 t -85.7 -70.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.426 ' OD1' ' OE1' ' A' ' 14' ' ' GLN . 4.7 t70 -45.85 -31.77 2.27 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.618 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -74.53 -48.63 25.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -57.66 -55.89 29.0 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.635 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.5 mt -49.32 -54.56 5.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.426 ' OE1' ' OD1' ' A' ' 10' ' ' ASP . 8.2 mt-30 -50.29 -42.64 52.72 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -77.14 -6.57 53.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -95.26 -43.41 8.07 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 110.192 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.424 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 10.5 p -34.5 -30.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.975 0.417 . . . . 0.0 111.521 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 m -89.32 -71.37 0.61 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.007 -1.058 . . . . 0.0 109.572 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.9 mt -47.58 -29.11 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.809 ' OE2' ' CG ' ' A' ' 33' ' ' TRP . 17.9 mm-40 -75.49 -53.16 9.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 17' ' ' THR . 13.4 mmm-85 -49.63 -32.17 12.42 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.38 -68.19 0.41 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.719 0.771 . . . . 0.0 110.351 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' GLY . 28.0 p -60.29 -16.14 31.65 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.652 -0.655 . . . . 0.0 109.584 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -93.13 -31.08 14.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.298 -0.876 . . . . 0.0 109.442 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -95.55 -56.85 2.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.298 -0.876 . . . . 0.0 110.527 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -63.52 -57.41 10.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 110.853 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.8 mp -100.51 -80.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.017 -1.052 . . . . 0.0 110.764 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 131.34 39.9 0.24 Allowed Glycine 0 N--CA 1.502 3.084 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.423 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 2.0 t90 -162.67 124.46 2.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.054 -1.262 . . . . 0.0 108.849 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.423 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.6 m -144.93 94.13 5.44 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.146 -0.971 . . . . 0.0 109.448 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 33' ' ' TRP . 94.3 Cg_endo -84.51 -27.8 1.27 Allowed 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.097 1.865 . . . . 0.0 112.437 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -62.54 -0.16 0.57 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.051 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.809 ' CG ' ' OE2' ' A' ' 20' ' ' GLU . 21.2 m-90 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.282 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 51.0 t30 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -78.35 87.41 4.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -0.901 . . . . 0.0 109.007 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.07 6.01 0.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.089 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.537 ' H ' ' C ' ' A' ' 2' ' ' GLU . 1.0 OUTLIER -86.12 102.95 14.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.292 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.619 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.2 t -74.48 -35.35 2.15 Favored Pre-proline 0 C--N 1.306 -1.321 0 O-C-N 121.23 -0.919 . . . . 0.0 110.801 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 74.3 Cg_exo -47.14 114.84 1.1 Allowed 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.234 1.956 . . . . 0.0 112.532 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 9' ' ' VAL . 39.4 tt0 -93.75 -67.63 0.85 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.669 -0.645 . . . . 0.0 110.441 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -50.14 -12.47 0.08 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.631 -1.293 . . . . 0.0 108.465 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.547 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -78.68 -64.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.535 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 6.0 t70 -43.93 -47.58 8.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 4.4 mptp? -59.49 -52.58 64.96 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -54.17 -50.97 65.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.567 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 16' ' ' ALA . 8.0 mt -56.79 -62.02 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 10' ' ' ASP . 2.4 mp0 -47.51 -20.08 0.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 109.024 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.443 ' N ' ' C ' ' A' ' 13' ' ' ILE . 46.7 mt-30 -102.08 -16.42 16.42 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.556 0.694 . . . . 0.0 109.347 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -52.98 -9.55 0.13 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.406 -0.809 . . . . 0.0 110.295 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 15' ' ' GLN . 14.3 p -78.89 -21.66 47.11 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.829 -1.17 . . . . 0.0 109.195 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -95.8 -71.88 0.65 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -0.832 . . . . 0.0 110.969 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 18' ' ' SER . 97.8 mt -42.92 -30.66 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.643 0.735 . . . . 0.0 110.073 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -73.85 -48.42 31.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 18' ' ' SER . 6.0 mmm180 -53.91 -35.27 61.46 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.6 mp -67.8 -67.51 0.45 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.718 0.771 . . . . 0.0 109.975 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 14.3 p -51.05 -58.58 5.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.295 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.639 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 78.8 mt-30 -47.88 -31.49 5.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.783 -1.198 . . . . 0.0 109.797 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -95.9 -59.09 1.93 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.259 -0.901 . . . . 0.0 111.304 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.52 ' N ' ' O ' ' A' ' 22' ' ' LEU . 22.9 m-85 -87.34 -80.32 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.986 -1.071 . . . . 0.0 112.245 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 mm -56.16 -65.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.805 -1.184 . . . . 0.0 110.412 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 107.28 -20.37 32.94 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -96.53 122.08 39.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.504 -0.998 . . . . 0.0 108.728 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.7 m -135.22 94.15 16.1 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -34.24 -98.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.444 2.096 . . . . 0.0 113.819 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.43 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 62.0 t80 -172.08 70.29 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.502 -1.374 . . . . 0.0 109.597 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.77 179.447 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.488 ' N ' ' OD1' ' A' ' 1' ' ' ASN . 2.0 p30 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.378 0.608 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.579 ' C ' ' H ' ' A' ' 4' ' ' ASP . 6.2 tp10 -67.08 131.44 45.83 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 tp -66.19 11.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.842 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.579 ' H ' ' C ' ' A' ' 2' ' ' GLU . 57.7 p30 -83.46 63.79 7.51 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.372 -0.83 . . . . 0.0 109.006 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 6' ' ' PRO . 21.5 t -43.34 -60.66 2.32 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.419 -0.801 . . . . 0.0 110.527 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 5' ' ' VAL . 16.6 Cg_exo -36.41 97.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 122.106 1.871 . . . . 0.0 112.215 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' C ' ' H ' ' A' ' 9' ' ' VAL . 1.4 tm-20 -95.97 -65.44 0.97 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.446 -0.784 . . . . 0.0 109.439 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.457 ' CD ' ' N ' ' A' ' 8' ' ' GLN . 2.9 mp0 -51.55 -13.04 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.786 -1.196 . . . . 0.0 108.232 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 7' ' ' GLU . 18.0 t -76.22 -65.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.544 ' CG ' HE21 ' A' ' 14' ' ' GLN . 3.1 t70 -43.4 -45.81 6.36 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -61.41 -51.26 69.49 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -56.51 -55.22 36.53 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 16' ' ' ALA . 10.3 mt -49.77 -55.53 4.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.544 HE21 ' CG ' ' A' ' 10' ' ' ASP . 2.8 mp0 -50.93 -41.18 58.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -75.1 -13.3 60.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -88.27 -25.92 22.58 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 14' ' ' GLN . 47.8 p -61.7 -31.76 71.93 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -69.05 -70.9 0.24 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.436 -0.79 . . . . 0.0 109.474 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 79.3 mt -46.41 -28.45 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -78.28 -54.24 6.43 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -51.27 -37.2 45.93 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 22' ' ' LEU . 3.7 mp -65.79 -69.93 0.27 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.877 0.846 . . . . 0.0 109.438 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' GLY . 9.0 p -52.64 -38.58 60.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.208 0.528 . . . . 0.0 109.638 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.505 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 37.3 mm-40 -67.15 -36.71 82.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.814 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -90.05 -38.85 13.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.201 -0.937 . . . . 0.0 110.076 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -75.95 -65.56 0.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.905 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.77 -68.64 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 119.68 -2.48 13.63 Favored Glycine 0 N--CA 1.501 3.029 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.451 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -131.97 123.39 27.25 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.539 -0.977 . . . . 0.0 108.496 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.451 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.3 m -147.59 69.63 11.33 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 108.943 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.67 8.96 3.12 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.385 2.056 . . . . 0.0 112.59 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -84.87 -1.21 56.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.035 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.049 179.852 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.4 m120 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.515 ' C ' ' H ' ' A' ' 4' ' ' ASP . 0.7 OUTLIER -70.53 124.44 24.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.955 . . . . 0.0 109.723 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 3.7 mm? -73.14 12.77 0.5 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 108.784 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 2' ' ' GLU . 38.0 p-10 -72.59 77.79 1.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.543 -0.723 . . . . 0.0 109.873 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.63 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.2 t -76.73 -33.15 1.11 Allowed Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.253 -0.904 . . . . 0.0 110.905 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 1.3 Cg_endo -93.41 110.55 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 122.953 2.436 . . . . 0.0 111.234 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.563 ' C ' ' H ' ' A' ' 9' ' ' VAL . 31.8 tt0 -85.02 -62.2 1.59 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.353 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -48.84 -14.08 0.06 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.706 -1.246 . . . . 0.0 108.249 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.563 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.2 t -77.92 -63.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.548 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 5.5 t70 -46.82 -47.6 21.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 108.833 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.42 -50.5 72.8 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.41 ' N ' HD21 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -57.7 -55.44 34.77 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.8 mt -51.33 -53.49 15.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.053 -1.03 . . . . 0.0 108.353 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.548 ' NE2' ' O ' ' A' ' 10' ' ' ASP . 2.3 mp0 -52.98 -37.74 61.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -72.39 -15.63 61.85 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -95.6 -13.37 24.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 14' ' ' GLN . 30.7 p -71.03 -31.64 68.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.116 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -65.75 -71.0 0.2 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.414 -0.804 . . . . 0.0 109.802 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 77.7 mt -46.79 -28.88 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.465 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 32.0 mt-10 -77.93 -49.29 14.45 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 25' ' ' HIS . 11.5 mmm180 -55.93 -34.32 65.52 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.69 -65.84 0.63 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.982 0.896 . . . . 0.0 109.815 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 28' ' ' GLY . 20.2 p -60.87 -18.4 55.96 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.87 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -95.2 -28.31 15.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 0.0 109.76 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 21' ' ' ARG . 46.9 t60 -95.24 -69.09 0.77 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.168 -0.958 . . . . 0.0 110.395 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -52.71 -54.76 29.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 110.784 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.9 mp -98.84 -80.84 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.154 -0.966 . . . . 0.0 110.798 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.47 42.57 0.24 Allowed Glycine 0 N--CA 1.501 2.988 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.442 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -170.29 130.37 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -1.195 . . . . 0.0 109.089 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.442 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.6 m -146.74 89.52 5.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.208 -0.932 . . . . 0.0 109.523 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 96.6 Cg_endo -84.83 51.73 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.196 1.93 . . . . 0.0 112.364 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 63.8 m-85 -158.52 28.11 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.974 -1.079 . . . . 0.0 109.74 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.465 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 2.9 m-90 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.017 -0.992 . . . . 0.0 108.767 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.552 0.692 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.62 ' C ' ' H ' ' A' ' 4' ' ' ASP . 26.8 tt0 -44.4 136.38 4.16 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.495 0.664 . . . . 0.0 109.946 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 5' ' ' VAL . 6.0 tp -67.42 19.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.51 0.672 . . . . 0.0 109.71 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 2' ' ' GLU . 25.0 p30 -67.01 58.08 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.375 -0.828 . . . . 0.0 109.2 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.502 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 71.2 t -41.24 -54.54 5.86 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.623 -0.673 . . . . 0.0 111.185 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 5' ' ' VAL . 88.0 Cg_exo -22.04 100.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.483 0.875 0 C-N-CA 123.547 2.832 . . . . 0.0 113.825 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 9' ' ' VAL . 28.5 tt0 -95.21 -53.12 3.9 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.526 ' CD ' ' H ' ' A' ' 8' ' ' GLN . 3.8 mp0 -56.78 -10.17 0.97 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.506 ' H ' ' C ' ' A' ' 7' ' ' GLU . 3.4 t -82.39 -64.88 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -46.27 -43.93 16.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -60.62 -50.2 74.47 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -58.48 -56.5 21.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 16' ' ' ALA . 10.1 mt -49.29 -52.28 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -51.2 -42.35 60.84 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -71.83 -13.91 61.81 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -86.42 -24.24 25.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.444 -0.785 . . . . 0.0 109.23 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -94.49 -12.55 27.45 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -95.54 -67.83 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 18' ' ' SER . 95.5 mt -38.11 -28.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.836 0.826 . . . . 0.0 109.876 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.531 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 15.7 pt-20 -82.55 -46.56 13.21 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' SER . 11.9 mtt85 -69.6 -30.18 67.88 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' A' ' 26' ' ' TYR . 4.3 mp -65.28 -68.74 0.34 Allowed 'General case' 0 C--O 1.204 -1.309 0 O-C-N 121.224 -0.923 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.58 ' O ' ' N ' ' A' ' 28' ' ' GLY . 3.2 p -41.56 -54.52 3.16 Favored 'General case' 0 N--CA 1.504 2.248 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.673 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.535 ' N ' ' OE1' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -45.99 -42.88 13.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 109.56 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -95.44 -54.86 3.24 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.119 -0.988 . . . . 0.0 109.682 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 22' ' ' LEU . 13.8 m-85 -61.68 -77.46 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.452 -0.78 . . . . 0.0 109.826 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.3 mp -99.15 -80.78 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.584 -0.697 . . . . 0.0 110.512 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 139.98 -7.89 2.97 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -88.17 115.25 25.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.319 -1.106 . . . . 0.0 109.494 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.6 m -160.3 108.55 1.38 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 108.923 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -40.12 -83.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.305 2.003 . . . . 0.0 113.642 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.49 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 53.3 t80 -176.23 71.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.798 -1.189 . . . . 0.0 110.093 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.091 -1.005 . . . . 0.0 109.553 178.85 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.493 ' C ' ' H ' ' A' ' 4' ' ' ASP . 51.0 mt-10 -68.81 117.06 10.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.45 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.0 tp -71.99 13.78 0.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.461 -0.774 . . . . 0.0 109.618 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 2' ' ' GLU . 12.9 p30 -72.02 78.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.377 -0.827 . . . . 0.0 109.555 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.543 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 18.6 t -102.95 -33.83 0.21 Allowed Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.318 -0.864 . . . . 0.0 113.168 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 35.6 Cg_exo -53.52 161.26 4.3 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.248 1.298 . . . . 0.0 114.53 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 9' ' ' VAL . 42.7 mm-40 -76.22 -59.99 2.53 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.417 -0.802 . . . . 0.0 109.532 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.699 ' NE2' ' H ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.65 -9.62 0.35 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.867 -1.133 . . . . 0.0 107.95 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.539 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -88.07 -67.44 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -49.62 -39.63 36.46 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.949 -1.094 . . . . 0.0 108.819 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 15' ' ' GLN . 37.2 mttp -63.46 -49.42 73.74 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.52 -54.37 41.97 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 mt -54.04 -56.51 9.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -56.74 -32.74 65.86 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.49 -0.756 . . . . 0.0 109.505 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 11' ' ' LYS . 49.3 mt-30 -69.32 -26.33 64.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.193 -0.942 . . . . 0.0 109.048 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.15 -13.09 0.74 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.298 -0.876 . . . . 0.0 109.131 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.413 ' N ' ' C ' ' A' ' 15' ' ' GLN . 8.6 p -51.56 -36.68 46.26 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -60.17 -69.27 0.23 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.447 -0.783 . . . . 0.0 109.105 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.3 mt -42.73 -29.6 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 121.883 0.849 . . . . 0.0 109.334 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.568 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 29.6 mt-10 -79.52 -48.88 13.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 18' ' ' SER . 16.6 mmt85 -60.61 -33.32 72.59 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.8 mp -63.99 -66.97 0.47 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 122.022 0.915 . . . . 0.0 109.699 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 28' ' ' GLY . 18.7 p -57.37 -16.69 9.72 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.767 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -95.48 -29.58 14.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.174 -0.954 . . . . 0.0 109.844 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -95.3 -68.53 0.8 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.208 -0.933 . . . . 0.0 110.635 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -52.49 -54.29 34.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.179 -0.951 . . . . 0.0 110.966 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.01 -80.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.078 -1.014 . . . . 0.0 111.192 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.95 37.91 0.37 Allowed Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -163.69 128.97 2.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -1.189 . . . . 0.0 109.246 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.6 m -144.12 105.19 4.79 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.14 -0.975 . . . . 0.0 109.022 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.52 ' C ' ' H ' ' A' ' 33' ' ' TRP . 89.6 Cg_endo -82.56 -29.22 1.49 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.836 1.69 . . . . 0.0 112.992 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.08 11.15 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 109.159 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.568 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 16.8 m-90 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.627 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.671 ' N ' HD21 ' A' ' 1' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.235 0.541 . . . . 0.0 109.543 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.477 ' H ' ' CG ' ' A' ' 1' ' ' ASN . 1.0 OUTLIER -50.05 90.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.612 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 1' ' ' ASN . 5.6 mt -65.03 -0.14 1.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.271 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 2' ' ' GLU . 0.9 OUTLIER -83.46 47.53 1.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 109.53 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 38.2 t -73.59 -34.88 2.34 Favored Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.329 -0.857 . . . . 0.0 110.622 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 89.1 Cg_exo -50.98 106.03 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.207 1.938 . . . . 0.0 112.845 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 9' ' ' VAL . 64.7 tt0 -95.46 -58.34 2.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.763 -0.586 . . . . 0.0 109.478 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -54.89 -9.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.537 ' H ' ' C ' ' A' ' 7' ' ' GLU . 3.9 t -84.74 -68.03 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -46.37 -33.81 4.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.595 -0.691 . . . . 0.0 109.569 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -73.03 -48.12 38.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -56.23 -55.13 36.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -49.16 -56.81 2.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -53.37 -42.76 67.19 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.46 -18.78 61.66 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.312 -0.868 . . . . 0.0 108.885 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -72.38 -9.36 58.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.321 -0.862 . . . . 0.0 109.078 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 20' ' ' GLU . 6.5 p -46.16 -65.54 0.54 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.785 . . . . 0.0 109.423 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -36.21 -66.59 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.618 0.723 . . . . 0.0 110.763 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -45.01 -27.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 109.914 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.518 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 0.3 OUTLIER -83.85 -35.78 23.93 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' SER . 10.7 mmt180 -72.21 -25.53 61.69 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.7 mp -64.21 -65.63 0.65 Allowed 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.636 0.731 . . . . 0.0 110.009 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 28' ' ' GLY . 5.0 p -47.09 -58.15 4.32 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -47.36 -34.56 7.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.968 . . . . 0.0 109.99 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -95.49 -70.4 0.71 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.044 . . . . 0.0 111.294 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 22' ' ' LEU . 52.5 m-85 -53.21 -67.68 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.74 -81.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.118 -0.989 . . . . 0.0 110.697 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 134.32 42.56 0.14 Allowed Glycine 0 N--CA 1.498 2.833 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -165.95 116.74 1.03 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -1.15 . . . . 0.0 109.201 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 m -130.24 90.04 43.02 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.76 41.09 0.99 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.974 1.783 . . . . 0.0 112.89 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.494 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 71.9 t80 -160.19 27.8 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.709 -1.245 . . . . 0.0 110.121 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.163 179.639 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.6 m120 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.292 0.568 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 4' ' ' ASP . 63.6 mm-40 -46.54 109.87 0.23 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.0 109.762 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.8 tp -50.54 -13.32 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 108.772 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 2' ' ' GLU . 3.5 p30 -100.44 56.73 0.91 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.51 -0.744 . . . . 0.0 109.333 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.624 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.0 t -73.55 -34.06 2.08 Favored Pre-proline 0 N--CA 1.486 1.333 0 O-C-N 121.084 -1.01 . . . . 0.0 110.837 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 48.8 Cg_exo -57.79 55.47 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.486 2.124 . . . . 0.0 113.455 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 9' ' ' VAL . 52.0 mt-10 -82.4 -66.26 0.91 Allowed 'General case' 0 C--N 1.286 -2.182 0 O-C-N 121.233 -0.917 . . . . 0.0 108.589 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -55.62 -9.73 0.57 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.856 -1.152 . . . . 0.0 108.041 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 7' ' ' GLU . 42.1 t -81.3 -67.04 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 14' ' ' GLN . 2.2 t0 -45.09 -44.17 10.2 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -62.64 -50.24 72.01 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.329 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.09 -54.99 36.13 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -50.26 -58.04 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -56.39 -36.6 69.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.557 -0.714 . . . . 0.0 109.812 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.525 ' C ' ' H ' ' A' ' 17' ' ' THR . 13.3 mt-30 -76.89 -49.9 14.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.947 -1.095 . . . . 0.0 109.42 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -53.02 -9.05 0.12 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 108.949 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.525 ' H ' ' C ' ' A' ' 15' ' ' GLN . 6.5 p -42.98 -23.88 0.05 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.072 0.939 . . . . 0.0 108.864 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.5 m -79.32 -70.81 0.48 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.9 mt -43.74 -37.57 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-O 122.027 0.918 . . . . 0.0 109.298 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.507 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 1.6 pt-20 -73.63 -45.51 52.4 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' NE ' ' OE1' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -58.0 -41.24 82.63 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mp -55.9 -59.25 5.15 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.154 0.978 . . . . 0.0 109.132 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 5.3 p -55.75 -32.6 63.54 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.19 -178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.542 ' OE1' ' NE ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -95.5 -25.42 16.22 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.763 -1.211 . . . . 0.0 110.968 -178.098 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 21' ' ' ARG . 3.6 t60 -87.82 -68.68 0.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.042 -1.036 . . . . 0.0 110.971 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -76.91 -47.92 19.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.149 -0.969 . . . . 0.0 111.408 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mm -76.34 -76.05 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.89 -1.131 . . . . 0.0 109.898 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.41 -36.95 2.36 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.508 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 4.1 t90 -90.84 151.36 21.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.4 -1.059 . . . . 0.0 109.4 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 60.1 m -156.99 150.47 19.0 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 56.2 Cg_endo -70.28 -89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 121.353 1.369 . . . . 0.0 111.949 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 31' ' ' PRO . 19.8 m-85 -155.4 47.12 0.51 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.844 -1.16 . . . . 0.0 111.164 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 O-C-N 120.563 -1.336 . . . . 0.0 108.718 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' A' ' 4' ' ' ASP . 1.2 pm0 -159.07 84.62 0.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.688 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' A' ' 3' ' ' LEU . 3.4 mm? -76.73 18.56 0.33 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 108.45 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 2' ' ' GLU . 20.8 p-10 -66.62 99.1 0.56 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.352 0.596 . . . . 0.0 110.331 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.603 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 53.1 t -80.29 -32.86 0.72 Allowed Pre-proline 0 N--CA 1.484 1.261 0 O-C-N 121.222 -0.924 . . . . 0.0 110.91 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 9.2 Cg_exo -40.27 119.68 0.74 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.307 2.005 . . . . 0.0 112.087 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.548 ' C ' ' H ' ' A' ' 9' ' ' VAL . 69.1 tt0 -85.33 -70.88 0.56 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.567 -0.708 . . . . 0.0 112.498 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.56 ' H ' ' NE2' ' A' ' 8' ' ' GLN . 4.1 mp0 -51.43 -12.28 0.15 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.425 -1.422 . . . . 0.0 108.329 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.548 ' H ' ' C ' ' A' ' 7' ' ' GLU . 2.3 t -81.35 -64.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.506 ' OD1' ' NE2' ' A' ' 14' ' ' GLN . 5.6 t70 -46.05 -45.63 16.21 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' NZ ' ' CG ' ' A' ' 7' ' ' GLU . 27.2 mttp -59.28 -51.96 67.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' N ' HD21 ' A' ' 12' ' ' LEU . 0.7 OUTLIER -54.34 -53.45 53.67 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.0 mt -54.42 -59.75 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.506 ' NE2' ' OD1' ' A' ' 10' ' ' ASP . 37.0 mt-30 -51.47 -38.09 52.1 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.329 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 17' ' ' THR . 42.9 mt-30 -64.19 -28.25 69.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -0.91 . . . . 0.0 108.683 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.33 -13.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.592 -0.693 . . . . 0.0 109.702 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' GLN . 5.9 p -52.17 -31.93 33.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 108.472 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -65.02 -70.63 0.22 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.051 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' SER . 94.6 mt -38.38 -30.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.864 0.84 . . . . 0.0 109.591 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' SER . 16.1 mt-10 -75.47 -53.01 9.37 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' SER . 5.3 mmt-85 -52.57 -43.74 65.46 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 25' ' ' HIS . 7.8 mp -59.9 -62.39 1.91 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.029 0.919 . . . . 0.0 109.443 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 1.7 p -44.13 -49.29 9.04 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.456 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.612 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 58.9 mt-30 -62.86 -24.19 67.67 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.887 -1.133 . . . . 0.0 108.71 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 22' ' ' LEU . 46.8 t-80 -96.13 -58.78 1.99 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.458 -0.776 . . . . 0.0 111.193 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.471 ' N ' ' O ' ' A' ' 22' ' ' LEU . 73.6 m-85 -88.93 -80.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 0.0 112.037 -177.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 29' ' ' TRP . 3.8 mm -48.62 -19.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.03 -1.044 . . . . 0.0 109.74 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 68.07 -55.44 0.41 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.471 ' N ' ' O ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -76.68 159.08 30.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -1.191 . . . . 0.0 108.856 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 31' ' ' PRO . 52.8 m -154.55 106.22 2.37 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 24.6 Cg_exo -37.08 -105.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.346 2.03 . . . . 0.0 113.58 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 68.5 m-85 -158.99 63.43 0.41 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.352 -1.468 . . . . 0.0 110.069 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.395 179.169 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.523 ' C ' ' N ' ' A' ' 9' ' ' VAL . 80.6 mt-10 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 120.633 0.254 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.547 ' O ' HD23 ' A' ' 12' ' ' LEU . 30.1 mt-30 -50.26 -12.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.638 -1.289 . . . . 0.0 108.542 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.523 ' N ' ' C ' ' A' ' 7' ' ' GLU . 3.2 t -79.14 -65.5 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -44.51 -45.58 9.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.634 -0.666 . . . . 0.0 109.325 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -62.29 -50.04 73.26 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -55.94 -55.1 36.77 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.618 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -50.22 -59.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -50.58 -27.86 7.59 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 108.981 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.78 -0.64 39.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.58 -0.7 . . . . 0.0 109.768 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -72.71 -10.71 60.11 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.367 -0.833 . . . . 0.0 110.132 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -50.11 -21.12 1.16 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -91.47 -68.31 0.8 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.492 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 95.1 mt -40.99 -28.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.731 0.777 . . . . 0.0 109.639 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 18' ' ' SER . 23.3 mt-10 -75.82 -47.72 24.53 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' SER . 5.4 mmt180 -60.2 -29.96 69.06 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -65.87 -67.89 0.41 Allowed 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.284 -0.885 . . . . 0.0 110.424 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.8 OUTLIER -54.83 -63.88 1.01 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.035 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.621 ' NE2' ' N ' ' A' ' 24' ' ' GLN . 0.7 OUTLIER -43.96 -32.52 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -0.877 . . . . 0.0 110.455 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -95.65 -70.16 0.72 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.91 -1.119 . . . . 0.0 110.924 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.479 ' HB2' HD12 ' A' ' 27' ' ' ILE . 48.1 m-85 -63.46 -69.77 0.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 111.101 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.496 ' H ' HD12 ' A' ' 27' ' ' ILE . 3.9 mp -92.26 -80.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.138 -0.976 . . . . 0.0 110.982 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 123.01 38.44 0.56 Allowed Glycine 0 N--CA 1.501 3.018 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.402 ' H ' ' HB2' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -137.16 91.4 2.62 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.441 -1.035 . . . . 0.0 109.107 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.1 m -139.43 69.7 39.35 Favored Pre-proline 0 N--CA 1.498 1.933 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 33' ' ' TRP . 79.8 Cg_endo -86.84 -21.69 2.07 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.099 2.533 . . . . 0.0 112.662 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -53.73 -7.27 0.11 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 0.0 109.038 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.508 ' H ' ' C ' ' A' ' 31' ' ' PRO . 8.4 m-90 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.552 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.523 ' C ' ' N ' ' A' ' 9' ' ' VAL . 2.3 pm0 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.056 -0.021 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.52 ' O ' HD23 ' A' ' 12' ' ' LEU . 4.2 mp0 -48.1 -16.64 0.1 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.611 -1.306 . . . . 0.0 108.264 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.523 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.2 t -73.08 -60.1 2.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -45.43 -45.28 12.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 0.0 109.127 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 15' ' ' GLN . 1.2 mptp? -61.64 -50.55 72.08 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -55.78 -55.5 31.6 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.651 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -48.55 -57.64 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -53.42 -36.72 61.83 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 11' ' ' LYS . 65.6 mt-30 -87.27 -3.49 59.04 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -78.33 -7.58 57.42 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.486 -0.759 . . . . 0.0 109.84 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 16' ' ' ALA . 3.3 p -37.97 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.9 0.857 . . . . 0.0 109.549 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 m -83.56 -70.38 0.57 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mt -42.81 -34.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.709 0.766 . . . . 0.0 109.299 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.506 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 2.3 pt-20 -75.94 -38.02 58.04 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' SER . 2.5 mmp_? -66.62 -33.91 76.71 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 24' ' ' GLN . 8.9 mp -62.67 -61.6 2.31 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.843 0.83 . . . . 0.0 110.212 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 14.4 p -43.43 -16.4 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.59 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' LEU . 73.2 mt-30 -91.57 -37.71 12.93 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.993 -1.067 . . . . 0.0 109.873 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -92.75 -70.16 0.71 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.161 -0.962 . . . . 0.0 110.258 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -44.56 -63.98 0.79 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.89 . . . . 0.0 110.356 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.13 -80.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.278 -0.889 . . . . 0.0 110.061 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 145.6 -54.55 0.55 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.514 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -73.01 165.01 25.85 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.335 -1.097 . . . . 0.0 108.571 179.532 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 70.7 m -155.63 118.6 2.37 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 108.383 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -39.48 -84.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.486 1.457 . . . . 0.0 112.908 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -172.65 66.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.414 -1.429 . . . . 0.0 110.164 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 120.528 -1.358 . . . . 0.0 108.845 178.661 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.477 ' C ' ' N ' ' A' ' 9' ' ' VAL . 64.3 mm-40 . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.552 ' O ' HD23 ' A' ' 12' ' ' LEU . 14.5 mm100 -57.85 -9.36 1.26 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.477 ' N ' ' C ' ' A' ' 7' ' ' GLU . 44.4 t -84.43 -68.79 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.59 -37.9 8.78 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -68.0 -48.02 66.9 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -56.91 -56.39 22.28 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.276 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.486 ' O ' HG23 ' A' ' 17' ' ' THR . 9.1 mt -47.4 -58.71 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.45 ' O ' ' OG1' ' A' ' 17' ' ' THR . 39.0 mt-30 -50.06 -31.86 14.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 17' ' ' THR . 14.8 mm-40 -87.43 -66.55 0.9 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.236 -0.915 . . . . 0.0 109.267 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -48.96 -9.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.793 . . . . 0.0 109.867 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 15' ' ' GLN . 0.8 OUTLIER -76.25 -45.25 33.66 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.833 -1.167 . . . . 0.0 108.213 179.285 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.624 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.8 m -51.93 -28.93 18.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.355 -0.84 . . . . 0.0 109.316 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 18' ' ' SER . 79.7 mt -45.92 -23.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 120.761 -1.212 . . . . 0.0 107.925 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.476 ' N ' ' C ' ' A' ' 18' ' ' SER . 42.1 mt-10 -77.1 -41.88 40.29 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.624 ' N ' ' O ' ' A' ' 18' ' ' SER . 2.2 mtm180 -66.46 -33.32 75.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -70.45 -69.72 0.34 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.358 -0.838 . . . . 0.0 110.439 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' A' ' 28' ' ' GLY . 21.7 p -46.76 -61.46 1.83 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.738 -0.601 . . . . 0.0 110.118 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.491 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 75.8 mt-30 -47.9 -29.94 3.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 109.776 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -95.48 -67.92 0.83 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.238 -0.914 . . . . 0.0 110.554 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.516 ' HB2' HD12 ' A' ' 27' ' ' ILE . 61.0 m-85 -68.42 -65.97 0.63 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 111.213 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.516 HD12 ' HB2' ' A' ' 26' ' ' TYR . 4.2 mp -98.9 -81.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.147 -0.97 . . . . 0.0 111.511 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 137.59 -5.13 3.43 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -86.14 118.51 25.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.203 -1.175 . . . . 0.0 109.613 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 m -160.21 101.36 1.4 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.477 -0.764 . . . . 0.0 108.957 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -41.81 -86.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.647 2.231 . . . . 0.0 113.864 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.407 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 53.2 t80 -178.5 74.21 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.854 -1.154 . . . . 0.0 109.327 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.403 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.481 ' C ' ' N ' ' A' ' 9' ' ' VAL . 33.9 tt0 . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.51 ' O ' HD23 ' A' ' 12' ' ' LEU . 6.6 pt20 -49.3 -19.67 0.53 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.674 -1.266 . . . . 0.0 108.004 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.481 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.7 t -71.76 -63.95 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 14' ' ' GLN . 23.2 t70 -46.52 -48.25 19.36 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -55.21 -50.82 68.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -59.54 -56.62 19.69 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 8.2 mt -51.84 -56.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 10' ' ' ASP . 32.4 mm-40 -48.93 -41.34 33.52 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.605 0.717 . . . . 0.0 109.187 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -67.26 -11.14 56.71 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 13' ' ' ILE . . . -76.48 -9.85 58.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.49 -0.756 . . . . 0.0 108.994 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 p -52.99 -32.38 46.02 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -64.89 -70.05 0.25 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' SER . 96.8 mt -43.46 -29.1 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.841 0.829 . . . . 0.0 109.149 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.572 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 34.9 mt-10 -75.79 -46.31 31.37 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -61.77 -38.23 87.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.85 -64.9 0.79 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.069 0.938 . . . . 0.0 109.051 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.4 ' O ' ' N ' ' A' ' 28' ' ' GLY . 13.7 p -55.51 -23.65 27.4 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.054 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -95.41 -29.54 14.37 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.981 -1.074 . . . . 0.0 110.588 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 21' ' ' ARG . 23.8 t60 -91.66 -70.38 0.69 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.008 -1.058 . . . . 0.0 111.246 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -66.46 -45.92 78.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.128 -0.982 . . . . 0.0 110.783 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.5 mm -85.75 -72.0 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.017 -1.052 . . . . 0.0 109.79 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 103.58 42.94 1.91 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.45 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -170.04 120.2 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.221 -1.164 . . . . 0.0 108.941 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.45 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.8 m -147.7 72.58 11.56 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 120.982 -1.074 . . . . 0.0 109.889 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -83.36 29.91 0.54 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.666 2.244 . . . . 0.0 112.338 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -127.79 17.17 6.85 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.402 -0.811 . . . . 0.0 109.041 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.572 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 2.9 m-90 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.976 -1.012 . . . . 0.0 108.747 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.781 ' OE2' ' NE2' ' A' ' 8' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 119.97 -0.062 . . . . 0.0 111.135 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.781 ' NE2' ' OE2' ' A' ' 7' ' ' GLU . 16.7 mp0 -57.35 -9.97 1.2 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 119.88 -1.763 . . . . 0.0 107.455 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.498 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -84.25 -65.93 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 9' ' ' VAL . 27.8 t70 -46.34 -43.67 16.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.633 -0.667 . . . . 0.0 109.21 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -62.51 -49.26 76.07 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.43 -57.06 14.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 17' ' ' THR . 9.7 mt -48.98 -61.26 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.417 ' O ' ' OG1' ' A' ' 17' ' ' THR . 51.9 mt-30 -46.71 -38.26 9.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -79.15 -25.88 42.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.584 -0.698 . . . . 0.0 109.264 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -95.62 -9.65 31.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.323 -0.86 . . . . 0.0 110.227 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 13' ' ' ILE . 1.6 p -48.11 -40.77 24.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.088 -1.007 . . . . 0.0 108.874 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.444 ' C ' HD13 ' A' ' 22' ' ' LEU . 1.7 m -65.52 -67.72 0.42 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.619 -0.676 . . . . 0.0 109.27 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.497 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 98.0 mt -41.35 -28.43 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.891 0.853 . . . . 0.0 109.516 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.574 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 27.3 mt-10 -78.08 -57.99 3.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -51.85 -27.09 11.49 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.4 mp -70.11 -67.44 0.49 Allowed 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.341 -0.849 . . . . 0.0 110.983 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.554 ' CA ' ' H ' ' A' ' 28' ' ' GLY . 1.6 p -64.04 -57.14 10.54 Favored 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.564 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.489 ' OE1' ' SG ' ' A' ' 23' ' ' CYS . 7.5 mp0 -46.4 -33.62 4.03 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.872 -1.143 . . . . 0.0 109.348 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -95.53 -61.58 1.44 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -0.923 . . . . 0.0 110.279 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' LEU . 6.2 m-85 -81.66 -73.89 0.36 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 111.558 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.549 HD13 ' N ' ' A' ' 27' ' ' ILE . 1.9 mm -76.56 -79.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.535 -1.353 . . . . 0.0 110.616 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.554 ' H ' ' CA ' ' A' ' 23' ' ' CYS . . . 122.26 -9.23 9.54 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.479 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 75.2 t90 -84.86 100.16 11.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.628 -0.925 . . . . 0.0 109.459 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.479 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 10.3 m -160.17 73.3 3.03 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 109.059 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 33' ' ' TRP . 94.7 Cg_endo -85.38 -22.73 2.53 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 123.115 2.544 . . . . 0.0 112.892 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -56.61 -3.2 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.055 -1.028 . . . . 0.0 109.239 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.574 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 8.4 m-90 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.655 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 9' ' ' VAL . 4.4 mp0 . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.58 ' O ' HD23 ' A' ' 12' ' ' LEU . 19.9 mp0 -49.77 -12.93 0.08 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.677 -1.264 . . . . 0.0 108.315 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 7' ' ' GLU . 2.3 t -82.22 -67.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' HG12 ' A' ' 9' ' ' VAL . 26.3 t0 -46.92 -40.43 14.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 108.876 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' GLN . 38.7 mttt -63.94 -50.68 67.7 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -53.46 -54.74 32.69 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.097 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.0 mt -51.2 -58.95 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 17' ' ' THR . 19.2 mt-30 -55.78 -35.52 66.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.627 -0.671 . . . . 0.0 109.804 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 11' ' ' LYS . 45.1 mt-30 -76.0 -23.72 55.25 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 108.926 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -50.04 -12.93 0.09 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 109.42 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 15' ' ' GLN . 32.3 p -52.65 -32.87 44.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 108.44 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.492 ' C ' HD13 ' A' ' 22' ' ' LEU . 1.6 m -63.02 -70.1 0.23 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.482 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 84.1 mt -42.91 -27.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 121.943 0.878 . . . . 0.0 109.313 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.532 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 36.1 mt-10 -81.28 -47.91 12.71 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 18' ' ' SER . 13.1 mmm-85 -63.68 -28.81 70.15 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.9 mp -61.77 -66.21 0.57 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.867 0.841 . . . . 0.0 109.919 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.535 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.8 OUTLIER -58.04 -60.97 2.91 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.841 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -45.28 -33.49 2.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.267 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -95.32 -65.58 0.97 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.073 -1.017 . . . . 0.0 110.58 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' A' ' 22' ' ' LEU . 45.5 m-85 -68.14 -68.18 0.41 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.157 -0.965 . . . . 0.0 110.843 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.488 HD12 ' HB2' ' A' ' 26' ' ' TYR . 4.1 mp -97.22 -80.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.198 -0.939 . . . . 0.0 111.269 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 131.93 6.8 3.12 Favored Glycine 0 N--CA 1.502 3.089 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -98.12 99.46 10.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.271 -1.135 . . . . 0.0 109.804 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.4 m -155.11 69.48 5.57 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.934 . . . . 0.0 108.898 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 33' ' ' TRP . 70.5 Cg_endo -86.54 -19.57 2.83 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.016 2.477 . . . . 0.0 112.651 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -60.02 1.01 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 109.663 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.532 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 7.1 m-90 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.504 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 9' ' ' VAL . 31.1 mp0 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.552 ' O ' HD23 ' A' ' 12' ' ' LEU . 16.2 mp0 -50.98 -10.11 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.835 -1.166 . . . . 0.0 108.669 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 7' ' ' GLU . 28.2 t -82.32 -68.42 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -43.63 -40.35 4.06 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.22 -50.11 62.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -56.08 -54.17 48.23 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.615 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -49.37 -57.21 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.41 -42.71 67.28 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -77.26 -9.73 58.98 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.313 -0.867 . . . . 0.0 109.048 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -90.33 -9.04 49.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.6 p -76.61 -29.99 56.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.453 -0.779 . . . . 0.0 110.649 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 21' ' ' ARG . 4.0 m -92.51 -14.87 27.78 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.967 -1.083 . . . . 0.0 110.627 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.491 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 43.1 mt -49.36 -23.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 120.446 -1.409 . . . . 0.0 107.399 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.524 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 16.2 pt-20 -78.08 -38.14 44.89 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' SER . 7.2 mmt-85 -69.83 -32.94 71.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.5 mp -66.48 -68.63 0.36 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.951 0.881 . . . . 0.0 110.499 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.524 ' SG ' ' NE2' ' A' ' 24' ' ' GLN . 2.5 p -48.57 -62.25 1.6 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.738 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.529 ' N ' ' OE1' ' A' ' 24' ' ' GLN . 1.2 mp0 -43.28 -33.54 1.0 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.404 -0.81 . . . . 0.0 110.041 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.473 ' CD2' ' CE1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -95.79 -52.33 4.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.416 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.473 ' CE1' ' CD2' ' A' ' 25' ' ' HIS . 13.8 m-85 -92.94 -68.52 0.8 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 111.85 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.535 HD13 ' N ' ' A' ' 27' ' ' ILE . 2.1 mm -82.07 -80.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.432 -1.418 . . . . 0.0 110.301 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.503 ' H ' ' CB ' ' A' ' 23' ' ' CYS . . . 130.5 -14.31 5.59 Favored Glycine 0 N--CA 1.501 2.997 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -90.12 115.81 27.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.189 -1.183 . . . . 0.0 109.168 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 31' ' ' PRO . 1.7 m -160.7 109.0 1.32 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 109.129 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.542 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 35.7 Cg_exo -38.31 -102.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.175 1.917 . . . . 0.0 113.493 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.542 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 51.8 m-85 -159.6 65.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.415 -1.428 . . . . 0.0 110.015 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.411 ' C ' ' O ' ' A' ' 32' ' ' PHE . 3.1 m-90 . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.644 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.471 ' C ' ' N ' ' A' ' 9' ' ' VAL . 15.7 tt0 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.556 ' O ' HD23 ' A' ' 12' ' ' LEU . 4.0 mp0 -56.4 -9.44 0.7 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.471 ' N ' ' C ' ' A' ' 7' ' ' GLU . 37.4 t -82.05 -66.73 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -46.1 -43.88 15.12 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.51 -49.55 74.9 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -56.01 -56.17 24.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.57 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' THR . 9.1 mt -49.78 -60.7 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -48.62 -33.0 9.06 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -82.0 -49.56 10.11 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.354 -0.841 . . . . 0.0 109.878 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.69 -16.25 62.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.975 . . . . 0.0 109.665 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 20' ' ' GLU . 1.1 p -66.53 -48.03 71.01 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -39.33 -57.6 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.692 0.758 . . . . 0.0 110.005 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.495 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 79.6 mt -45.18 -25.9 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.5 0.667 . . . . 0.0 109.337 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.514 ' OE1' ' NE2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -84.83 -34.16 22.76 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' SER . 34.7 mtm180 -73.33 -36.44 66.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.9 mp -51.9 -61.07 2.49 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.025 0.917 . . . . 0.0 109.713 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -63.45 -62.24 1.81 Allowed 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.383 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.514 ' NE2' ' OE1' ' A' ' 20' ' ' GLU . 73.9 mt-30 -48.48 -29.7 4.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.176 -0.953 . . . . 0.0 110.036 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.426 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 50.4 t60 -95.1 -62.24 1.34 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.05 -1.031 . . . . 0.0 110.367 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' HB2' HD12 ' A' ' 27' ' ' ILE . 38.3 m-85 -75.64 -65.14 0.94 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.13 -0.981 . . . . 0.0 110.936 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 26' ' ' TYR . 3.9 mp -99.49 -81.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.101 -0.999 . . . . 0.0 111.58 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 126.95 32.96 0.66 Allowed Glycine 0 N--CA 1.505 3.238 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -116.33 78.19 1.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.55 -0.971 . . . . 0.0 109.176 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.4 m -150.51 69.21 8.7 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.143 -0.973 . . . . 0.0 109.766 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.19 60.04 7.64 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.634 2.222 . . . . 0.0 111.698 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 32' ' ' PHE . 71.2 t80 -162.2 29.36 0.11 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.029 -1.044 . . . . 0.0 110.336 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.018 -0.991 . . . . 0.0 108.766 179.34 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.527 ' C ' ' N ' ' A' ' 9' ' ' VAL . 65.5 tt0 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.531 ' O ' HD23 ' A' ' 12' ' ' LEU . 79.2 mt-30 -52.8 -12.02 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.527 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -77.6 -70.04 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.513 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -44.81 -42.25 7.69 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.013 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -60.88 -52.51 64.76 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.104 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -55.65 -55.4 32.54 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.8 mt -52.21 -56.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -54.61 -38.67 67.07 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.395 0.617 . . . . 0.0 109.812 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 11' ' ' LYS . 17.9 mt-30 -65.05 -24.64 67.53 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.465 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.41 -15.84 1.91 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.293 -0.879 . . . . 0.0 109.125 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 p -55.51 -32.92 63.3 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -62.63 -70.25 0.21 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 18' ' ' SER . 72.8 mt -40.32 -33.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 122.063 0.935 . . . . 0.0 109.051 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.408 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 19.2 mt-10 -73.21 -54.14 9.19 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 18' ' ' SER . 31.6 mmt-85 -52.52 -39.13 60.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 24' ' ' GLN . 9.5 mp -63.52 -66.06 0.59 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.975 0.893 . . . . 0.0 109.299 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 6.9 p -46.06 -18.83 0.05 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.319 0.58 . . . . 0.0 109.937 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 22' ' ' LEU . 70.6 mt-30 -95.27 -27.18 15.62 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -96.07 -69.66 0.75 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.049 -1.032 . . . . 0.0 110.827 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -58.85 -58.92 6.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.459 -0.776 . . . . 0.0 111.66 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.449 ' H ' HD12 ' A' ' 27' ' ' ILE . 3.3 mp -94.12 -27.47 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.234 -0.916 . . . . 0.0 111.114 -177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.31 -45.17 2.78 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.499 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 4.1 m95 -69.8 151.6 45.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -1.121 . . . . 0.0 109.127 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 82.4 m -156.04 108.41 2.1 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -36.78 -92.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.919 1.746 . . . . 0.0 113.093 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 65.4 t80 -174.26 69.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.518 -1.364 . . . . 0.0 109.76 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.36 179.274 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.491 ' C ' ' N ' ' A' ' 9' ' ' VAL . 8.7 pt-20 . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.551 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -56.72 -9.83 0.87 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.414 -1.429 . . . . 0.0 107.596 179.269 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.491 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -82.22 -65.85 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.417 ' N ' HG12 ' A' ' 9' ' ' VAL . 9.1 t70 -46.02 -43.29 14.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.472 -0.767 . . . . 0.0 109.123 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -62.17 -50.22 72.69 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.1 -56.15 25.46 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.634 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.8 mt -49.49 -57.04 2.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -48.81 -34.63 12.77 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -87.66 -11.12 49.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -75.33 -11.91 60.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.088 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.3 p -77.05 -9.47 58.74 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -94.36 -70.72 0.69 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.78 -0.575 . . . . 0.0 110.007 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.1 mt -38.79 -31.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.602 0.715 . . . . 0.0 109.921 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.48 ' CG ' ' N ' ' A' ' 21' ' ' ARG . 11.9 pt-20 -75.83 -46.4 30.69 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' SER . 1.5 mmm180 -58.91 -40.85 85.75 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.12 -60.6 3.26 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.964 0.888 . . . . 0.0 109.93 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.653 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 7.0 p -51.25 -52.32 45.86 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.428 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.653 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 79.4 mt-30 -62.02 -24.52 67.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.783 -1.198 . . . . 0.0 110.09 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -95.49 -49.02 5.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -0.944 . . . . 0.0 110.538 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -97.81 -76.84 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 111.672 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 27' ' ' ILE . 3.6 mm -59.19 -80.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.834 -1.166 . . . . 0.0 110.323 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 135.53 -60.24 0.64 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.472 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 8.5 t90 -64.42 142.03 58.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.371 -1.076 . . . . 0.0 108.901 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.472 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 3.1 m -155.01 120.61 2.63 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.546 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 60.9 Cg_exo -37.66 -94.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.567 1.512 . . . . 0.0 113.039 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 86.2 m-85 -158.2 59.21 0.46 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.325 -1.485 . . . . 0.0 110.723 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.436 ' HE1' ' HB1' ' A' ' 16' ' ' ALA . 1.1 m-90 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 120.693 -1.254 . . . . 0.0 108.84 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.509 ' C ' ' N ' ' A' ' 9' ' ' VAL . 28.2 mm-40 . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.574 ' O ' HD23 ' A' ' 12' ' ' LEU . 17.3 mp0 -54.23 -9.9 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.885 -1.134 . . . . 0.0 108.081 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.509 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -82.54 -67.36 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.42 ' N ' HG12 ' A' ' 9' ' ' VAL . 1.5 t70 -44.84 -33.86 2.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.616 -0.677 . . . . 0.0 109.614 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 15' ' ' GLN . 14.8 tttt -73.76 -49.14 26.89 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -54.23 -53.44 53.59 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.344 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 mt -50.01 -58.32 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -56.95 -27.42 61.1 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.415 0.626 . . . . 0.0 109.714 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' LYS . 75.8 mt-30 -99.73 0.09 41.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.193 -0.942 . . . . 0.0 110.176 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -67.59 -9.81 46.24 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.29 -0.881 . . . . 0.0 110.189 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.0 p -70.6 -15.15 62.72 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -93.28 -58.4 2.32 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.506 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 77.5 mt -39.59 -26.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 121.866 0.841 . . . . 0.0 109.346 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 18' ' ' SER . 3.5 mm-40 -74.49 -50.26 18.91 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -55.74 -31.86 62.89 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.367 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -69.81 -69.45 0.35 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.463 -0.773 . . . . 0.0 110.724 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.5 p -54.58 -57.03 13.03 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.192 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -46.33 -33.11 3.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.082 -1.011 . . . . 0.0 109.779 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -95.62 -65.6 0.96 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.159 -0.963 . . . . 0.0 110.153 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 22' ' ' LEU . 50.2 m-85 -67.25 -72.02 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 110.912 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.432 ' H ' HD12 ' A' ' 27' ' ' ILE . 4.1 mp -93.14 -81.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.054 -1.029 . . . . 0.0 111.16 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 129.53 0.82 5.7 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -92.51 98.92 11.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.271 -1.135 . . . . 0.0 109.258 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.8 m -153.44 77.22 6.03 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 109.068 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 33' ' ' TRP . 65.6 Cg_endo -87.98 -26.05 0.75 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.015 2.477 . . . . 0.0 112.572 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.424 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 86.9 t80 -55.86 -3.9 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.659 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.505 ' H ' ' C ' ' A' ' 31' ' ' PRO . 13.8 m-90 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.607 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.489 ' C ' ' H ' ' A' ' 9' ' ' VAL . 49.1 mt-10 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.56 ' O ' HD23 ' A' ' 12' ' ' LEU . 68.4 mt-30 -54.71 -9.24 0.31 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.956 -1.09 . . . . 0.0 108.347 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 7' ' ' GLU . 54.2 t -85.7 -70.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.58 ' OD1' ' NE2' ' A' ' 14' ' ' GLN . 4.7 t70 -45.85 -31.77 2.27 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.618 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -74.53 -48.63 25.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.66 -55.89 29.0 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.635 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.5 mt -49.32 -54.56 5.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.58 ' NE2' ' OD1' ' A' ' 10' ' ' ASP . 38.1 mt-30 -50.29 -42.64 52.72 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -77.14 -6.57 53.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -95.26 -43.41 8.07 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 110.192 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.424 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 10.5 p -34.5 -30.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.975 0.417 . . . . 0.0 111.521 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 m -89.32 -71.37 0.61 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.007 -1.058 . . . . 0.0 109.572 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.9 mt -47.58 -29.11 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.809 ' OE2' ' CG ' ' A' ' 33' ' ' TRP . 17.9 mm-40 -75.49 -53.16 9.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 17' ' ' THR . 13.4 mmm-85 -49.63 -32.17 12.42 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 18' ' ' SER . 8.7 mp -68.38 -68.19 0.41 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.719 0.771 . . . . 0.0 110.351 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' GLY . 28.0 p -60.29 -16.14 31.65 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.652 -0.655 . . . . 0.0 109.584 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -93.13 -31.08 14.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.298 -0.876 . . . . 0.0 109.442 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -95.55 -56.85 2.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.298 -0.876 . . . . 0.0 110.527 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -63.52 -57.41 10.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 110.853 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.8 mp -100.51 -80.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.017 -1.052 . . . . 0.0 110.764 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 131.34 39.9 0.24 Allowed Glycine 0 N--CA 1.502 3.084 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.423 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 2.0 t90 -162.67 124.46 2.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.054 -1.262 . . . . 0.0 108.849 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.423 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.6 m -144.93 94.13 5.44 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.146 -0.971 . . . . 0.0 109.448 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 33' ' ' TRP . 94.3 Cg_endo -84.51 -27.8 1.27 Allowed 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.097 1.865 . . . . 0.0 112.437 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -62.54 -0.16 0.57 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.051 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.809 ' CG ' ' OE2' ' A' ' 20' ' ' GLU . 21.2 m-90 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.282 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.526 ' C ' ' N ' ' A' ' 9' ' ' VAL . 39.4 tt0 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.545 ' O ' HD23 ' A' ' 12' ' ' LEU . 36.0 mm-40 -50.14 -12.47 0.08 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.631 -1.293 . . . . 0.0 108.465 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.526 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -78.68 -64.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.4 ' N ' HG12 ' A' ' 9' ' ' VAL . 6.0 t70 -43.93 -47.58 8.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 4.4 mptp? -59.49 -52.58 64.96 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -54.17 -50.97 65.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.567 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 16' ' ' ALA . 8.0 mt -56.79 -62.02 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -47.51 -20.08 0.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 109.024 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.443 ' N ' ' C ' ' A' ' 13' ' ' ILE . 46.7 mt-30 -102.08 -16.42 16.42 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.556 0.694 . . . . 0.0 109.347 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -52.98 -9.55 0.13 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.406 -0.809 . . . . 0.0 110.295 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.402 ' N ' ' C ' ' A' ' 15' ' ' GLN . 14.3 p -78.89 -21.66 47.11 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.829 -1.17 . . . . 0.0 109.195 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -95.8 -71.88 0.65 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -0.832 . . . . 0.0 110.969 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 18' ' ' SER . 97.8 mt -42.92 -30.66 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.643 0.735 . . . . 0.0 110.073 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -73.85 -48.42 31.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 18' ' ' SER . 6.0 mmm180 -53.91 -35.27 61.46 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.6 mp -67.8 -67.51 0.45 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.718 0.771 . . . . 0.0 109.975 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 14.3 p -51.05 -58.58 5.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.295 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.639 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 78.8 mt-30 -47.88 -31.49 5.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.783 -1.198 . . . . 0.0 109.797 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -95.9 -59.09 1.93 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.259 -0.901 . . . . 0.0 111.304 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.481 ' N ' ' O ' ' A' ' 22' ' ' LEU . 22.9 m-85 -87.34 -80.32 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.986 -1.071 . . . . 0.0 112.245 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.532 ' N ' HD13 ' A' ' 27' ' ' ILE . 2.3 mm -56.16 -65.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.805 -1.184 . . . . 0.0 110.412 -177.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 107.28 -20.37 32.94 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -96.53 122.08 39.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.504 -0.998 . . . . 0.0 108.728 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.7 m -135.22 94.15 16.1 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -34.24 -98.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.444 2.096 . . . . 0.0 113.819 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.43 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 62.0 t80 -172.08 70.29 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.502 -1.374 . . . . 0.0 109.597 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.77 179.447 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.499 ' C ' ' N ' ' A' ' 9' ' ' VAL . 1.4 tm-20 . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.508 ' O ' HD23 ' A' ' 12' ' ' LEU . 3.2 mp0 -51.55 -13.04 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.786 -1.196 . . . . 0.0 108.232 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.499 ' N ' ' C ' ' A' ' 7' ' ' GLU . 18.0 t -76.22 -65.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -43.4 -45.81 6.36 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -61.41 -51.26 69.49 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -56.51 -55.22 36.53 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.527 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 16' ' ' ALA . 10.3 mt -49.77 -55.53 4.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.401 ' O ' ' OG1' ' A' ' 17' ' ' THR . 1.5 mp0 -50.93 -41.18 58.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -75.1 -13.3 60.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -88.27 -25.92 22.58 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 14' ' ' GLN . 47.8 p -61.7 -31.76 71.93 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -69.05 -70.9 0.24 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.436 -0.79 . . . . 0.0 109.474 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 79.3 mt -46.41 -28.45 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -78.28 -54.24 6.43 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -51.27 -37.2 45.93 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mp -65.79 -69.93 0.27 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.877 0.846 . . . . 0.0 109.438 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' GLY . 9.0 p -52.64 -38.58 60.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.208 0.528 . . . . 0.0 109.638 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.505 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 37.3 mm-40 -67.15 -36.71 82.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.814 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -90.05 -38.85 13.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.201 -0.937 . . . . 0.0 110.076 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -75.95 -65.56 0.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.905 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.77 -68.64 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 119.68 -2.48 13.63 Favored Glycine 0 N--CA 1.501 3.029 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.451 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -131.97 123.39 27.25 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.539 -0.977 . . . . 0.0 108.496 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.451 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.3 m -147.59 69.63 11.33 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 108.943 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.67 8.96 3.12 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.385 2.056 . . . . 0.0 112.59 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -84.87 -1.21 56.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.035 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.049 179.852 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.541 ' C ' ' N ' ' A' ' 9' ' ' VAL . 31.8 tt0 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.538 ' O ' HD23 ' A' ' 12' ' ' LEU . 24.4 mm100 -48.84 -14.08 0.06 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.706 -1.246 . . . . 0.0 108.249 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.541 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.2 t -77.92 -63.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.41 ' N ' HG12 ' A' ' 9' ' ' VAL . 5.5 t70 -46.82 -47.6 21.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 108.833 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -57.42 -50.5 72.8 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.653 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.7 -55.44 34.77 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.877 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.8 mt -51.33 -53.49 15.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.053 -1.03 . . . . 0.0 108.353 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.445 ' O ' ' OG1' ' A' ' 17' ' ' THR . 1.8 mp0 -52.98 -37.74 61.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -72.39 -15.63 61.85 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -95.6 -13.37 24.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 14' ' ' GLN . 30.7 p -71.03 -31.64 68.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.116 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.452 ' O ' HD13 ' A' ' 22' ' ' LEU . 1.7 m -65.75 -71.0 0.2 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.414 -0.804 . . . . 0.0 109.802 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 77.7 mt -46.79 -28.88 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.465 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 32.0 mt-10 -77.93 -49.29 14.45 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 25' ' ' HIS . 11.5 mmm180 -55.93 -34.32 65.52 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 18' ' ' SER . 8.4 mp -62.69 -65.84 0.63 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.982 0.896 . . . . 0.0 109.815 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 28' ' ' GLY . 20.2 p -60.87 -18.4 55.96 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.87 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -95.2 -28.31 15.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 0.0 109.76 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 21' ' ' ARG . 46.9 t60 -95.24 -69.09 0.77 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.168 -0.958 . . . . 0.0 110.395 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -52.71 -54.76 29.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 110.784 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.9 mp -98.84 -80.84 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.154 -0.966 . . . . 0.0 110.798 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.47 42.57 0.24 Allowed Glycine 0 N--CA 1.501 2.988 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.442 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -170.29 130.37 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -1.195 . . . . 0.0 109.089 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.442 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.6 m -146.74 89.52 5.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.208 -0.932 . . . . 0.0 109.523 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 96.6 Cg_endo -84.83 51.73 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.196 1.93 . . . . 0.0 112.364 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 63.8 m-85 -158.52 28.11 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.974 -1.079 . . . . 0.0 109.74 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.465 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 2.9 m-90 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.017 -0.992 . . . . 0.0 108.767 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.494 ' C ' ' N ' ' A' ' 9' ' ' VAL . 28.5 tt0 . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.608 ' CD ' ' H ' ' A' ' 8' ' ' GLN . 3.8 mp0 -56.78 -10.17 0.97 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.494 ' N ' ' C ' ' A' ' 7' ' ' GLU . 3.4 t -82.39 -64.88 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -46.27 -43.93 16.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -60.62 -50.2 74.47 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -58.48 -56.5 21.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 16' ' ' ALA . 10.1 mt -49.29 -52.28 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -51.2 -42.35 60.84 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -71.83 -13.91 61.81 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -86.42 -24.24 25.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.444 -0.785 . . . . 0.0 109.23 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -94.49 -12.55 27.45 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -95.54 -67.83 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 18' ' ' SER . 95.5 mt -38.11 -28.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.836 0.826 . . . . 0.0 109.876 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.531 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 15.7 pt-20 -82.55 -46.56 13.21 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' SER . 11.9 mtt85 -69.6 -30.18 67.88 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' A' ' 26' ' ' TYR . 4.3 mp -65.28 -68.74 0.34 Allowed 'General case' 0 C--O 1.204 -1.309 0 O-C-N 121.224 -0.923 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.58 ' O ' ' N ' ' A' ' 28' ' ' GLY . 3.2 p -41.56 -54.52 3.16 Favored 'General case' 0 N--CA 1.504 2.248 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.673 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.535 ' N ' ' OE1' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -45.99 -42.88 13.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 109.56 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -95.44 -54.86 3.24 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.119 -0.988 . . . . 0.0 109.682 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 22' ' ' LEU . 13.8 m-85 -61.68 -77.46 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.452 -0.78 . . . . 0.0 109.826 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' A' ' 26' ' ' TYR . 5.3 mp -99.15 -80.78 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.584 -0.697 . . . . 0.0 110.512 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 139.98 -7.89 2.97 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -88.17 115.25 25.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.319 -1.106 . . . . 0.0 109.494 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.6 m -160.3 108.55 1.38 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 108.923 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -40.12 -83.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.305 2.003 . . . . 0.0 113.642 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.49 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 53.3 t80 -176.23 71.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.798 -1.189 . . . . 0.0 110.093 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.091 -1.005 . . . . 0.0 109.553 178.85 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.514 ' C ' ' N ' ' A' ' 9' ' ' VAL . 42.7 mm-40 . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.574 ' O ' HD23 ' A' ' 12' ' ' LEU . 14.8 mp0 -54.65 -9.62 0.35 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.867 -1.133 . . . . 0.0 107.95 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.514 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -88.07 -67.44 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -49.62 -39.63 36.46 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.949 -1.094 . . . . 0.0 108.819 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 15' ' ' GLN . 37.2 mttp -63.46 -49.42 73.74 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -54.52 -54.37 41.97 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.366 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 mt -54.04 -56.51 9.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -56.74 -32.74 65.86 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.49 -0.756 . . . . 0.0 109.505 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 11' ' ' LYS . 49.3 mt-30 -69.32 -26.33 64.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.193 -0.942 . . . . 0.0 109.048 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.15 -13.09 0.74 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.298 -0.876 . . . . 0.0 109.131 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.413 ' N ' ' C ' ' A' ' 15' ' ' GLN . 8.6 p -51.56 -36.68 46.26 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -60.17 -69.27 0.23 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.447 -0.783 . . . . 0.0 109.105 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.3 mt -42.73 -29.6 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 121.883 0.849 . . . . 0.0 109.334 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.568 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 29.6 mt-10 -79.52 -48.88 13.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 18' ' ' SER . 16.6 mmt85 -60.61 -33.32 72.59 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.8 mp -63.99 -66.97 0.47 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 122.022 0.915 . . . . 0.0 109.699 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 28' ' ' GLY . 18.7 p -57.37 -16.69 9.72 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.767 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -95.48 -29.58 14.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.174 -0.954 . . . . 0.0 109.844 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -95.3 -68.53 0.8 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.208 -0.933 . . . . 0.0 110.635 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -52.49 -54.29 34.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.179 -0.951 . . . . 0.0 110.966 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.01 -80.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.078 -1.014 . . . . 0.0 111.192 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.95 37.91 0.37 Allowed Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -163.69 128.97 2.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -1.189 . . . . 0.0 109.246 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.6 m -144.12 105.19 4.79 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.14 -0.975 . . . . 0.0 109.022 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 33' ' ' TRP . 89.6 Cg_endo -82.56 -29.22 1.49 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.836 1.69 . . . . 0.0 112.992 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.08 11.15 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 109.159 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.568 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 16.8 m-90 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.627 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.499 ' C ' ' N ' ' A' ' 9' ' ' VAL . 64.7 tt0 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.595 ' O ' HD23 ' A' ' 12' ' ' LEU . 26.0 mm-40 -54.89 -9.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.499 ' N ' ' C ' ' A' ' 7' ' ' GLU . 3.9 t -84.74 -68.03 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -46.37 -33.81 4.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.595 -0.691 . . . . 0.0 109.569 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -73.03 -48.12 38.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -56.23 -55.13 36.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -49.16 -56.81 2.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 17' ' ' THR . 19.0 mt-30 -53.37 -42.76 67.19 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -72.46 -18.78 61.66 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.312 -0.868 . . . . 0.0 108.885 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -72.38 -9.36 58.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.321 -0.862 . . . . 0.0 109.078 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 20' ' ' GLU . 6.5 p -46.16 -65.54 0.54 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.785 . . . . 0.0 109.423 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -36.21 -66.59 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.618 0.723 . . . . 0.0 110.763 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -45.01 -27.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 109.914 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.518 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 0.3 OUTLIER -83.85 -35.78 23.93 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' SER . 10.7 mmt180 -72.21 -25.53 61.69 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.7 mp -64.21 -65.63 0.65 Allowed 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.636 0.731 . . . . 0.0 110.009 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 28' ' ' GLY . 5.0 p -47.09 -58.15 4.32 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -47.36 -34.56 7.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.968 . . . . 0.0 109.99 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -95.49 -70.4 0.71 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.044 . . . . 0.0 111.294 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 22' ' ' LEU . 52.5 m-85 -53.21 -67.68 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.74 -81.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.118 -0.989 . . . . 0.0 110.697 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 134.32 42.56 0.14 Allowed Glycine 0 N--CA 1.498 2.833 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -165.95 116.74 1.03 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -1.15 . . . . 0.0 109.201 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 m -130.24 90.04 43.02 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.76 41.09 0.99 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.974 1.783 . . . . 0.0 112.89 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.494 ' CG ' ' O ' ' A' ' 32' ' ' PHE . 71.9 t80 -160.19 27.8 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.709 -1.245 . . . . 0.0 110.121 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.163 179.639 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' C ' ' N ' ' A' ' 9' ' ' VAL . 52.0 mt-10 . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.516 ' O ' HD23 ' A' ' 12' ' ' LEU . 14.5 mm100 -55.62 -9.73 0.57 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.856 -1.152 . . . . 0.0 108.041 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.487 ' N ' ' C ' ' A' ' 7' ' ' GLU . 42.1 t -81.3 -67.04 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 14' ' ' GLN . 2.2 t0 -45.09 -44.17 10.2 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -62.64 -50.24 72.01 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.329 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -55.09 -54.99 36.13 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.395 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -50.26 -58.04 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -56.39 -36.6 69.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.557 -0.714 . . . . 0.0 109.812 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 11' ' ' LYS . 52.3 mt-30 -76.89 -49.9 14.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.947 -1.095 . . . . 0.0 109.42 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -53.02 -9.05 0.12 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 108.949 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 14' ' ' GLN . 6.5 p -42.98 -23.88 0.05 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.072 0.939 . . . . 0.0 108.864 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.5 m -79.32 -70.81 0.48 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.9 mt -43.74 -37.57 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-O 122.027 0.918 . . . . 0.0 109.298 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.507 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 1.6 pt-20 -73.63 -45.51 52.4 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.542 ' NE ' ' OE1' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -58.0 -41.24 82.63 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mp -55.9 -59.25 5.15 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.154 0.978 . . . . 0.0 109.132 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 5.3 p -55.75 -32.6 63.54 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.19 -178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.542 ' OE1' ' NE ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -95.5 -25.42 16.22 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.763 -1.211 . . . . 0.0 110.968 -178.098 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 21' ' ' ARG . 10.2 t-80 -87.82 -68.68 0.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.042 -1.036 . . . . 0.0 110.971 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -76.91 -47.92 19.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.149 -0.969 . . . . 0.0 111.408 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mm -76.34 -76.05 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.89 -1.131 . . . . 0.0 109.898 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.41 -36.95 2.36 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.508 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 4.1 t90 -90.84 151.36 21.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.4 -1.059 . . . . 0.0 109.4 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 60.1 m -156.99 150.47 19.0 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 56.2 Cg_endo -70.28 -89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 121.353 1.369 . . . . 0.0 111.949 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 31' ' ' PRO . 19.8 m-85 -155.4 47.12 0.51 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.844 -1.16 . . . . 0.0 111.164 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 O-C-N 120.563 -1.336 . . . . 0.0 108.718 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.521 ' C ' ' N ' ' A' ' 9' ' ' VAL . 69.1 tt0 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.606 ' CD ' ' H ' ' A' ' 8' ' ' GLN . 22.7 mp0 -51.43 -12.28 0.15 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.425 -1.422 . . . . 0.0 108.329 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.521 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.3 t -81.35 -64.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.506 ' OD1' ' NE2' ' A' ' 14' ' ' GLN . 5.6 t70 -46.05 -45.63 16.21 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' NZ ' ' CG ' ' A' ' 7' ' ' GLU . 27.2 mttp -59.28 -51.96 67.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.584 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -54.34 -53.45 53.67 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 8.0 mt -54.42 -59.75 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.506 ' NE2' ' OD1' ' A' ' 10' ' ' ASP . 37.0 mt-30 -51.47 -38.09 52.1 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.329 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 17' ' ' THR . 42.9 mt-30 -64.19 -28.25 69.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -0.91 . . . . 0.0 108.683 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 13' ' ' ILE . . . -46.33 -13.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.592 -0.693 . . . . 0.0 109.702 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' GLN . 5.9 p -52.17 -31.93 33.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 108.472 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -65.02 -70.63 0.22 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.051 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' SER . 94.6 mt -38.38 -30.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.864 0.84 . . . . 0.0 109.591 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' SER . 16.1 mt-10 -75.47 -53.01 9.37 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' SER . 5.3 mmt-85 -52.57 -43.74 65.46 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 25' ' ' HIS . 7.8 mp -59.9 -62.39 1.91 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.029 0.919 . . . . 0.0 109.443 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 1.7 p -44.13 -49.29 9.04 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.456 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.612 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 58.9 mt-30 -62.86 -24.19 67.67 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.887 -1.133 . . . . 0.0 108.71 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 22' ' ' LEU . 46.8 t-80 -96.13 -58.78 1.99 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.458 -0.776 . . . . 0.0 111.193 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.481 ' N ' ' O ' ' A' ' 22' ' ' LEU . 73.6 m-85 -88.93 -80.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 0.0 112.037 -177.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 29' ' ' TRP . 3.8 mm -48.62 -19.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.03 -1.044 . . . . 0.0 109.74 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 68.07 -55.44 0.41 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.471 ' N ' ' O ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -76.68 159.08 30.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -1.191 . . . . 0.0 108.856 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 31' ' ' PRO . 52.8 m -154.55 106.22 2.37 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 24.6 Cg_exo -37.08 -105.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.346 2.03 . . . . 0.0 113.58 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 68.5 m-85 -158.99 63.43 0.41 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.352 -1.468 . . . . 0.0 110.069 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.395 179.169 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 3' ' ' LEU . 34.4 p-10 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.462 ' C ' ' N ' ' A' ' 4' ' ' ASP . 56.2 mt-10 -63.89 77.36 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.208 -0.932 . . . . 0.0 109.523 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 1' ' ' ASN . 31.6 tp -50.19 -13.33 0.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 0.0 108.903 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.462 ' N ' ' C ' ' A' ' 2' ' ' GLU . 1.7 p30 -77.96 52.95 1.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.775 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.627 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.2 t -72.8 -35.77 3.15 Favored Pre-proline 0 C--N 1.306 -1.289 0 O-C-N 121.106 -0.996 . . . . 0.0 110.199 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 84.0 Cg_exo -48.82 117.68 2.91 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.407 2.071 . . . . 0.0 112.271 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.523 ' C ' ' N ' ' A' ' 9' ' ' VAL . 80.6 mt-10 -93.94 -70.53 0.7 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.39 -0.819 . . . . 0.0 111.067 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.547 ' O ' HD23 ' A' ' 12' ' ' LEU . 30.1 mt-30 -50.26 -12.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.638 -1.289 . . . . 0.0 108.542 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.523 ' N ' ' C ' ' A' ' 7' ' ' GLU . 3.2 t -79.14 -65.5 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -44.51 -45.58 9.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.634 -0.666 . . . . 0.0 109.325 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -62.29 -50.04 73.26 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -55.94 -55.1 36.77 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -50.22 -59.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -50.58 -27.86 7.59 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 108.981 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.78 -0.64 39.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.58 -0.7 . . . . 0.0 109.768 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -72.71 -10.71 60.11 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.367 -0.833 . . . . 0.0 110.132 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -50.11 -21.12 1.16 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -91.47 -68.31 0.8 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.492 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 95.1 mt -40.99 -28.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.731 0.777 . . . . 0.0 109.639 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 18' ' ' SER . 23.3 mt-10 -75.82 -47.72 24.53 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' SER . 5.4 mmt180 -60.2 -29.96 69.06 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -65.87 -67.89 0.41 Allowed 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.284 -0.885 . . . . 0.0 110.424 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.8 OUTLIER -54.83 -63.88 1.01 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.035 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.621 ' NE2' ' N ' ' A' ' 24' ' ' GLN . 0.7 OUTLIER -43.96 -32.52 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -0.877 . . . . 0.0 110.455 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -95.65 -70.16 0.72 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.91 -1.119 . . . . 0.0 110.924 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.479 ' HB2' HD12 ' A' ' 27' ' ' ILE . 48.1 m-85 -63.46 -69.77 0.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 111.101 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.496 ' H ' HD12 ' A' ' 27' ' ' ILE . 3.9 mp -92.26 -80.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.138 -0.976 . . . . 0.0 110.982 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 123.01 38.44 0.56 Allowed Glycine 0 N--CA 1.501 3.018 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.402 ' H ' ' HB2' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -137.16 91.4 2.62 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.441 -1.035 . . . . 0.0 109.107 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.1 m -139.43 69.7 39.35 Favored Pre-proline 0 N--CA 1.498 1.933 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 33' ' ' TRP . 79.8 Cg_endo -86.84 -21.69 2.07 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.099 2.533 . . . . 0.0 112.662 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -53.73 -7.27 0.11 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 0.0 109.038 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.508 ' H ' ' C ' ' A' ' 31' ' ' PRO . 8.4 m-90 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.552 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.478 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 8.4 t-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 4' ' ' ASP . 18.6 mt-10 -84.07 93.33 8.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 109.83 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 5' ' ' VAL . 10.1 mp -75.2 19.91 0.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 108.689 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 2' ' ' GLU . 19.5 p-10 -65.98 40.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 110.167 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.622 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.7 t -76.43 -35.25 1.51 Allowed Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.242 -0.912 . . . . 0.0 110.281 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 41.2 Cg_exo -44.63 113.2 0.43 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.395 2.063 . . . . 0.0 112.816 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.523 ' C ' ' N ' ' A' ' 9' ' ' VAL . 2.3 pm0 -88.99 -68.41 0.77 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.737 -0.602 . . . . 0.0 110.979 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.52 ' O ' HD23 ' A' ' 12' ' ' LEU . 4.2 mp0 -48.1 -16.64 0.1 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.611 -1.306 . . . . 0.0 108.264 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.523 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.2 t -73.08 -60.1 2.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -45.43 -45.28 12.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 0.0 109.127 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 15' ' ' GLN . 1.2 mptp? -61.64 -50.55 72.08 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -55.78 -55.5 31.6 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -48.55 -57.64 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -53.42 -36.72 61.83 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 11' ' ' LYS . 65.6 mt-30 -87.27 -3.49 59.04 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -78.33 -7.58 57.42 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.486 -0.759 . . . . 0.0 109.84 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 16' ' ' ALA . 3.3 p -37.97 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.9 0.857 . . . . 0.0 109.549 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 m -83.56 -70.38 0.57 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mt -42.81 -34.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.709 0.766 . . . . 0.0 109.299 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.506 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 2.3 pt-20 -75.94 -38.02 58.04 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' SER . 2.5 mmp_? -66.62 -33.91 76.71 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 24' ' ' GLN . 8.9 mp -62.67 -61.6 2.31 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.843 0.83 . . . . 0.0 110.212 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 14.4 p -43.43 -16.4 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.59 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' LEU . 73.2 mt-30 -91.57 -37.71 12.93 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.993 -1.067 . . . . 0.0 109.873 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -92.75 -70.16 0.71 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.161 -0.962 . . . . 0.0 110.258 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -44.56 -63.98 0.79 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.89 . . . . 0.0 110.356 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.13 -80.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.278 -0.889 . . . . 0.0 110.061 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 145.6 -54.55 0.55 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.514 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -73.01 165.01 25.85 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.335 -1.097 . . . . 0.0 108.571 179.532 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 70.7 m -155.63 118.6 2.37 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 108.383 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -39.48 -84.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.486 1.457 . . . . 0.0 112.908 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -172.65 66.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.414 -1.429 . . . . 0.0 110.164 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 120.528 -1.358 . . . . 0.0 108.845 178.661 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.476 ' C ' ' N ' ' A' ' 4' ' ' ASP . 4.3 pt-20 -48.25 103.91 0.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 109.701 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.3 mp -52.59 -12.38 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.476 ' N ' ' C ' ' A' ' 2' ' ' GLU . 4.6 p-10 -95.49 78.6 3.39 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.592 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 9.8 t -71.86 -35.22 3.45 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.332 -0.855 . . . . 0.0 110.599 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 72.8 Cg_exo -52.38 84.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.627 1.551 . . . . 0.0 112.493 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.477 ' C ' ' N ' ' A' ' 9' ' ' VAL . 64.3 mm-40 -94.59 -52.78 4.15 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.552 ' O ' HD23 ' A' ' 12' ' ' LEU . 14.5 mm100 -57.85 -9.36 1.26 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.477 ' N ' ' C ' ' A' ' 7' ' ' GLU . 44.4 t -84.43 -68.79 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.59 -37.9 8.78 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -68.0 -48.02 66.9 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -56.91 -56.39 22.28 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.276 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.486 ' O ' HG23 ' A' ' 17' ' ' THR . 9.1 mt -47.4 -58.71 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.45 ' O ' ' OG1' ' A' ' 17' ' ' THR . 39.0 mt-30 -50.06 -31.86 14.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 17' ' ' THR . 14.8 mm-40 -87.43 -66.55 0.9 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.236 -0.915 . . . . 0.0 109.267 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -48.96 -9.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.793 . . . . 0.0 109.867 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 15' ' ' GLN . 0.8 OUTLIER -76.25 -45.25 33.66 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.833 -1.167 . . . . 0.0 108.213 179.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.624 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.8 m -51.93 -28.93 18.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.355 -0.84 . . . . 0.0 109.316 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 18' ' ' SER . 79.7 mt -45.92 -23.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 120.761 -1.212 . . . . 0.0 107.925 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.476 ' N ' ' C ' ' A' ' 18' ' ' SER . 42.1 mt-10 -77.1 -41.88 40.29 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.624 ' N ' ' O ' ' A' ' 18' ' ' SER . 2.2 mtm180 -66.46 -33.32 75.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -70.45 -69.72 0.34 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.358 -0.838 . . . . 0.0 110.439 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' A' ' 28' ' ' GLY . 21.7 p -46.76 -61.46 1.83 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.738 -0.601 . . . . 0.0 110.118 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.491 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 75.8 mt-30 -47.9 -29.94 3.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 109.776 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -95.48 -67.92 0.83 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.238 -0.914 . . . . 0.0 110.554 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.516 ' HB2' HD12 ' A' ' 27' ' ' ILE . 61.0 m-85 -68.42 -65.97 0.63 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 111.213 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.516 HD12 ' HB2' ' A' ' 26' ' ' TYR . 4.2 mp -98.9 -81.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.147 -0.97 . . . . 0.0 111.511 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 137.59 -5.13 3.43 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -86.14 118.51 25.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.203 -1.175 . . . . 0.0 109.613 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 m -160.21 101.36 1.4 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.477 -0.764 . . . . 0.0 108.957 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -41.81 -86.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.647 2.231 . . . . 0.0 113.864 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.407 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 53.2 t80 -178.5 74.21 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.854 -1.154 . . . . 0.0 109.327 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.403 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.535 ' C ' ' H ' ' A' ' 4' ' ' ASP . 7.9 tp10 -76.63 113.01 13.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.001 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 3' ' ' LEU . 9.2 mp -69.7 12.9 0.16 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.168 -0.958 . . . . 0.0 109.203 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' A' ' 2' ' ' GLU . 55.2 p30 -71.53 38.0 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.489 -0.757 . . . . 0.0 110.095 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.636 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.8 t -78.78 -34.85 1.02 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 110.351 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 78.0 Cg_exo -48.79 122.03 7.49 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.447 2.098 . . . . 0.0 112.08 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' C ' ' N ' ' A' ' 9' ' ' VAL . 33.9 tt0 -93.98 -71.24 0.67 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.286 -0.883 . . . . 0.0 111.665 -177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.51 ' O ' HD23 ' A' ' 12' ' ' LEU . 6.6 pt20 -49.3 -19.67 0.53 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.674 -1.266 . . . . 0.0 108.004 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.7 t -71.76 -63.95 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 14' ' ' GLN . 23.2 t70 -46.52 -48.25 19.36 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -55.21 -50.82 68.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -59.54 -56.62 19.69 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 8.2 mt -51.84 -56.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 10' ' ' ASP . 32.4 mm-40 -48.93 -41.34 33.52 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.605 0.717 . . . . 0.0 109.187 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -67.26 -11.14 56.71 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 13' ' ' ILE . . . -76.48 -9.85 58.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.49 -0.756 . . . . 0.0 108.994 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 p -52.99 -32.38 46.02 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -64.89 -70.05 0.25 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' SER . 96.8 mt -43.46 -29.1 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.841 0.829 . . . . 0.0 109.149 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.572 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 34.9 mt-10 -75.79 -46.31 31.37 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -61.77 -38.23 87.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.85 -64.9 0.79 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.069 0.938 . . . . 0.0 109.051 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.4 ' O ' ' N ' ' A' ' 28' ' ' GLY . 13.7 p -55.51 -23.65 27.4 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.054 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -95.41 -29.54 14.37 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.981 -1.074 . . . . 0.0 110.588 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 21' ' ' ARG . 23.8 t60 -91.66 -70.38 0.69 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.008 -1.058 . . . . 0.0 111.246 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -66.46 -45.92 78.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.128 -0.982 . . . . 0.0 110.783 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.5 mm -85.75 -72.0 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.017 -1.052 . . . . 0.0 109.79 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 103.58 42.94 1.91 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.45 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -170.04 120.2 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.221 -1.164 . . . . 0.0 108.941 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.45 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.8 m -147.7 72.58 11.56 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 120.982 -1.074 . . . . 0.0 109.889 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -83.36 29.91 0.54 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.666 2.244 . . . . 0.0 112.338 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -127.79 17.17 6.85 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.402 -0.811 . . . . 0.0 109.041 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.572 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 2.9 m-90 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.976 -1.012 . . . . 0.0 108.747 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.0 m120 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 4' ' ' ASP . 27.1 mm-40 -69.35 104.5 2.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 109.43 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.475 ' O ' HD23 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -72.9 12.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.343 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 4' ' ' ASP . 46.7 p-10 -85.55 96.47 9.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.242 -0.911 . . . . 0.0 109.907 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.0 t -70.59 -36.86 5.99 Favored Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 120.962 -1.086 . . . . 0.0 110.024 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 79.8 Cg_exo -49.5 113.44 0.95 Allowed 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.327 2.018 . . . . 0.0 112.096 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.781 ' OE2' ' NE2' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -95.42 -56.04 2.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.413 -0.804 . . . . 0.0 111.135 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.781 ' NE2' ' OE2' ' A' ' 7' ' ' GLU . 16.7 mp0 -57.35 -9.97 1.2 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 119.88 -1.763 . . . . 0.0 107.455 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.498 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -84.25 -65.93 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 9' ' ' VAL . 27.8 t70 -46.34 -43.67 16.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.633 -0.667 . . . . 0.0 109.21 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -62.51 -49.26 76.07 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.43 -57.06 14.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 17' ' ' THR . 9.7 mt -48.98 -61.26 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.417 ' O ' ' OG1' ' A' ' 17' ' ' THR . 51.9 mt-30 -46.71 -38.26 9.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -79.15 -25.88 42.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.584 -0.698 . . . . 0.0 109.264 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -95.62 -9.65 31.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.323 -0.86 . . . . 0.0 110.227 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 13' ' ' ILE . 1.6 p -48.11 -40.77 24.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.088 -1.007 . . . . 0.0 108.874 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.444 ' C ' HD13 ' A' ' 22' ' ' LEU . 1.7 m -65.52 -67.72 0.42 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.619 -0.676 . . . . 0.0 109.27 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.497 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 98.0 mt -41.35 -28.43 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.891 0.853 . . . . 0.0 109.516 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.574 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 27.3 mt-10 -78.08 -57.99 3.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -51.85 -27.09 11.49 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.4 mp -70.11 -67.44 0.49 Allowed 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.341 -0.849 . . . . 0.0 110.983 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.554 ' CA ' ' H ' ' A' ' 28' ' ' GLY . 1.6 p -64.04 -57.14 10.54 Favored 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.564 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.489 ' OE1' ' SG ' ' A' ' 23' ' ' CYS . 7.5 mp0 -46.4 -33.62 4.03 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.872 -1.143 . . . . 0.0 109.348 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -95.53 -61.58 1.44 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -0.923 . . . . 0.0 110.279 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' LEU . 6.2 m-85 -81.66 -73.89 0.36 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 111.558 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.549 HD13 ' N ' ' A' ' 27' ' ' ILE . 1.9 mm -76.56 -79.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.535 -1.353 . . . . 0.0 110.616 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.554 ' H ' ' CA ' ' A' ' 23' ' ' CYS . . . 122.26 -9.23 9.54 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.479 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 75.2 t90 -84.86 100.16 11.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.628 -0.925 . . . . 0.0 109.459 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.479 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 10.3 m -160.17 73.3 3.03 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 109.059 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 33' ' ' TRP . 94.7 Cg_endo -85.38 -22.73 2.53 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 123.115 2.544 . . . . 0.0 112.892 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -56.61 -3.2 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.055 -1.028 . . . . 0.0 109.239 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.574 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 8.4 m-90 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.655 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 24.0 t30 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 4' ' ' ASP . 43.8 tt0 -97.9 146.37 25.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.296 -0.878 . . . . 0.0 109.387 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.1 tp -66.04 12.02 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.296 -0.877 . . . . 0.0 109.976 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 2' ' ' GLU . 50.0 p-10 -80.18 83.93 5.96 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.221 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 45.3 t -75.92 -33.08 1.23 Allowed Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.153 -0.967 . . . . 0.0 111.425 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 10.0 Cg_endo -89.53 116.49 0.7 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.464 2.109 . . . . 0.0 111.41 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.571 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 4.4 mp0 -81.41 -62.92 1.51 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.513 -176.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.58 ' O ' HD23 ' A' ' 12' ' ' LEU . 19.9 mp0 -49.77 -12.93 0.08 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.677 -1.264 . . . . 0.0 108.315 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 7' ' ' GLU . 2.3 t -82.22 -67.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' HG12 ' A' ' 9' ' ' VAL . 26.3 t0 -46.92 -40.43 14.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 108.876 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' GLN . 38.7 mttt -63.94 -50.68 67.7 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -53.46 -54.74 32.69 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.097 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.0 mt -51.2 -58.95 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 17' ' ' THR . 19.2 mt-30 -55.78 -35.52 66.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.627 -0.671 . . . . 0.0 109.804 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 11' ' ' LYS . 45.1 mt-30 -76.0 -23.72 55.25 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 108.926 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -50.04 -12.93 0.09 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 109.42 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 15' ' ' GLN . 32.3 p -52.65 -32.87 44.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 108.44 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.492 ' C ' HD13 ' A' ' 22' ' ' LEU . 1.6 m -63.02 -70.1 0.23 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.482 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 84.1 mt -42.91 -27.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 121.943 0.878 . . . . 0.0 109.313 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.532 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 36.1 mt-10 -81.28 -47.91 12.71 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 18' ' ' SER . 13.1 mmm-85 -63.68 -28.81 70.15 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.9 mp -61.77 -66.21 0.57 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.867 0.841 . . . . 0.0 109.919 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.535 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.8 OUTLIER -58.04 -60.97 2.91 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.841 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -45.28 -33.49 2.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.267 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -95.32 -65.58 0.97 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.073 -1.017 . . . . 0.0 110.58 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' A' ' 22' ' ' LEU . 45.5 m-85 -68.14 -68.18 0.41 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.157 -0.965 . . . . 0.0 110.843 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.488 HD12 ' HB2' ' A' ' 26' ' ' TYR . 4.1 mp -97.22 -80.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.198 -0.939 . . . . 0.0 111.269 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 131.93 6.8 3.12 Favored Glycine 0 N--CA 1.502 3.089 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -98.12 99.46 10.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.271 -1.135 . . . . 0.0 109.804 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.4 m -155.11 69.48 5.57 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.934 . . . . 0.0 108.898 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 33' ' ' TRP . 70.5 Cg_endo -86.54 -19.57 2.83 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.016 2.477 . . . . 0.0 112.651 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -60.02 1.01 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 109.663 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.532 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 7.1 m-90 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.504 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.481 ' C ' ' N ' ' A' ' 4' ' ' ASP . 80.3 mt-10 -49.92 120.43 4.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.587 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.6 tp -51.99 -12.99 0.25 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.481 ' N ' ' C ' ' A' ' 2' ' ' GLU . 7.3 p-10 -115.5 69.61 0.73 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 6' ' ' PRO . 8.0 t -51.48 -60.81 5.09 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 0.0 110.654 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.431 ' C ' ' O ' ' A' ' 5' ' ' VAL . 56.6 Cg_exo -28.46 106.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 122.972 2.448 . . . . 0.0 113.208 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 9' ' ' VAL . 31.1 mp0 -95.43 -70.2 0.72 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.576 -0.702 . . . . 0.0 109.949 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.552 ' O ' HD23 ' A' ' 12' ' ' LEU . 16.2 mp0 -50.98 -10.11 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.835 -1.166 . . . . 0.0 108.669 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 7' ' ' GLU . 28.2 t -82.32 -68.42 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -43.63 -40.35 4.06 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.22 -50.11 62.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -56.08 -54.17 48.23 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.615 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -49.37 -57.21 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.41 -42.71 67.28 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -77.26 -9.73 58.98 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.313 -0.867 . . . . 0.0 109.048 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -90.33 -9.04 49.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.6 p -76.61 -29.99 56.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.453 -0.779 . . . . 0.0 110.649 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 21' ' ' ARG . 4.0 m -92.51 -14.87 27.78 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.967 -1.083 . . . . 0.0 110.627 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.491 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 43.1 mt -49.36 -23.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 120.446 -1.409 . . . . 0.0 107.399 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.524 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 16.2 pt-20 -78.08 -38.14 44.89 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' SER . 7.2 mmt-85 -69.83 -32.94 71.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.5 mp -66.48 -68.63 0.36 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.951 0.881 . . . . 0.0 110.499 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.524 ' SG ' ' NE2' ' A' ' 24' ' ' GLN . 2.5 p -48.57 -62.25 1.6 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.738 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' N ' ' OE1' ' A' ' 24' ' ' GLN . 1.2 mp0 -43.28 -33.54 1.0 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.404 -0.81 . . . . 0.0 110.041 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.473 ' CD2' ' CE1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -95.79 -52.33 4.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.416 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.473 ' CE1' ' CD2' ' A' ' 25' ' ' HIS . 13.8 m-85 -92.94 -68.52 0.8 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 111.85 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.535 HD13 ' N ' ' A' ' 27' ' ' ILE . 2.1 mm -82.07 -80.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.432 -1.418 . . . . 0.0 110.301 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.503 ' H ' ' CB ' ' A' ' 23' ' ' CYS . . . 130.5 -14.31 5.59 Favored Glycine 0 N--CA 1.501 2.997 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -90.12 115.81 27.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.189 -1.183 . . . . 0.0 109.168 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 31' ' ' PRO . 1.7 m -160.7 109.0 1.32 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 109.129 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.542 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 35.7 Cg_exo -38.31 -102.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.175 1.917 . . . . 0.0 113.493 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.542 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 51.8 m-85 -159.6 65.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.415 -1.428 . . . . 0.0 110.015 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.411 ' C ' ' O ' ' A' ' 32' ' ' PHE . 3.1 m-90 . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.644 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -53.31 124.51 14.85 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.522 ' N ' ' OE1' ' A' ' 2' ' ' GLU . 1.4 tp -50.33 -9.62 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.432 -0.792 . . . . 0.0 109.144 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 2' ' ' GLU . 0.8 OUTLIER -94.14 124.75 38.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.617 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.2 t -91.5 -33.65 0.35 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.155 -0.966 . . . . 0.0 111.566 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 72.7 Cg_exo -50.74 82.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.89 1.726 . . . . 0.0 112.946 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 5' ' ' VAL . 15.7 tt0 -95.47 -54.08 3.52 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.556 ' O ' HD23 ' A' ' 12' ' ' LEU . 4.0 mp0 -56.4 -9.44 0.7 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.471 ' N ' ' C ' ' A' ' 7' ' ' GLU . 37.4 t -82.05 -66.73 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -46.1 -43.88 15.12 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.51 -49.55 74.9 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -56.01 -56.17 24.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.57 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' THR . 9.1 mt -49.78 -60.7 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -48.62 -33.0 9.06 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -82.0 -49.56 10.11 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.354 -0.841 . . . . 0.0 109.878 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.69 -16.25 62.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.975 . . . . 0.0 109.665 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 20' ' ' GLU . 1.1 p -66.53 -48.03 71.01 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -39.33 -57.6 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.692 0.758 . . . . 0.0 110.005 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.495 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 79.6 mt -45.18 -25.9 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.5 0.667 . . . . 0.0 109.337 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.514 ' OE1' ' NE2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -84.83 -34.16 22.76 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' SER . 34.7 mtm180 -73.33 -36.44 66.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.9 mp -51.9 -61.07 2.49 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.025 0.917 . . . . 0.0 109.713 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -63.45 -62.24 1.81 Allowed 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.383 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.514 ' NE2' ' OE1' ' A' ' 20' ' ' GLU . 73.9 mt-30 -48.48 -29.7 4.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.176 -0.953 . . . . 0.0 110.036 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.426 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 50.4 t60 -95.1 -62.24 1.34 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.05 -1.031 . . . . 0.0 110.367 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' HB2' HD12 ' A' ' 27' ' ' ILE . 38.3 m-85 -75.64 -65.14 0.94 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.13 -0.981 . . . . 0.0 110.936 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 26' ' ' TYR . 3.9 mp -99.49 -81.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.101 -0.999 . . . . 0.0 111.58 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 126.95 32.96 0.66 Allowed Glycine 0 N--CA 1.505 3.238 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -116.33 78.19 1.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.55 -0.971 . . . . 0.0 109.176 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.4 m -150.51 69.21 8.7 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.143 -0.973 . . . . 0.0 109.766 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.19 60.04 7.64 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.634 2.222 . . . . 0.0 111.698 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.53 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 71.2 t80 -162.2 29.36 0.11 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.029 -1.044 . . . . 0.0 110.336 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.018 -0.991 . . . . 0.0 108.766 179.34 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.564 0.697 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.518 ' C ' ' H ' ' A' ' 4' ' ' ASP . 29.6 tt0 -48.71 167.8 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.419 -0.801 . . . . 0.0 109.358 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.2 tp -71.99 16.25 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.48 -0.762 . . . . 0.0 109.63 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 2' ' ' GLU . 37.2 p-10 -83.64 105.36 14.5 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.561 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 1.7 t -72.21 -39.12 6.19 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 120.954 -1.092 . . . . 0.0 110.009 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 11.9 Cg_exo -71.78 92.6 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 121.983 1.789 . . . . 0.0 111.521 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' C ' ' N ' ' A' ' 9' ' ' VAL . 65.5 tt0 -94.87 -55.4 3.12 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.531 ' O ' HD23 ' A' ' 12' ' ' LEU . 79.2 mt-30 -52.8 -12.02 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.527 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -77.6 -70.04 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.513 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -44.81 -42.25 7.69 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.013 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -60.88 -52.51 64.76 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.104 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -55.65 -55.4 32.54 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.8 mt -52.21 -56.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -54.61 -38.67 67.07 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.395 0.617 . . . . 0.0 109.812 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 11' ' ' LYS . 17.9 mt-30 -65.05 -24.64 67.53 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.465 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.41 -15.84 1.91 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.293 -0.879 . . . . 0.0 109.125 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 p -55.51 -32.92 63.3 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -62.63 -70.25 0.21 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 18' ' ' SER . 72.8 mt -40.32 -33.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 122.063 0.935 . . . . 0.0 109.051 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.408 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 19.2 mt-10 -73.21 -54.14 9.19 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 18' ' ' SER . 31.6 mmt-85 -52.52 -39.13 60.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 24' ' ' GLN . 9.5 mp -63.52 -66.06 0.59 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.975 0.893 . . . . 0.0 109.299 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 6.9 p -46.06 -18.83 0.05 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.319 0.58 . . . . 0.0 109.937 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 22' ' ' LEU . 70.6 mt-30 -95.27 -27.18 15.62 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -96.07 -69.66 0.75 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.049 -1.032 . . . . 0.0 110.827 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -58.85 -58.92 6.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.459 -0.776 . . . . 0.0 111.66 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.449 ' H ' HD12 ' A' ' 27' ' ' ILE . 3.3 mp -94.12 -27.47 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.234 -0.916 . . . . 0.0 111.114 -177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.31 -45.17 2.78 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.499 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 4.1 m95 -69.8 151.6 45.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -1.121 . . . . 0.0 109.127 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 82.4 m -156.04 108.41 2.1 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -36.78 -92.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.919 1.746 . . . . 0.0 113.093 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 65.4 t80 -174.26 69.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.518 -1.364 . . . . 0.0 109.76 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.36 179.274 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 2' ' ' GLU . 10.7 p30 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 4' ' ' ASP . 2.8 pt-20 -47.27 107.24 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.865 . . . . 0.0 109.696 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.7 tp -59.23 -4.45 0.54 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.07 -1.019 . . . . 0.0 108.4 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 2' ' ' GLU . 4.5 p-10 -108.35 118.59 37.18 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.0 t -78.66 -35.17 1.08 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.232 -0.918 . . . . 0.0 111.071 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 80.9 Cg_exo -47.67 110.54 0.32 Allowed 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.384 2.056 . . . . 0.0 113.088 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.491 ' C ' ' N ' ' A' ' 9' ' ' VAL . 8.7 pt-20 -95.54 -55.92 2.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.573 -0.704 . . . . 0.0 110.338 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.551 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -56.72 -9.83 0.87 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.414 -1.429 . . . . 0.0 107.596 179.269 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.491 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -82.22 -65.85 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.417 ' N ' HG12 ' A' ' 9' ' ' VAL . 9.1 t70 -46.02 -43.29 14.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.472 -0.767 . . . . 0.0 109.123 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -62.17 -50.22 72.69 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.1 -56.15 25.46 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.8 mt -49.49 -57.04 2.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -48.81 -34.63 12.77 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -87.66 -11.12 49.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -75.33 -11.91 60.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.088 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.3 p -77.05 -9.47 58.74 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -94.36 -70.72 0.69 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.78 -0.575 . . . . 0.0 110.007 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.1 mt -38.79 -31.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.602 0.715 . . . . 0.0 109.921 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.48 ' CG ' ' N ' ' A' ' 21' ' ' ARG . 11.9 pt-20 -75.83 -46.4 30.69 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' SER . 1.5 mmm180 -58.91 -40.85 85.75 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.12 -60.6 3.26 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.964 0.888 . . . . 0.0 109.93 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.653 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 7.0 p -51.25 -52.32 45.86 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.428 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.653 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 79.4 mt-30 -62.02 -24.52 67.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.783 -1.198 . . . . 0.0 110.09 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 -95.49 -49.02 5.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -0.944 . . . . 0.0 110.538 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -97.81 -76.84 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 111.672 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 27' ' ' ILE . 3.6 mm -59.19 -80.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.834 -1.166 . . . . 0.0 110.323 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 135.53 -60.24 0.64 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.472 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 8.5 t90 -64.42 142.03 58.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.371 -1.076 . . . . 0.0 108.901 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.472 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 3.1 m -155.01 120.61 2.63 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.546 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 60.9 Cg_exo -37.66 -94.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.567 1.512 . . . . 0.0 113.039 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 86.2 m-85 -158.2 59.21 0.46 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.325 -1.485 . . . . 0.0 110.723 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.436 ' HE1' ' HB1' ' A' ' 16' ' ' ALA . 1.1 m-90 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 120.693 -1.254 . . . . 0.0 108.84 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 4' ' ' ASP . 3.9 pt-20 -61.66 98.06 0.09 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.134 -0.979 . . . . 0.0 109.474 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -73.17 13.92 0.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.196 -0.94 . . . . 0.0 108.662 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 2' ' ' GLU . 38.5 p-10 -44.3 91.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.603 -0.686 . . . . 0.0 110.141 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.626 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.2 t -76.15 -35.23 1.58 Allowed Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.248 -0.908 . . . . 0.0 110.479 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 81.4 Cg_exo -49.97 108.0 0.19 Allowed 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.472 2.115 . . . . 0.0 113.113 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' C ' ' N ' ' A' ' 9' ' ' VAL . 28.2 mm-40 -95.63 -59.48 1.86 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.747 -0.595 . . . . 0.0 109.449 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.574 ' O ' HD23 ' A' ' 12' ' ' LEU . 17.3 mp0 -54.23 -9.9 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.885 -1.134 . . . . 0.0 108.081 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.509 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -82.54 -67.36 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.42 ' N ' HG12 ' A' ' 9' ' ' VAL . 1.5 t70 -44.84 -33.86 2.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.616 -0.677 . . . . 0.0 109.614 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 15' ' ' GLN . 14.8 tttt -73.76 -49.14 26.89 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -54.23 -53.44 53.59 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.344 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 mt -50.01 -58.32 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -56.95 -27.42 61.1 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.415 0.626 . . . . 0.0 109.714 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' LYS . 75.8 mt-30 -99.73 0.09 41.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.193 -0.942 . . . . 0.0 110.176 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -67.59 -9.81 46.24 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.29 -0.881 . . . . 0.0 110.189 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.0 p -70.6 -15.15 62.72 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -93.28 -58.4 2.32 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.506 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 77.5 mt -39.59 -26.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 121.866 0.841 . . . . 0.0 109.346 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 18' ' ' SER . 3.5 mm-40 -74.49 -50.26 18.91 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -55.74 -31.86 62.89 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -69.81 -69.45 0.35 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.463 -0.773 . . . . 0.0 110.724 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.5 p -54.58 -57.03 13.03 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.192 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -46.33 -33.11 3.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.082 -1.011 . . . . 0.0 109.779 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -95.62 -65.6 0.96 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.159 -0.963 . . . . 0.0 110.153 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 22' ' ' LEU . 50.2 m-85 -67.25 -72.02 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 110.912 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.432 ' H ' HD12 ' A' ' 27' ' ' ILE . 4.1 mp -93.14 -81.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.054 -1.029 . . . . 0.0 111.16 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 129.53 0.82 5.7 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -92.51 98.92 11.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.271 -1.135 . . . . 0.0 109.258 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.8 m -153.44 77.22 6.03 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 109.068 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 33' ' ' TRP . 65.6 Cg_endo -87.98 -26.05 0.75 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.015 2.477 . . . . 0.0 112.572 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.424 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 86.9 t80 -55.86 -3.9 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.659 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.505 ' H ' ' C ' ' A' ' 31' ' ' PRO . 13.8 m-90 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.607 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.487 ' ND2' ' OE2' ' A' ' 7' ' ' GLU . 1.1 m120 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.339 0.59 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 4' ' ' ASP . 6.0 tt0 -154.34 -165.42 2.08 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.1 mt -75.98 16.84 0.38 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.103 -0.998 . . . . 0.0 108.751 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 2' ' ' GLU . 28.4 p-10 -114.4 109.7 18.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.624 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.1 t -71.62 -36.32 4.44 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 120.944 -1.098 . . . . 0.0 110.27 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 32.3 Cg_exo -60.06 100.16 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.21 1.94 . . . . 0.0 112.413 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.489 ' C ' ' N ' ' A' ' 9' ' ' VAL . 49.1 mt-10 -95.68 -63.4 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.501 -0.749 . . . . 0.0 109.357 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.56 ' O ' HD23 ' A' ' 12' ' ' LEU . 68.4 mt-30 -54.71 -9.24 0.31 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.956 -1.09 . . . . 0.0 108.347 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.489 ' N ' ' C ' ' A' ' 7' ' ' GLU . 54.2 t -85.7 -70.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.58 ' OD1' ' NE2' ' A' ' 14' ' ' GLN . 4.7 t70 -45.85 -31.77 2.27 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.618 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -74.53 -48.63 25.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.66 -55.89 29.0 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.635 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.5 mt -49.32 -54.56 5.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.58 ' NE2' ' OD1' ' A' ' 10' ' ' ASP . 38.1 mt-30 -50.29 -42.64 52.72 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -77.14 -6.57 53.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -95.26 -43.41 8.07 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 110.192 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.424 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 10.5 p -34.5 -30.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.975 0.417 . . . . 0.0 111.521 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 m -89.32 -71.37 0.61 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.007 -1.058 . . . . 0.0 109.572 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.9 mt -47.58 -29.11 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.809 ' OE2' ' CG ' ' A' ' 33' ' ' TRP . 17.9 mm-40 -75.49 -53.16 9.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 17' ' ' THR . 13.4 mmm-85 -49.63 -32.17 12.42 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 18' ' ' SER . 8.7 mp -68.38 -68.19 0.41 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.719 0.771 . . . . 0.0 110.351 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' GLY . 28.0 p -60.29 -16.14 31.65 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.652 -0.655 . . . . 0.0 109.584 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -93.13 -31.08 14.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.298 -0.876 . . . . 0.0 109.442 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -95.55 -56.85 2.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.298 -0.876 . . . . 0.0 110.527 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -63.52 -57.41 10.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 110.853 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.8 mp -100.51 -80.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.017 -1.052 . . . . 0.0 110.764 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 131.34 39.9 0.24 Allowed Glycine 0 N--CA 1.502 3.084 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.423 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 2.0 t90 -162.67 124.46 2.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.054 -1.262 . . . . 0.0 108.849 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.423 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.6 m -144.93 94.13 5.44 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.146 -0.971 . . . . 0.0 109.448 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 33' ' ' TRP . 94.3 Cg_endo -84.51 -27.8 1.27 Allowed 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.097 1.865 . . . . 0.0 112.437 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -62.54 -0.16 0.57 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.051 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.809 ' CG ' ' OE2' ' A' ' 20' ' ' GLU . 21.2 m-90 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.282 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 51.0 t30 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -78.35 87.41 4.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -0.901 . . . . 0.0 109.007 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.47 ' O ' HD23 ' A' ' 3' ' ' LEU . 0.9 OUTLIER -66.07 6.01 0.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.089 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 2' ' ' GLU . 1.0 OUTLIER -86.12 102.95 14.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.292 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.619 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.2 t -74.48 -35.35 2.15 Favored Pre-proline 0 C--N 1.306 -1.321 0 O-C-N 121.23 -0.919 . . . . 0.0 110.801 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 74.3 Cg_exo -47.14 114.84 1.1 Allowed 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.234 1.956 . . . . 0.0 112.532 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.526 ' C ' ' N ' ' A' ' 9' ' ' VAL . 39.4 tt0 -93.75 -67.63 0.85 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.669 -0.645 . . . . 0.0 110.441 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.545 ' O ' HD23 ' A' ' 12' ' ' LEU . 36.0 mm-40 -50.14 -12.47 0.08 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.631 -1.293 . . . . 0.0 108.465 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -78.68 -64.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.4 ' N ' HG12 ' A' ' 9' ' ' VAL . 6.0 t70 -43.93 -47.58 8.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 4.4 mptp? -59.49 -52.58 64.96 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -54.17 -50.97 65.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.567 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 16' ' ' ALA . 8.0 mt -56.79 -62.02 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -47.51 -20.08 0.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 109.024 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.443 ' N ' ' C ' ' A' ' 13' ' ' ILE . 46.7 mt-30 -102.08 -16.42 16.42 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.556 0.694 . . . . 0.0 109.347 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -52.98 -9.55 0.13 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.406 -0.809 . . . . 0.0 110.295 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.402 ' N ' ' C ' ' A' ' 15' ' ' GLN . 14.3 p -78.89 -21.66 47.11 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.829 -1.17 . . . . 0.0 109.195 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -95.8 -71.88 0.65 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -0.832 . . . . 0.0 110.969 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 18' ' ' SER . 97.8 mt -42.92 -30.66 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.643 0.735 . . . . 0.0 110.073 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -73.85 -48.42 31.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 18' ' ' SER . 6.0 mmm180 -53.91 -35.27 61.46 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.6 mp -67.8 -67.51 0.45 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.718 0.771 . . . . 0.0 109.975 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 14.3 p -51.05 -58.58 5.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.295 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.639 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 78.8 mt-30 -47.88 -31.49 5.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.783 -1.198 . . . . 0.0 109.797 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -95.9 -59.09 1.93 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.259 -0.901 . . . . 0.0 111.304 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.481 ' N ' ' O ' ' A' ' 22' ' ' LEU . 22.9 m-85 -87.34 -80.32 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.986 -1.071 . . . . 0.0 112.245 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.532 HD13 ' N ' ' A' ' 27' ' ' ILE . 2.3 mm -56.16 -65.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.805 -1.184 . . . . 0.0 110.412 -177.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 107.28 -20.37 32.94 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -96.53 122.08 39.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.504 -0.998 . . . . 0.0 108.728 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.7 m -135.22 94.15 16.1 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -34.24 -98.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.444 2.096 . . . . 0.0 113.819 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.43 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 62.0 t80 -172.08 70.29 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.502 -1.374 . . . . 0.0 109.597 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.77 179.447 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.454 ' OD1' ' N ' ' A' ' 1' ' ' ASN . 2.0 p30 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.378 0.608 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.545 ' C ' ' H ' ' A' ' 4' ' ' ASP . 6.2 tp10 -67.08 131.44 45.83 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 tp -66.19 11.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.842 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.545 ' H ' ' C ' ' A' ' 2' ' ' GLU . 57.7 p30 -83.46 63.79 7.51 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.372 -0.83 . . . . 0.0 109.006 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 6' ' ' PRO . 21.5 t -43.34 -60.66 2.32 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.419 -0.801 . . . . 0.0 110.527 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 5' ' ' VAL . 16.6 Cg_exo -36.41 97.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 122.106 1.871 . . . . 0.0 112.215 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.499 ' C ' ' N ' ' A' ' 9' ' ' VAL . 1.4 tm-20 -95.97 -65.44 0.97 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.446 -0.784 . . . . 0.0 109.439 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.508 ' O ' HD23 ' A' ' 12' ' ' LEU . 3.2 mp0 -51.55 -13.04 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.786 -1.196 . . . . 0.0 108.232 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' N ' ' C ' ' A' ' 7' ' ' GLU . 18.0 t -76.22 -65.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -43.4 -45.81 6.36 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -61.41 -51.26 69.49 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -56.51 -55.22 36.53 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.527 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 16' ' ' ALA . 10.3 mt -49.77 -55.53 4.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.401 ' O ' ' OG1' ' A' ' 17' ' ' THR . 1.5 mp0 -50.93 -41.18 58.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -75.1 -13.3 60.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -88.27 -25.92 22.58 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 14' ' ' GLN . 47.8 p -61.7 -31.76 71.93 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -69.05 -70.9 0.24 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.436 -0.79 . . . . 0.0 109.474 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 79.3 mt -46.41 -28.45 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -78.28 -54.24 6.43 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -51.27 -37.2 45.93 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mp -65.79 -69.93 0.27 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.877 0.846 . . . . 0.0 109.438 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' GLY . 9.0 p -52.64 -38.58 60.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.208 0.528 . . . . 0.0 109.638 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.505 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 37.3 mm-40 -67.15 -36.71 82.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.814 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -90.05 -38.85 13.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.201 -0.937 . . . . 0.0 110.076 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -75.95 -65.56 0.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.905 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.77 -68.64 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 119.68 -2.48 13.63 Favored Glycine 0 N--CA 1.501 3.029 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.451 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -131.97 123.39 27.25 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.539 -0.977 . . . . 0.0 108.496 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.451 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.3 m -147.59 69.63 11.33 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 108.943 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.67 8.96 3.12 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.385 2.056 . . . . 0.0 112.59 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -84.87 -1.21 56.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.035 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.049 179.852 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.4 m120 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' A' ' 4' ' ' ASP . 0.7 OUTLIER -70.53 124.44 24.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.955 . . . . 0.0 109.723 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.604 HD22 ' N ' ' A' ' 3' ' ' LEU . 3.7 mm? -73.14 12.77 0.5 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 108.784 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 2' ' ' GLU . 38.0 p-10 -72.59 77.79 1.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.543 -0.723 . . . . 0.0 109.873 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.63 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.2 t -76.73 -33.15 1.11 Allowed Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.253 -0.904 . . . . 0.0 110.905 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 1.3 Cg_endo -93.41 110.55 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 122.953 2.436 . . . . 0.0 111.234 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.541 ' C ' ' N ' ' A' ' 9' ' ' VAL . 31.8 tt0 -85.02 -62.2 1.59 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.353 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.538 ' O ' HD23 ' A' ' 12' ' ' LEU . 24.4 mm100 -48.84 -14.08 0.06 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.706 -1.246 . . . . 0.0 108.249 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.541 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.2 t -77.92 -63.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.41 ' N ' HG12 ' A' ' 9' ' ' VAL . 5.5 t70 -46.82 -47.6 21.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 108.833 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -57.42 -50.5 72.8 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.653 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.7 -55.44 34.77 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.8 mt -51.33 -53.49 15.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.053 -1.03 . . . . 0.0 108.353 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.445 ' O ' ' OG1' ' A' ' 17' ' ' THR . 1.8 mp0 -52.98 -37.74 61.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -72.39 -15.63 61.85 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -95.6 -13.37 24.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 14' ' ' GLN . 30.7 p -71.03 -31.64 68.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.116 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.452 ' O ' HD13 ' A' ' 22' ' ' LEU . 1.7 m -65.75 -71.0 0.2 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.414 -0.804 . . . . 0.0 109.802 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 77.7 mt -46.79 -28.88 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.465 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 32.0 mt-10 -77.93 -49.29 14.45 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 25' ' ' HIS . 11.5 mmm180 -55.93 -34.32 65.52 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 18' ' ' SER . 8.4 mp -62.69 -65.84 0.63 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.982 0.896 . . . . 0.0 109.815 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 28' ' ' GLY . 20.2 p -60.87 -18.4 55.96 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.87 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -95.2 -28.31 15.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 0.0 109.76 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 21' ' ' ARG . 46.9 t60 -95.24 -69.09 0.77 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.168 -0.958 . . . . 0.0 110.395 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -52.71 -54.76 29.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 110.784 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.9 mp -98.84 -80.84 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.154 -0.966 . . . . 0.0 110.798 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.47 42.57 0.24 Allowed Glycine 0 N--CA 1.501 2.988 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.442 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -170.29 130.37 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -1.195 . . . . 0.0 109.089 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.442 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.6 m -146.74 89.52 5.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.208 -0.932 . . . . 0.0 109.523 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 96.6 Cg_endo -84.83 51.73 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.196 1.93 . . . . 0.0 112.364 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 63.8 m-85 -158.52 28.11 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.974 -1.079 . . . . 0.0 109.74 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.465 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 2.9 m-90 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.017 -0.992 . . . . 0.0 108.767 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.552 0.692 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.601 ' C ' ' H ' ' A' ' 4' ' ' ASP . 26.8 tt0 -44.4 136.38 4.16 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.495 0.664 . . . . 0.0 109.946 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 5' ' ' VAL . 6.0 tp -67.42 19.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.51 0.672 . . . . 0.0 109.71 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.601 ' H ' ' C ' ' A' ' 2' ' ' GLU . 25.0 p30 -67.01 58.08 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.375 -0.828 . . . . 0.0 109.2 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 3' ' ' LEU . 71.2 t -41.24 -54.54 5.86 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.623 -0.673 . . . . 0.0 111.185 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 5' ' ' VAL . 88.0 Cg_exo -22.04 100.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.483 0.875 0 C-N-CA 123.547 2.832 . . . . 0.0 113.825 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.494 ' C ' ' N ' ' A' ' 9' ' ' VAL . 28.5 tt0 -95.21 -53.12 3.9 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.608 ' CD ' ' H ' ' A' ' 8' ' ' GLN . 3.8 mp0 -56.78 -10.17 0.97 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.494 ' N ' ' C ' ' A' ' 7' ' ' GLU . 3.4 t -82.39 -64.88 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -46.27 -43.93 16.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -60.62 -50.2 74.47 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -58.48 -56.5 21.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 16' ' ' ALA . 10.1 mt -49.29 -52.28 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -51.2 -42.35 60.84 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -71.83 -13.91 61.81 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -86.42 -24.24 25.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.444 -0.785 . . . . 0.0 109.23 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -94.49 -12.55 27.45 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -95.54 -67.83 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 18' ' ' SER . 95.5 mt -38.11 -28.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.836 0.826 . . . . 0.0 109.876 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.531 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 15.7 pt-20 -82.55 -46.56 13.21 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' SER . 11.9 mtt85 -69.6 -30.18 67.88 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' A' ' 26' ' ' TYR . 4.3 mp -65.28 -68.74 0.34 Allowed 'General case' 0 C--O 1.204 -1.309 0 O-C-N 121.224 -0.923 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.58 ' O ' ' N ' ' A' ' 28' ' ' GLY . 3.2 p -41.56 -54.52 3.16 Favored 'General case' 0 N--CA 1.504 2.248 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.673 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.535 ' N ' ' OE1' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -45.99 -42.88 13.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 109.56 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -95.44 -54.86 3.24 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.119 -0.988 . . . . 0.0 109.682 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 22' ' ' LEU . 13.8 m-85 -61.68 -77.46 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.452 -0.78 . . . . 0.0 109.826 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' A' ' 26' ' ' TYR . 5.3 mp -99.15 -80.78 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.584 -0.697 . . . . 0.0 110.512 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 139.98 -7.89 2.97 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -88.17 115.25 25.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.319 -1.106 . . . . 0.0 109.494 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.6 m -160.3 108.55 1.38 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 108.923 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -40.12 -83.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.305 2.003 . . . . 0.0 113.642 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.49 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 53.3 t80 -176.23 71.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.798 -1.189 . . . . 0.0 110.093 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.091 -1.005 . . . . 0.0 109.553 178.85 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 4' ' ' ASP . 51.0 mt-10 -68.81 117.06 10.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.45 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.0 tp -71.99 13.78 0.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.461 -0.774 . . . . 0.0 109.618 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 2' ' ' GLU . 12.9 p30 -72.02 78.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.377 -0.827 . . . . 0.0 109.555 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.543 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 18.6 t -102.95 -33.83 0.21 Allowed Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.318 -0.864 . . . . 0.0 113.168 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 35.6 Cg_exo -53.52 161.26 4.3 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.248 1.298 . . . . 0.0 114.53 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.514 ' C ' ' N ' ' A' ' 9' ' ' VAL . 42.7 mm-40 -76.22 -59.99 2.53 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.417 -0.802 . . . . 0.0 109.532 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.574 ' O ' HD23 ' A' ' 12' ' ' LEU . 14.8 mp0 -54.65 -9.62 0.35 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.867 -1.133 . . . . 0.0 107.95 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.514 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -88.07 -67.44 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -49.62 -39.63 36.46 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.949 -1.094 . . . . 0.0 108.819 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 15' ' ' GLN . 37.2 mttp -63.46 -49.42 73.74 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -54.52 -54.37 41.97 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.366 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 mt -54.04 -56.51 9.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -56.74 -32.74 65.86 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.49 -0.756 . . . . 0.0 109.505 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 11' ' ' LYS . 49.3 mt-30 -69.32 -26.33 64.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.193 -0.942 . . . . 0.0 109.048 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.15 -13.09 0.74 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.298 -0.876 . . . . 0.0 109.131 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.413 ' N ' ' C ' ' A' ' 15' ' ' GLN . 8.6 p -51.56 -36.68 46.26 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -60.17 -69.27 0.23 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.447 -0.783 . . . . 0.0 109.105 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.3 mt -42.73 -29.6 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 121.883 0.849 . . . . 0.0 109.334 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.568 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 29.6 mt-10 -79.52 -48.88 13.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 18' ' ' SER . 16.6 mmt85 -60.61 -33.32 72.59 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.8 mp -63.99 -66.97 0.47 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 122.022 0.915 . . . . 0.0 109.699 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 28' ' ' GLY . 18.7 p -57.37 -16.69 9.72 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.767 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -95.48 -29.58 14.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.174 -0.954 . . . . 0.0 109.844 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -95.3 -68.53 0.8 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.208 -0.933 . . . . 0.0 110.635 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -52.49 -54.29 34.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.179 -0.951 . . . . 0.0 110.966 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.01 -80.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.078 -1.014 . . . . 0.0 111.192 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.95 37.91 0.37 Allowed Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -163.69 128.97 2.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -1.189 . . . . 0.0 109.246 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.6 m -144.12 105.19 4.79 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.14 -0.975 . . . . 0.0 109.022 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 33' ' ' TRP . 89.6 Cg_endo -82.56 -29.22 1.49 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.836 1.69 . . . . 0.0 112.992 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.08 11.15 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 109.159 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.568 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 16.8 m-90 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.627 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 3' ' ' LEU . 9.3 p30 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.235 0.541 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.463 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 1.0 OUTLIER -50.05 90.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.612 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 1' ' ' ASN . 5.6 mt -65.03 -0.14 1.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.271 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 2' ' ' GLU . 0.9 OUTLIER -83.46 47.53 1.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 109.53 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 38.2 t -73.59 -34.88 2.34 Favored Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.329 -0.857 . . . . 0.0 110.622 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 89.1 Cg_exo -50.98 106.03 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.207 1.938 . . . . 0.0 112.845 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.499 ' C ' ' N ' ' A' ' 9' ' ' VAL . 64.7 tt0 -95.46 -58.34 2.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.763 -0.586 . . . . 0.0 109.478 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.595 ' O ' HD23 ' A' ' 12' ' ' LEU . 26.0 mm-40 -54.89 -9.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' N ' ' C ' ' A' ' 7' ' ' GLU . 3.9 t -84.74 -68.03 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -46.37 -33.81 4.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.595 -0.691 . . . . 0.0 109.569 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -73.03 -48.12 38.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -56.23 -55.13 36.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -49.16 -56.81 2.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 17' ' ' THR . 19.0 mt-30 -53.37 -42.76 67.19 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -72.46 -18.78 61.66 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.312 -0.868 . . . . 0.0 108.885 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -72.38 -9.36 58.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.321 -0.862 . . . . 0.0 109.078 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 20' ' ' GLU . 6.5 p -46.16 -65.54 0.54 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.785 . . . . 0.0 109.423 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -36.21 -66.59 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.618 0.723 . . . . 0.0 110.763 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -45.01 -27.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 109.914 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.518 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 0.3 OUTLIER -83.85 -35.78 23.93 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' SER . 10.7 mmt180 -72.21 -25.53 61.69 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.7 mp -64.21 -65.63 0.65 Allowed 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.636 0.731 . . . . 0.0 110.009 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 28' ' ' GLY . 5.0 p -47.09 -58.15 4.32 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -47.36 -34.56 7.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.968 . . . . 0.0 109.99 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -95.49 -70.4 0.71 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.044 . . . . 0.0 111.294 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 22' ' ' LEU . 52.5 m-85 -53.21 -67.68 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.74 -81.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.118 -0.989 . . . . 0.0 110.697 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 134.32 42.56 0.14 Allowed Glycine 0 N--CA 1.498 2.833 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -165.95 116.74 1.03 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -1.15 . . . . 0.0 109.201 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 m -130.24 90.04 43.02 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.76 41.09 0.99 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.974 1.783 . . . . 0.0 112.89 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.494 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 71.9 t80 -160.19 27.8 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.709 -1.245 . . . . 0.0 110.121 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.163 179.639 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.6 m120 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.292 0.568 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.481 ' C ' ' N ' ' A' ' 4' ' ' ASP . 63.6 mm-40 -46.54 109.87 0.23 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.0 109.762 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.8 tp -50.54 -13.32 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 108.772 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.481 ' N ' ' C ' ' A' ' 2' ' ' GLU . 3.5 p30 -100.44 56.73 0.91 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.51 -0.744 . . . . 0.0 109.333 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.624 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.0 t -73.55 -34.06 2.08 Favored Pre-proline 0 N--CA 1.486 1.333 0 O-C-N 121.084 -1.01 . . . . 0.0 110.837 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 48.8 Cg_exo -57.79 55.47 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.486 2.124 . . . . 0.0 113.455 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 5' ' ' VAL . 52.0 mt-10 -82.4 -66.26 0.91 Allowed 'General case' 0 C--N 1.286 -2.182 0 O-C-N 121.233 -0.917 . . . . 0.0 108.589 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.516 ' O ' HD23 ' A' ' 12' ' ' LEU . 14.5 mm100 -55.62 -9.73 0.57 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.856 -1.152 . . . . 0.0 108.041 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.487 ' N ' ' C ' ' A' ' 7' ' ' GLU . 42.1 t -81.3 -67.04 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 14' ' ' GLN . 2.2 t0 -45.09 -44.17 10.2 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -62.64 -50.24 72.01 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.329 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -55.09 -54.99 36.13 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.395 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -50.26 -58.04 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -56.39 -36.6 69.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.557 -0.714 . . . . 0.0 109.812 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 11' ' ' LYS . 52.3 mt-30 -76.89 -49.9 14.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.947 -1.095 . . . . 0.0 109.42 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -53.02 -9.05 0.12 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 108.949 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 14' ' ' GLN . 6.5 p -42.98 -23.88 0.05 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.072 0.939 . . . . 0.0 108.864 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.5 m -79.32 -70.81 0.48 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.9 mt -43.74 -37.57 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-O 122.027 0.918 . . . . 0.0 109.298 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.507 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 1.6 pt-20 -73.63 -45.51 52.4 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' NE ' ' OE1' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -58.0 -41.24 82.63 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mp -55.9 -59.25 5.15 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.154 0.978 . . . . 0.0 109.132 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 5.3 p -55.75 -32.6 63.54 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.19 -178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.542 ' OE1' ' NE ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -95.5 -25.42 16.22 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.763 -1.211 . . . . 0.0 110.968 -178.098 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 21' ' ' ARG . 10.2 t-80 -87.82 -68.68 0.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.042 -1.036 . . . . 0.0 110.971 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -76.91 -47.92 19.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.149 -0.969 . . . . 0.0 111.408 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mm -76.34 -76.05 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.89 -1.131 . . . . 0.0 109.898 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.41 -36.95 2.36 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.508 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 4.1 t90 -90.84 151.36 21.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.4 -1.059 . . . . 0.0 109.4 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 60.1 m -156.99 150.47 19.0 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 56.2 Cg_endo -70.28 -89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 121.353 1.369 . . . . 0.0 111.949 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 31' ' ' PRO . 19.8 m-85 -155.4 47.12 0.51 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.844 -1.16 . . . . 0.0 111.164 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 O-C-N 120.563 -1.336 . . . . 0.0 108.718 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.484 ' C ' ' H ' ' A' ' 4' ' ' ASP . 1.2 pm0 -159.07 84.62 0.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.688 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.621 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.4 mm? -76.73 18.56 0.33 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 108.45 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 20.8 p-10 -66.62 99.1 0.56 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.352 0.596 . . . . 0.0 110.331 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.603 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 53.1 t -80.29 -32.86 0.72 Allowed Pre-proline 0 N--CA 1.484 1.261 0 O-C-N 121.222 -0.924 . . . . 0.0 110.91 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 9.2 Cg_exo -40.27 119.68 0.74 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.307 2.005 . . . . 0.0 112.087 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.521 ' C ' ' N ' ' A' ' 9' ' ' VAL . 69.1 tt0 -85.33 -70.88 0.56 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.567 -0.708 . . . . 0.0 112.498 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.606 ' CD ' ' H ' ' A' ' 8' ' ' GLN . 22.7 mp0 -51.43 -12.28 0.15 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.425 -1.422 . . . . 0.0 108.329 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.521 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.3 t -81.35 -64.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.506 ' OD1' ' NE2' ' A' ' 14' ' ' GLN . 5.6 t70 -46.05 -45.63 16.21 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' NZ ' ' CG ' ' A' ' 7' ' ' GLU . 27.2 mttp -59.28 -51.96 67.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.584 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -54.34 -53.45 53.67 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 8.0 mt -54.42 -59.75 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.506 ' NE2' ' OD1' ' A' ' 10' ' ' ASP . 37.0 mt-30 -51.47 -38.09 52.1 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.329 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 17' ' ' THR . 42.9 mt-30 -64.19 -28.25 69.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -0.91 . . . . 0.0 108.683 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 13' ' ' ILE . . . -46.33 -13.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.592 -0.693 . . . . 0.0 109.702 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' GLN . 5.9 p -52.17 -31.93 33.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 108.472 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -65.02 -70.63 0.22 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.051 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' SER . 94.6 mt -38.38 -30.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.864 0.84 . . . . 0.0 109.591 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' SER . 16.1 mt-10 -75.47 -53.01 9.37 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' SER . 5.3 mmt-85 -52.57 -43.74 65.46 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 25' ' ' HIS . 7.8 mp -59.9 -62.39 1.91 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.029 0.919 . . . . 0.0 109.443 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 1.7 p -44.13 -49.29 9.04 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.456 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.612 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 58.9 mt-30 -62.86 -24.19 67.67 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.887 -1.133 . . . . 0.0 108.71 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 22' ' ' LEU . 46.8 t-80 -96.13 -58.78 1.99 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.458 -0.776 . . . . 0.0 111.193 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.481 ' N ' ' O ' ' A' ' 22' ' ' LEU . 73.6 m-85 -88.93 -80.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 0.0 112.037 -177.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 29' ' ' TRP . 3.8 mm -48.62 -19.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.03 -1.044 . . . . 0.0 109.74 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 68.07 -55.44 0.41 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.471 ' N ' ' O ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -76.68 159.08 30.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -1.191 . . . . 0.0 108.856 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 31' ' ' PRO . 52.8 m -154.55 106.22 2.37 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 24.6 Cg_exo -37.08 -105.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.346 2.03 . . . . 0.0 113.58 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 68.5 m-85 -158.99 63.43 0.41 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.352 -1.468 . . . . 0.0 110.069 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.395 179.169 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.523 ' C ' ' N ' ' A' ' 9' ' ' VAL . 80.6 mt-10 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 120.633 0.254 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.547 ' O ' HD23 ' A' ' 12' ' ' LEU . 30.1 mt-30 -50.26 -12.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.638 -1.289 . . . . 0.0 108.542 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.523 ' N ' ' C ' ' A' ' 7' ' ' GLU . 3.2 t -79.14 -65.5 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -44.51 -45.58 9.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.634 -0.666 . . . . 0.0 109.325 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -62.29 -50.04 73.26 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -55.94 -55.1 36.77 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -50.22 -59.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -50.58 -27.86 7.59 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 108.981 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -99.78 -0.64 39.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.58 -0.7 . . . . 0.0 109.768 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -72.71 -10.71 60.11 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.367 -0.833 . . . . 0.0 110.132 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -50.11 -21.12 1.16 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -91.47 -68.31 0.8 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.492 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 95.1 mt -40.99 -28.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.731 0.777 . . . . 0.0 109.639 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 18' ' ' SER . 23.3 mt-10 -75.82 -47.72 24.53 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' SER . 5.4 mmt180 -60.2 -29.96 69.06 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -65.87 -67.89 0.41 Allowed 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.284 -0.885 . . . . 0.0 110.424 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.8 OUTLIER -54.83 -63.88 1.01 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.035 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.621 ' NE2' ' N ' ' A' ' 24' ' ' GLN . 0.7 OUTLIER -43.96 -32.52 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -0.877 . . . . 0.0 110.455 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -95.65 -70.16 0.72 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.91 -1.119 . . . . 0.0 110.924 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.479 ' HB2' HD12 ' A' ' 27' ' ' ILE . 48.1 m-85 -63.46 -69.77 0.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 111.101 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.496 ' H ' HD12 ' A' ' 27' ' ' ILE . 3.9 mp -92.26 -80.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.138 -0.976 . . . . 0.0 110.982 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 123.01 38.44 0.56 Allowed Glycine 0 N--CA 1.501 3.018 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.402 ' H ' ' HB2' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -137.16 91.4 2.62 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.441 -1.035 . . . . 0.0 109.107 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.1 m -139.43 69.7 39.35 Favored Pre-proline 0 N--CA 1.498 1.933 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 33' ' ' TRP . 79.8 Cg_endo -86.84 -21.69 2.07 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.099 2.533 . . . . 0.0 112.662 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -53.73 -7.27 0.11 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 0.0 109.038 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.508 ' H ' ' C ' ' A' ' 31' ' ' PRO . 8.4 m-90 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.552 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.523 ' C ' ' N ' ' A' ' 9' ' ' VAL . 2.3 pm0 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.056 -0.021 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.52 ' O ' HD23 ' A' ' 12' ' ' LEU . 4.2 mp0 -48.1 -16.64 0.1 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.611 -1.306 . . . . 0.0 108.264 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.523 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.2 t -73.08 -60.1 2.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -45.43 -45.28 12.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 0.0 109.127 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 15' ' ' GLN . 1.2 mptp? -61.64 -50.55 72.08 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -55.78 -55.5 31.6 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -48.55 -57.64 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -53.42 -36.72 61.83 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 11' ' ' LYS . 18.7 mt-30 -87.27 -3.49 59.04 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -78.33 -7.58 57.42 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.486 -0.759 . . . . 0.0 109.84 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 16' ' ' ALA . 3.3 p -37.97 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.9 0.857 . . . . 0.0 109.549 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 m -83.56 -70.38 0.57 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mt -42.81 -34.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.709 0.766 . . . . 0.0 109.299 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.506 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 2.3 pt-20 -75.94 -38.02 58.04 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' SER . 2.5 mmp_? -66.62 -33.91 76.71 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 24' ' ' GLN . 8.9 mp -62.67 -61.6 2.31 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.843 0.83 . . . . 0.0 110.212 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 14.4 p -43.43 -16.4 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.59 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' LEU . 73.2 mt-30 -91.57 -37.71 12.93 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.993 -1.067 . . . . 0.0 109.873 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -92.75 -70.16 0.71 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.161 -0.962 . . . . 0.0 110.258 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -44.56 -63.98 0.79 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.89 . . . . 0.0 110.356 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.13 -80.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.278 -0.889 . . . . 0.0 110.061 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 145.6 -54.55 0.55 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.514 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -73.01 165.01 25.85 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.335 -1.097 . . . . 0.0 108.571 179.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 70.7 m -155.63 118.6 2.37 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 108.383 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -39.48 -84.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.486 1.457 . . . . 0.0 112.908 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -172.65 66.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.414 -1.429 . . . . 0.0 110.164 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 120.528 -1.358 . . . . 0.0 108.845 178.661 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.477 ' C ' ' N ' ' A' ' 9' ' ' VAL . 64.3 mm-40 . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.552 ' O ' HD23 ' A' ' 12' ' ' LEU . 20.4 mm-40 -57.85 -9.36 1.26 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.477 ' N ' ' C ' ' A' ' 7' ' ' GLU . 44.4 t -84.43 -68.79 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.59 -37.9 8.78 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -68.0 -48.02 66.9 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -56.91 -56.39 22.28 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.486 ' O ' HG23 ' A' ' 17' ' ' THR . 9.1 mt -47.4 -58.71 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.45 ' O ' ' OG1' ' A' ' 17' ' ' THR . 39.0 mt-30 -50.06 -31.86 14.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 17' ' ' THR . 14.8 mm-40 -87.43 -66.55 0.9 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.236 -0.915 . . . . 0.0 109.267 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -48.96 -9.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.793 . . . . 0.0 109.867 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 15' ' ' GLN . 0.8 OUTLIER -76.25 -45.25 33.66 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.833 -1.167 . . . . 0.0 108.213 179.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.624 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.8 m -51.93 -28.93 18.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.355 -0.84 . . . . 0.0 109.316 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 18' ' ' SER . 79.7 mt -45.92 -23.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 120.761 -1.212 . . . . 0.0 107.925 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.476 ' N ' ' C ' ' A' ' 18' ' ' SER . 42.1 mt-10 -77.1 -41.88 40.29 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.624 ' N ' ' O ' ' A' ' 18' ' ' SER . 2.2 mtm180 -66.46 -33.32 75.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -70.45 -69.72 0.34 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.358 -0.838 . . . . 0.0 110.439 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' A' ' 28' ' ' GLY . 21.7 p -46.76 -61.46 1.83 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.738 -0.601 . . . . 0.0 110.118 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.491 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 75.8 mt-30 -47.9 -29.94 3.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 109.776 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -95.48 -67.92 0.83 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.238 -0.914 . . . . 0.0 110.554 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.516 ' HB2' HD12 ' A' ' 27' ' ' ILE . 61.0 m-85 -68.42 -65.97 0.63 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 111.213 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.516 HD12 ' HB2' ' A' ' 26' ' ' TYR . 4.2 mp -98.9 -81.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.147 -0.97 . . . . 0.0 111.511 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 137.59 -5.13 3.43 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -86.14 118.51 25.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.203 -1.175 . . . . 0.0 109.613 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 m -160.21 101.36 1.4 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.477 -0.764 . . . . 0.0 108.957 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -41.81 -86.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.647 2.231 . . . . 0.0 113.864 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.407 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 53.2 t80 -178.5 74.21 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.854 -1.154 . . . . 0.0 109.327 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.403 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.481 ' C ' ' N ' ' A' ' 9' ' ' VAL . 33.9 tt0 . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.51 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.6 pt20 -49.3 -19.67 0.53 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.674 -1.266 . . . . 0.0 108.004 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.481 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.7 t -71.76 -63.95 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 14' ' ' GLN . 23.2 t70 -46.52 -48.25 19.36 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -55.21 -50.82 68.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -59.54 -56.62 19.69 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 8.2 mt -51.84 -56.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 10' ' ' ASP . 32.4 mm-40 -48.93 -41.34 33.52 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.605 0.717 . . . . 0.0 109.187 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -67.26 -11.14 56.71 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 13' ' ' ILE . . . -76.48 -9.85 58.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.49 -0.756 . . . . 0.0 108.994 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 p -52.99 -32.38 46.02 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -64.89 -70.05 0.25 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' SER . 96.8 mt -43.46 -29.1 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.841 0.829 . . . . 0.0 109.149 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.572 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 34.9 mt-10 -75.79 -46.31 31.37 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -61.77 -38.23 87.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.85 -64.9 0.79 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.069 0.938 . . . . 0.0 109.051 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.4 ' O ' ' N ' ' A' ' 28' ' ' GLY . 13.7 p -55.51 -23.65 27.4 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.054 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -95.41 -29.54 14.37 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.981 -1.074 . . . . 0.0 110.588 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 21' ' ' ARG . 23.8 t60 -91.66 -70.38 0.69 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.008 -1.058 . . . . 0.0 111.246 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -66.46 -45.92 78.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.128 -0.982 . . . . 0.0 110.783 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.5 mm -85.75 -72.0 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.017 -1.052 . . . . 0.0 109.79 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 103.58 42.94 1.91 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.45 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -170.04 120.2 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.221 -1.164 . . . . 0.0 108.941 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.45 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.8 m -147.7 72.58 11.56 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 120.982 -1.074 . . . . 0.0 109.889 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -83.36 29.91 0.54 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.666 2.244 . . . . 0.0 112.338 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -127.79 17.17 6.85 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.402 -0.811 . . . . 0.0 109.041 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.572 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 2.9 m-90 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.976 -1.012 . . . . 0.0 108.747 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.631 ' OE2' ' OE1' ' A' ' 8' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 119.97 -0.062 . . . . 0.0 111.135 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.631 ' OE1' ' OE2' ' A' ' 7' ' ' GLU . 1.0 OUTLIER -57.35 -9.97 1.2 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 119.88 -1.763 . . . . 0.0 107.455 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.498 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -84.25 -65.93 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 9' ' ' VAL . 27.8 t70 -46.34 -43.67 16.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.633 -0.667 . . . . 0.0 109.21 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -62.51 -49.26 76.07 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.43 -57.06 14.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 17' ' ' THR . 9.7 mt -48.98 -61.26 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.417 ' O ' ' OG1' ' A' ' 17' ' ' THR . 51.9 mt-30 -46.71 -38.26 9.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -79.15 -25.88 42.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.584 -0.698 . . . . 0.0 109.264 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -95.62 -9.65 31.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.323 -0.86 . . . . 0.0 110.227 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 13' ' ' ILE . 1.6 p -48.11 -40.77 24.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.088 -1.007 . . . . 0.0 108.874 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.444 ' C ' HD13 ' A' ' 22' ' ' LEU . 1.7 m -65.52 -67.72 0.42 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.619 -0.676 . . . . 0.0 109.27 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.497 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 98.0 mt -41.35 -28.43 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.891 0.853 . . . . 0.0 109.516 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.574 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 27.3 mt-10 -78.08 -57.99 3.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -51.85 -27.09 11.49 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.4 mp -70.11 -67.44 0.49 Allowed 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.341 -0.849 . . . . 0.0 110.983 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.554 ' CA ' ' H ' ' A' ' 28' ' ' GLY . 1.6 p -64.04 -57.14 10.54 Favored 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.564 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.489 ' OE1' ' SG ' ' A' ' 23' ' ' CYS . 7.5 mp0 -46.4 -33.62 4.03 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.872 -1.143 . . . . 0.0 109.348 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -95.53 -61.58 1.44 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -0.923 . . . . 0.0 110.279 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' LEU . 6.2 m-85 -81.66 -73.89 0.36 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 111.558 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.549 HD13 ' N ' ' A' ' 27' ' ' ILE . 1.9 mm -76.56 -79.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.535 -1.353 . . . . 0.0 110.616 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.554 ' H ' ' CA ' ' A' ' 23' ' ' CYS . . . 122.26 -9.23 9.54 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.479 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 75.2 t90 -84.86 100.16 11.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.628 -0.925 . . . . 0.0 109.459 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.479 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 10.3 m -160.17 73.3 3.03 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 109.059 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 33' ' ' TRP . 94.7 Cg_endo -85.38 -22.73 2.53 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 123.115 2.544 . . . . 0.0 112.892 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -56.61 -3.2 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.055 -1.028 . . . . 0.0 109.239 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.574 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 8.4 m-90 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.655 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 9' ' ' VAL . 4.4 mp0 . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.58 ' O ' HD23 ' A' ' 12' ' ' LEU . 19.9 mp0 -49.77 -12.93 0.08 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.677 -1.264 . . . . 0.0 108.315 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 7' ' ' GLU . 2.3 t -82.22 -67.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' HG12 ' A' ' 9' ' ' VAL . 26.3 t0 -46.92 -40.43 14.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 108.876 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' GLN . 38.7 mttt -63.94 -50.68 67.7 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -53.46 -54.74 32.69 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.0 mt -51.2 -58.95 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 17' ' ' THR . 32.1 mt-30 -55.78 -35.52 66.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.627 -0.671 . . . . 0.0 109.804 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 11' ' ' LYS . 45.1 mt-30 -76.0 -23.72 55.25 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 108.926 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -50.04 -12.93 0.09 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 109.42 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 15' ' ' GLN . 32.3 p -52.65 -32.87 44.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 108.44 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.492 ' C ' HD13 ' A' ' 22' ' ' LEU . 1.6 m -63.02 -70.1 0.23 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.482 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 84.1 mt -42.91 -27.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 121.943 0.878 . . . . 0.0 109.313 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.532 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 36.1 mt-10 -81.28 -47.91 12.71 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 18' ' ' SER . 13.1 mmm-85 -63.68 -28.81 70.15 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.9 mp -61.77 -66.21 0.57 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.867 0.841 . . . . 0.0 109.919 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.535 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.8 OUTLIER -58.04 -60.97 2.91 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.841 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -45.28 -33.49 2.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.267 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -95.32 -65.58 0.97 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.073 -1.017 . . . . 0.0 110.58 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' A' ' 22' ' ' LEU . 45.5 m-85 -68.14 -68.18 0.41 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.157 -0.965 . . . . 0.0 110.843 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.488 HD12 ' HB2' ' A' ' 26' ' ' TYR . 4.1 mp -97.22 -80.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.198 -0.939 . . . . 0.0 111.269 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 131.93 6.8 3.12 Favored Glycine 0 N--CA 1.502 3.089 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -98.12 99.46 10.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.271 -1.135 . . . . 0.0 109.804 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.4 m -155.11 69.48 5.57 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.934 . . . . 0.0 108.898 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 33' ' ' TRP . 70.5 Cg_endo -86.54 -19.57 2.83 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.016 2.477 . . . . 0.0 112.651 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -60.02 1.01 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 109.663 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.532 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 7.1 m-90 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.504 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 9' ' ' VAL . 31.1 mp0 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.552 ' O ' HD23 ' A' ' 12' ' ' LEU . 16.2 mp0 -50.98 -10.11 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.835 -1.166 . . . . 0.0 108.669 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 7' ' ' GLU . 28.2 t -82.32 -68.42 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.564 ' CG ' HE21 ' A' ' 14' ' ' GLN . 2.7 t70 -43.63 -40.35 4.06 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.22 -50.11 62.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -56.08 -54.17 48.23 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -49.37 -57.21 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.564 HE21 ' CG ' ' A' ' 10' ' ' ASP . 2.8 mp0 -53.41 -42.71 67.28 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -77.26 -9.73 58.98 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.313 -0.867 . . . . 0.0 109.048 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -90.33 -9.04 49.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.6 p -76.61 -29.99 56.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.453 -0.779 . . . . 0.0 110.649 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 21' ' ' ARG . 4.0 m -92.51 -14.87 27.78 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.967 -1.083 . . . . 0.0 110.627 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.491 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 43.1 mt -49.36 -23.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 120.446 -1.409 . . . . 0.0 107.399 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.524 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 16.2 pt-20 -78.08 -38.14 44.89 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' SER . 7.2 mmt-85 -69.83 -32.94 71.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.5 mp -66.48 -68.63 0.36 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.951 0.881 . . . . 0.0 110.499 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.524 ' SG ' ' NE2' ' A' ' 24' ' ' GLN . 2.5 p -48.57 -62.25 1.6 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.738 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.529 ' N ' ' OE1' ' A' ' 24' ' ' GLN . 1.2 mp0 -43.28 -33.54 1.0 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.404 -0.81 . . . . 0.0 110.041 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.473 ' CD2' ' CE1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -95.79 -52.33 4.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.416 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.473 ' CE1' ' CD2' ' A' ' 25' ' ' HIS . 13.8 m-85 -92.94 -68.52 0.8 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 111.85 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.535 HD13 ' N ' ' A' ' 27' ' ' ILE . 2.1 mm -82.07 -80.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.432 -1.418 . . . . 0.0 110.301 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.503 ' H ' ' CB ' ' A' ' 23' ' ' CYS . . . 130.5 -14.31 5.59 Favored Glycine 0 N--CA 1.501 2.997 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -90.12 115.81 27.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.189 -1.183 . . . . 0.0 109.168 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 31' ' ' PRO . 1.7 m -160.7 109.0 1.32 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 109.129 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.542 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 35.7 Cg_exo -38.31 -102.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.175 1.917 . . . . 0.0 113.493 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.542 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 51.8 m-85 -159.6 65.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.415 -1.428 . . . . 0.0 110.015 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.411 ' C ' ' O ' ' A' ' 32' ' ' PHE . 3.1 m-90 . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.644 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.471 ' C ' ' N ' ' A' ' 9' ' ' VAL . 15.7 tt0 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.556 ' O ' HD23 ' A' ' 12' ' ' LEU . 4.0 mp0 -56.4 -9.44 0.7 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.471 ' N ' ' C ' ' A' ' 7' ' ' GLU . 37.4 t -82.05 -66.73 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -46.1 -43.88 15.12 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.51 -49.55 74.9 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -56.01 -56.17 24.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' THR . 9.1 mt -49.78 -60.7 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -48.62 -33.0 9.06 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -82.0 -49.56 10.11 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.354 -0.841 . . . . 0.0 109.878 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.69 -16.25 62.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.975 . . . . 0.0 109.665 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 20' ' ' GLU . 1.1 p -66.53 -48.03 71.01 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -39.33 -57.6 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.692 0.758 . . . . 0.0 110.005 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.495 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 79.6 mt -45.18 -25.9 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.5 0.667 . . . . 0.0 109.337 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.514 ' OE1' ' NE2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -84.83 -34.16 22.76 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' SER . 34.7 mtm180 -73.33 -36.44 66.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.9 mp -51.9 -61.07 2.49 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.025 0.917 . . . . 0.0 109.713 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -63.45 -62.24 1.81 Allowed 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.383 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.514 ' NE2' ' OE1' ' A' ' 20' ' ' GLU . 73.9 mt-30 -48.48 -29.7 4.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.176 -0.953 . . . . 0.0 110.036 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.426 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 50.4 t60 -95.1 -62.24 1.34 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.05 -1.031 . . . . 0.0 110.367 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' HB2' HD12 ' A' ' 27' ' ' ILE . 38.3 m-85 -75.64 -65.14 0.94 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.13 -0.981 . . . . 0.0 110.936 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 26' ' ' TYR . 3.9 mp -99.49 -81.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.101 -0.999 . . . . 0.0 111.58 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 126.95 32.96 0.66 Allowed Glycine 0 N--CA 1.505 3.238 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -116.33 78.19 1.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.55 -0.971 . . . . 0.0 109.176 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.4 m -150.51 69.21 8.7 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.143 -0.973 . . . . 0.0 109.766 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.19 60.04 7.64 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.634 2.222 . . . . 0.0 111.698 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.53 ' CG ' ' O ' ' A' ' 32' ' ' PHE . 71.2 t80 -162.2 29.36 0.11 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.029 -1.044 . . . . 0.0 110.336 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.018 -0.991 . . . . 0.0 108.766 179.34 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.527 ' C ' ' N ' ' A' ' 9' ' ' VAL . 65.5 tt0 . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.531 ' O ' HD23 ' A' ' 12' ' ' LEU . 79.2 mt-30 -52.8 -12.02 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.527 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -77.6 -70.04 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.513 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -44.81 -42.25 7.69 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -60.88 -52.51 64.76 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -55.65 -55.4 32.54 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.8 mt -52.21 -56.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -54.61 -38.67 67.07 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.395 0.617 . . . . 0.0 109.812 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 11' ' ' LYS . 17.9 mt-30 -65.05 -24.64 67.53 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.465 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.41 -15.84 1.91 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.293 -0.879 . . . . 0.0 109.125 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 p -55.51 -32.92 63.3 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -62.63 -70.25 0.21 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 18' ' ' SER . 72.8 mt -40.32 -33.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 122.063 0.935 . . . . 0.0 109.051 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.408 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 19.2 mt-10 -73.21 -54.14 9.19 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 18' ' ' SER . 31.6 mmt-85 -52.52 -39.13 60.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 24' ' ' GLN . 9.5 mp -63.52 -66.06 0.59 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.975 0.893 . . . . 0.0 109.299 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 6.9 p -46.06 -18.83 0.05 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.319 0.58 . . . . 0.0 109.937 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 22' ' ' LEU . 70.6 mt-30 -95.27 -27.18 15.62 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -96.07 -69.66 0.75 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.049 -1.032 . . . . 0.0 110.827 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -58.85 -58.92 6.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.459 -0.776 . . . . 0.0 111.66 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.449 ' H ' HD12 ' A' ' 27' ' ' ILE . 3.3 mp -94.12 -27.47 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.234 -0.916 . . . . 0.0 111.114 -177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.31 -45.17 2.78 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.499 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 4.1 m95 -69.8 151.6 45.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -1.121 . . . . 0.0 109.127 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 82.4 m -156.04 108.41 2.1 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -36.78 -92.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.919 1.746 . . . . 0.0 113.093 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 65.4 t80 -174.26 69.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.518 -1.364 . . . . 0.0 109.76 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.36 179.274 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.491 ' C ' ' N ' ' A' ' 9' ' ' VAL . 8.7 pt-20 . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.551 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -56.72 -9.83 0.87 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.414 -1.429 . . . . 0.0 107.596 179.269 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.491 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -82.22 -65.85 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.417 ' N ' HG12 ' A' ' 9' ' ' VAL . 9.1 t70 -46.02 -43.29 14.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.472 -0.767 . . . . 0.0 109.123 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -62.17 -50.22 72.69 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.1 -56.15 25.46 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.8 mt -49.49 -57.04 2.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -48.81 -34.63 12.77 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -87.66 -11.12 49.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -75.33 -11.91 60.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.088 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.3 p -77.05 -9.47 58.74 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -94.36 -70.72 0.69 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.78 -0.575 . . . . 0.0 110.007 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.1 mt -38.79 -31.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.602 0.715 . . . . 0.0 109.921 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.48 ' CG ' ' N ' ' A' ' 21' ' ' ARG . 11.9 pt-20 -75.83 -46.4 30.69 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' SER . 1.5 mmm180 -58.91 -40.85 85.75 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.12 -60.6 3.26 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.964 0.888 . . . . 0.0 109.93 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.653 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 7.0 p -51.25 -52.32 45.86 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.428 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.653 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 79.4 mt-30 -62.02 -24.52 67.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.783 -1.198 . . . . 0.0 110.09 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -95.49 -49.02 5.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -0.944 . . . . 0.0 110.538 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -97.81 -76.84 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 111.672 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 27' ' ' ILE . 3.6 mm -59.19 -80.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.834 -1.166 . . . . 0.0 110.323 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 135.53 -60.24 0.64 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.472 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 8.5 t90 -64.42 142.03 58.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.371 -1.076 . . . . 0.0 108.901 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.472 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 3.1 m -155.01 120.61 2.63 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.546 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 60.9 Cg_exo -37.66 -94.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.567 1.512 . . . . 0.0 113.039 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 86.2 m-85 -158.2 59.21 0.46 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.325 -1.485 . . . . 0.0 110.723 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.436 ' HE1' ' HB1' ' A' ' 16' ' ' ALA . 1.1 m-90 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 120.693 -1.254 . . . . 0.0 108.84 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.509 ' C ' ' N ' ' A' ' 9' ' ' VAL . 28.2 mm-40 . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.574 ' O ' HD23 ' A' ' 12' ' ' LEU . 17.3 mp0 -54.23 -9.9 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.885 -1.134 . . . . 0.0 108.081 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.509 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -82.54 -67.36 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.42 ' N ' HG12 ' A' ' 9' ' ' VAL . 1.5 t70 -44.84 -33.86 2.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.616 -0.677 . . . . 0.0 109.614 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 15' ' ' GLN . 14.8 tttt -73.76 -49.14 26.89 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -54.23 -53.44 53.59 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.344 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 mt -50.01 -58.32 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -56.95 -27.42 61.1 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.415 0.626 . . . . 0.0 109.714 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' LYS . 75.8 mt-30 -99.73 0.09 41.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.193 -0.942 . . . . 0.0 110.176 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -67.59 -9.81 46.24 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.29 -0.881 . . . . 0.0 110.189 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.0 p -70.6 -15.15 62.72 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -93.28 -58.4 2.32 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.506 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 77.5 mt -39.59 -26.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 121.866 0.841 . . . . 0.0 109.346 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 18' ' ' SER . 3.5 mm-40 -74.49 -50.26 18.91 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -55.74 -31.86 62.89 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -69.81 -69.45 0.35 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.463 -0.773 . . . . 0.0 110.724 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.5 p -54.58 -57.03 13.03 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.192 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -46.33 -33.11 3.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.082 -1.011 . . . . 0.0 109.779 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -95.62 -65.6 0.96 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.159 -0.963 . . . . 0.0 110.153 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 22' ' ' LEU . 50.2 m-85 -67.25 -72.02 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 110.912 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.432 ' H ' HD12 ' A' ' 27' ' ' ILE . 4.1 mp -93.14 -81.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.054 -1.029 . . . . 0.0 111.16 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 129.53 0.82 5.7 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -92.51 98.92 11.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.271 -1.135 . . . . 0.0 109.258 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.8 m -153.44 77.22 6.03 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 109.068 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 33' ' ' TRP . 65.6 Cg_endo -87.98 -26.05 0.75 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.015 2.477 . . . . 0.0 112.572 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.424 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 86.9 t80 -55.86 -3.9 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.659 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.505 ' H ' ' C ' ' A' ' 31' ' ' PRO . 13.8 m-90 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.607 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.489 ' C ' ' H ' ' A' ' 9' ' ' VAL . 49.1 mt-10 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.56 ' O ' HD23 ' A' ' 12' ' ' LEU . 19.5 mt-30 -54.71 -9.24 0.31 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.956 -1.09 . . . . 0.0 108.347 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 7' ' ' GLU . 54.2 t -85.7 -70.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.426 ' OD1' ' OE1' ' A' ' 14' ' ' GLN . 4.7 t70 -45.85 -31.77 2.27 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.618 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -74.53 -48.63 25.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.66 -55.89 29.0 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.5 mt -49.32 -54.56 5.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.426 ' OE1' ' OD1' ' A' ' 10' ' ' ASP . 8.2 mt-30 -50.29 -42.64 52.72 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -77.14 -6.57 53.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -95.26 -43.41 8.07 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 110.192 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.424 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 10.5 p -34.5 -30.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.975 0.417 . . . . 0.0 111.521 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 m -89.32 -71.37 0.61 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.007 -1.058 . . . . 0.0 109.572 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.9 mt -47.58 -29.11 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.809 ' OE2' ' CG ' ' A' ' 33' ' ' TRP . 17.9 mm-40 -75.49 -53.16 9.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 17' ' ' THR . 13.4 mmm-85 -49.63 -32.17 12.42 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 18' ' ' SER . 8.7 mp -68.38 -68.19 0.41 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.719 0.771 . . . . 0.0 110.351 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' GLY . 28.0 p -60.29 -16.14 31.65 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.652 -0.655 . . . . 0.0 109.584 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -93.13 -31.08 14.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.298 -0.876 . . . . 0.0 109.442 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -95.55 -56.85 2.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.298 -0.876 . . . . 0.0 110.527 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -63.52 -57.41 10.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 110.853 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.8 mp -100.51 -80.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.017 -1.052 . . . . 0.0 110.764 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 131.34 39.9 0.24 Allowed Glycine 0 N--CA 1.502 3.084 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.423 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 2.0 t90 -162.67 124.46 2.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.054 -1.262 . . . . 0.0 108.849 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.423 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.6 m -144.93 94.13 5.44 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.146 -0.971 . . . . 0.0 109.448 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 33' ' ' TRP . 94.3 Cg_endo -84.51 -27.8 1.27 Allowed 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.097 1.865 . . . . 0.0 112.437 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -62.54 -0.16 0.57 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.051 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.809 ' CG ' ' OE2' ' A' ' 20' ' ' GLU . 21.2 m-90 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.282 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.526 ' C ' ' N ' ' A' ' 9' ' ' VAL . 39.4 tt0 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.545 ' O ' HD23 ' A' ' 12' ' ' LEU . 36.0 mm-40 -50.14 -12.47 0.08 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.631 -1.293 . . . . 0.0 108.465 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.526 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -78.68 -64.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.547 ' CG ' HE21 ' A' ' 14' ' ' GLN . 6.0 t70 -43.93 -47.58 8.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 4.4 mptp? -59.49 -52.58 64.96 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -54.17 -50.97 65.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.567 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 16' ' ' ALA . 8.0 mt -56.79 -62.02 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.547 HE21 ' CG ' ' A' ' 10' ' ' ASP . 2.4 mp0 -47.51 -20.08 0.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 109.024 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.443 ' N ' ' C ' ' A' ' 13' ' ' ILE . 46.7 mt-30 -102.08 -16.42 16.42 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.556 0.694 . . . . 0.0 109.347 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -52.98 -9.55 0.13 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.406 -0.809 . . . . 0.0 110.295 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.402 ' N ' ' C ' ' A' ' 15' ' ' GLN . 14.3 p -78.89 -21.66 47.11 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.829 -1.17 . . . . 0.0 109.195 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -95.8 -71.88 0.65 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -0.832 . . . . 0.0 110.969 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 18' ' ' SER . 97.8 mt -42.92 -30.66 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.643 0.735 . . . . 0.0 110.073 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -73.85 -48.42 31.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 18' ' ' SER . 6.0 mmm180 -53.91 -35.27 61.46 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.6 mp -67.8 -67.51 0.45 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.718 0.771 . . . . 0.0 109.975 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 14.3 p -51.05 -58.58 5.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.295 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.639 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 78.8 mt-30 -47.88 -31.49 5.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.783 -1.198 . . . . 0.0 109.797 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -95.9 -59.09 1.93 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.259 -0.901 . . . . 0.0 111.304 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.481 ' N ' ' O ' ' A' ' 22' ' ' LEU . 22.9 m-85 -87.34 -80.32 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.986 -1.071 . . . . 0.0 112.245 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.532 HD13 ' N ' ' A' ' 27' ' ' ILE . 2.3 mm -56.16 -65.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.805 -1.184 . . . . 0.0 110.412 -177.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 107.28 -20.37 32.94 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -96.53 122.08 39.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.504 -0.998 . . . . 0.0 108.728 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.7 m -135.22 94.15 16.1 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -34.24 -98.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.444 2.096 . . . . 0.0 113.819 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.43 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 62.0 t80 -172.08 70.29 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.502 -1.374 . . . . 0.0 109.597 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.77 179.447 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.499 ' C ' ' N ' ' A' ' 9' ' ' VAL . 1.4 tm-20 . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.508 ' O ' HD23 ' A' ' 12' ' ' LEU . 2.9 mp0 -51.55 -13.04 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.786 -1.196 . . . . 0.0 108.232 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.499 ' N ' ' C ' ' A' ' 7' ' ' GLU . 18.0 t -76.22 -65.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.572 ' CG ' HE21 ' A' ' 14' ' ' GLN . 3.1 t70 -43.4 -45.81 6.36 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -61.41 -51.26 69.49 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -56.51 -55.22 36.53 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 16' ' ' ALA . 10.3 mt -49.77 -55.53 4.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.572 HE21 ' CG ' ' A' ' 10' ' ' ASP . 2.8 mp0 -50.93 -41.18 58.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -75.1 -13.3 60.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -88.27 -25.92 22.58 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 14' ' ' GLN . 47.8 p -61.7 -31.76 71.93 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -69.05 -70.9 0.24 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.436 -0.79 . . . . 0.0 109.474 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 79.3 mt -46.41 -28.45 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -78.28 -54.24 6.43 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -51.27 -37.2 45.93 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mp -65.79 -69.93 0.27 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.877 0.846 . . . . 0.0 109.438 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' GLY . 9.0 p -52.64 -38.58 60.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.208 0.528 . . . . 0.0 109.638 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.505 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 37.3 mm-40 -67.15 -36.71 82.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.814 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -90.05 -38.85 13.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.201 -0.937 . . . . 0.0 110.076 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -75.95 -65.56 0.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.905 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.77 -68.64 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 119.68 -2.48 13.63 Favored Glycine 0 N--CA 1.501 3.029 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.451 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -131.97 123.39 27.25 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.539 -0.977 . . . . 0.0 108.496 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.451 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.3 m -147.59 69.63 11.33 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 108.943 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.67 8.96 3.12 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.385 2.056 . . . . 0.0 112.59 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -84.87 -1.21 56.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.035 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.049 179.852 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.541 ' C ' ' N ' ' A' ' 9' ' ' VAL . 31.8 tt0 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.538 ' O ' HD23 ' A' ' 12' ' ' LEU . 24.4 mm100 -48.84 -14.08 0.06 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.706 -1.246 . . . . 0.0 108.249 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.541 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.2 t -77.92 -63.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.552 ' CG ' HE21 ' A' ' 14' ' ' GLN . 5.5 t70 -46.82 -47.6 21.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 108.833 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -57.42 -50.5 72.8 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.7 -55.44 34.77 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.8 mt -51.33 -53.49 15.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.053 -1.03 . . . . 0.0 108.353 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.552 HE21 ' CG ' ' A' ' 10' ' ' ASP . 2.3 mp0 -52.98 -37.74 61.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -72.39 -15.63 61.85 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -95.6 -13.37 24.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 14' ' ' GLN . 30.7 p -71.03 -31.64 68.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.116 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.452 ' O ' HD13 ' A' ' 22' ' ' LEU . 1.7 m -65.75 -71.0 0.2 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.414 -0.804 . . . . 0.0 109.802 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 77.7 mt -46.79 -28.88 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.465 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 32.0 mt-10 -77.93 -49.29 14.45 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 25' ' ' HIS . 11.5 mmm180 -55.93 -34.32 65.52 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 18' ' ' SER . 8.4 mp -62.69 -65.84 0.63 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.982 0.896 . . . . 0.0 109.815 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 28' ' ' GLY . 20.2 p -60.87 -18.4 55.96 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.87 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -95.2 -28.31 15.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 0.0 109.76 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 21' ' ' ARG . 46.9 t60 -95.24 -69.09 0.77 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.168 -0.958 . . . . 0.0 110.395 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -52.71 -54.76 29.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 110.784 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.9 mp -98.84 -80.84 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.154 -0.966 . . . . 0.0 110.798 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.47 42.57 0.24 Allowed Glycine 0 N--CA 1.501 2.988 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.442 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -170.29 130.37 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -1.195 . . . . 0.0 109.089 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.442 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.6 m -146.74 89.52 5.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.208 -0.932 . . . . 0.0 109.523 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 96.6 Cg_endo -84.83 51.73 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.196 1.93 . . . . 0.0 112.364 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 63.8 m-85 -158.52 28.11 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.974 -1.079 . . . . 0.0 109.74 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.465 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 2.9 m-90 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.017 -0.992 . . . . 0.0 108.767 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.494 ' C ' ' N ' ' A' ' 9' ' ' VAL . 28.5 tt0 . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.608 ' CD ' ' H ' ' A' ' 8' ' ' GLN . 3.8 mp0 -56.78 -10.17 0.97 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.494 ' N ' ' C ' ' A' ' 7' ' ' GLU . 3.4 t -82.39 -64.88 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -46.27 -43.93 16.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -60.62 -50.2 74.47 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -58.48 -56.5 21.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 16' ' ' ALA . 10.1 mt -49.29 -52.28 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -51.2 -42.35 60.84 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -71.83 -13.91 61.81 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -86.42 -24.24 25.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.444 -0.785 . . . . 0.0 109.23 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -94.49 -12.55 27.45 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -95.54 -67.83 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 18' ' ' SER . 95.5 mt -38.11 -28.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.836 0.826 . . . . 0.0 109.876 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.531 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 15.7 pt-20 -82.55 -46.56 13.21 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' SER . 11.9 mtt85 -69.6 -30.18 67.88 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' A' ' 26' ' ' TYR . 4.3 mp -65.28 -68.74 0.34 Allowed 'General case' 0 C--O 1.204 -1.309 0 O-C-N 121.224 -0.923 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.58 ' O ' ' N ' ' A' ' 28' ' ' GLY . 3.2 p -41.56 -54.52 3.16 Favored 'General case' 0 N--CA 1.504 2.248 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.673 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.535 ' N ' ' OE1' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -45.99 -42.88 13.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 109.56 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -95.44 -54.86 3.24 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.119 -0.988 . . . . 0.0 109.682 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 22' ' ' LEU . 13.8 m-85 -61.68 -77.46 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.452 -0.78 . . . . 0.0 109.826 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' A' ' 26' ' ' TYR . 5.3 mp -99.15 -80.78 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.584 -0.697 . . . . 0.0 110.512 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 139.98 -7.89 2.97 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -88.17 115.25 25.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.319 -1.106 . . . . 0.0 109.494 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.6 m -160.3 108.55 1.38 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 108.923 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -40.12 -83.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.305 2.003 . . . . 0.0 113.642 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.49 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 53.3 t80 -176.23 71.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.798 -1.189 . . . . 0.0 110.093 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.091 -1.005 . . . . 0.0 109.553 178.85 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.514 ' C ' ' N ' ' A' ' 9' ' ' VAL . 42.7 mm-40 . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.758 ' NE2' ' H ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.65 -9.62 0.35 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.867 -1.133 . . . . 0.0 107.95 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.514 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -88.07 -67.44 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -49.62 -39.63 36.46 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.949 -1.094 . . . . 0.0 108.819 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 15' ' ' GLN . 37.2 mttp -63.46 -49.42 73.74 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -54.52 -54.37 41.97 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.366 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 mt -54.04 -56.51 9.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -56.74 -32.74 65.86 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.49 -0.756 . . . . 0.0 109.505 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 11' ' ' LYS . 49.3 mt-30 -69.32 -26.33 64.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.193 -0.942 . . . . 0.0 109.048 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.15 -13.09 0.74 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.298 -0.876 . . . . 0.0 109.131 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.413 ' N ' ' C ' ' A' ' 15' ' ' GLN . 8.6 p -51.56 -36.68 46.26 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -60.17 -69.27 0.23 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.447 -0.783 . . . . 0.0 109.105 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.3 mt -42.73 -29.6 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 121.883 0.849 . . . . 0.0 109.334 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.568 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 29.6 mt-10 -79.52 -48.88 13.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 18' ' ' SER . 16.6 mmt85 -60.61 -33.32 72.59 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.8 mp -63.99 -66.97 0.47 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 122.022 0.915 . . . . 0.0 109.699 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 28' ' ' GLY . 18.7 p -57.37 -16.69 9.72 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.767 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -95.48 -29.58 14.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.174 -0.954 . . . . 0.0 109.844 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -95.3 -68.53 0.8 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.208 -0.933 . . . . 0.0 110.635 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -52.49 -54.29 34.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.179 -0.951 . . . . 0.0 110.966 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.01 -80.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.078 -1.014 . . . . 0.0 111.192 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.95 37.91 0.37 Allowed Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -163.69 128.97 2.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -1.189 . . . . 0.0 109.246 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.6 m -144.12 105.19 4.79 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.14 -0.975 . . . . 0.0 109.022 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 33' ' ' TRP . 89.6 Cg_endo -82.56 -29.22 1.49 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.836 1.69 . . . . 0.0 112.992 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.08 11.15 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 109.159 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.568 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 16.8 m-90 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.627 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.499 ' C ' ' N ' ' A' ' 9' ' ' VAL . 64.7 tt0 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.595 ' O ' HD23 ' A' ' 12' ' ' LEU . 26.0 mm-40 -54.89 -9.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.499 ' N ' ' C ' ' A' ' 7' ' ' GLU . 3.9 t -84.74 -68.03 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -46.37 -33.81 4.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.595 -0.691 . . . . 0.0 109.569 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -73.03 -48.12 38.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -56.23 -55.13 36.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -49.16 -56.81 2.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 17' ' ' THR . 34.5 mt-30 -53.37 -42.76 67.19 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.46 -18.78 61.66 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.312 -0.868 . . . . 0.0 108.885 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -72.38 -9.36 58.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.321 -0.862 . . . . 0.0 109.078 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 20' ' ' GLU . 6.5 p -46.16 -65.54 0.54 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.785 . . . . 0.0 109.423 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -36.21 -66.59 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.618 0.723 . . . . 0.0 110.763 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -45.01 -27.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 109.914 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.518 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 0.3 OUTLIER -83.85 -35.78 23.93 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' SER . 10.7 mmt180 -72.21 -25.53 61.69 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.7 mp -64.21 -65.63 0.65 Allowed 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.636 0.731 . . . . 0.0 110.009 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 28' ' ' GLY . 5.0 p -47.09 -58.15 4.32 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -47.36 -34.56 7.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.968 . . . . 0.0 109.99 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -95.49 -70.4 0.71 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.044 . . . . 0.0 111.294 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 22' ' ' LEU . 52.5 m-85 -53.21 -67.68 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.74 -81.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.118 -0.989 . . . . 0.0 110.697 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 134.32 42.56 0.14 Allowed Glycine 0 N--CA 1.498 2.833 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -165.95 116.74 1.03 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -1.15 . . . . 0.0 109.201 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 m -130.24 90.04 43.02 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.76 41.09 0.99 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.974 1.783 . . . . 0.0 112.89 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.494 ' CG ' ' O ' ' A' ' 32' ' ' PHE . 71.9 t80 -160.19 27.8 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.709 -1.245 . . . . 0.0 110.121 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.163 179.639 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.487 ' C ' ' N ' ' A' ' 9' ' ' VAL . 52.0 mt-10 . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.516 ' O ' HD23 ' A' ' 12' ' ' LEU . 19.0 mm-40 -55.62 -9.73 0.57 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.856 -1.152 . . . . 0.0 108.041 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.487 ' N ' ' C ' ' A' ' 7' ' ' GLU . 42.1 t -81.3 -67.04 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 14' ' ' GLN . 2.2 t0 -45.09 -44.17 10.2 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -62.64 -50.24 72.01 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.329 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -55.09 -54.99 36.13 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.395 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -50.26 -58.04 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -56.39 -36.6 69.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.557 -0.714 . . . . 0.0 109.812 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 11' ' ' LYS . 13.3 mt-30 -76.89 -49.9 14.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.947 -1.095 . . . . 0.0 109.42 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -53.02 -9.05 0.12 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 108.949 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 14' ' ' GLN . 6.5 p -42.98 -23.88 0.05 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.072 0.939 . . . . 0.0 108.864 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.5 m -79.32 -70.81 0.48 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.9 mt -43.74 -37.57 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-O 122.027 0.918 . . . . 0.0 109.298 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.507 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 1.6 pt-20 -73.63 -45.51 52.4 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.542 ' NE ' ' OE1' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -58.0 -41.24 82.63 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mp -55.9 -59.25 5.15 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.154 0.978 . . . . 0.0 109.132 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 5.3 p -55.75 -32.6 63.54 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.19 -178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.542 ' OE1' ' NE ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -95.5 -25.42 16.22 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.763 -1.211 . . . . 0.0 110.968 -178.098 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 21' ' ' ARG . 3.6 t60 -87.82 -68.68 0.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.042 -1.036 . . . . 0.0 110.971 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -76.91 -47.92 19.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.149 -0.969 . . . . 0.0 111.408 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mm -76.34 -76.05 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.89 -1.131 . . . . 0.0 109.898 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.41 -36.95 2.36 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.508 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 4.1 t90 -90.84 151.36 21.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.4 -1.059 . . . . 0.0 109.4 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 60.1 m -156.99 150.47 19.0 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 56.2 Cg_endo -70.28 -89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 121.353 1.369 . . . . 0.0 111.949 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 31' ' ' PRO . 19.8 m-85 -155.4 47.12 0.51 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.844 -1.16 . . . . 0.0 111.164 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 O-C-N 120.563 -1.336 . . . . 0.0 108.718 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.521 ' C ' ' N ' ' A' ' 9' ' ' VAL . 69.1 tt0 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.642 ' H ' ' NE2' ' A' ' 8' ' ' GLN . 4.1 mp0 -51.43 -12.28 0.15 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.425 -1.422 . . . . 0.0 108.329 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.521 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.3 t -81.35 -64.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.506 ' OD1' ' NE2' ' A' ' 14' ' ' GLN . 5.6 t70 -46.05 -45.63 16.21 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' NZ ' ' CG ' ' A' ' 7' ' ' GLU . 27.2 mttp -59.28 -51.96 67.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.584 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -54.34 -53.45 53.67 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 8.0 mt -54.42 -59.75 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.506 ' NE2' ' OD1' ' A' ' 10' ' ' ASP . 37.0 mt-30 -51.47 -38.09 52.1 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.329 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 17' ' ' THR . 42.9 mt-30 -64.19 -28.25 69.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -0.91 . . . . 0.0 108.683 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 13' ' ' ILE . . . -46.33 -13.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.592 -0.693 . . . . 0.0 109.702 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' GLN . 5.9 p -52.17 -31.93 33.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 108.472 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -65.02 -70.63 0.22 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.051 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' SER . 94.6 mt -38.38 -30.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.864 0.84 . . . . 0.0 109.591 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' SER . 16.1 mt-10 -75.47 -53.01 9.37 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' SER . 5.3 mmt-85 -52.57 -43.74 65.46 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 25' ' ' HIS . 7.8 mp -59.9 -62.39 1.91 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.029 0.919 . . . . 0.0 109.443 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 1.7 p -44.13 -49.29 9.04 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.456 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.612 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 58.9 mt-30 -62.86 -24.19 67.67 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.887 -1.133 . . . . 0.0 108.71 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 22' ' ' LEU . 46.8 t-80 -96.13 -58.78 1.99 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.458 -0.776 . . . . 0.0 111.193 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.481 ' N ' ' O ' ' A' ' 22' ' ' LEU . 73.6 m-85 -88.93 -80.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 0.0 112.037 -177.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 29' ' ' TRP . 3.8 mm -48.62 -19.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.03 -1.044 . . . . 0.0 109.74 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 68.07 -55.44 0.41 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.471 ' N ' ' O ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -76.68 159.08 30.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -1.191 . . . . 0.0 108.856 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 31' ' ' PRO . 52.8 m -154.55 106.22 2.37 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 24.6 Cg_exo -37.08 -105.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.346 2.03 . . . . 0.0 113.58 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 68.5 m-85 -158.99 63.43 0.41 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.352 -1.468 . . . . 0.0 110.069 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.395 179.169 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.473 ' O ' ' N ' ' A' ' 3' ' ' LEU . 34.4 p-10 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.462 ' C ' ' N ' ' A' ' 4' ' ' ASP . 56.2 mt-10 -63.89 77.36 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.208 -0.932 . . . . 0.0 109.523 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 1' ' ' ASN . 31.6 tp -50.19 -13.33 0.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 0.0 108.903 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.462 ' N ' ' C ' ' A' ' 2' ' ' GLU . 1.7 p30 -77.96 52.95 1.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.775 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.627 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.2 t -72.8 -35.77 3.15 Favored Pre-proline 0 C--N 1.306 -1.289 0 O-C-N 121.106 -0.996 . . . . 0.0 110.199 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 84.0 Cg_exo -48.82 117.68 2.91 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.407 2.071 . . . . 0.0 112.271 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.523 ' C ' ' N ' ' A' ' 9' ' ' VAL . 80.6 mt-10 -93.94 -70.53 0.7 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.39 -0.819 . . . . 0.0 111.067 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.547 ' O ' HD23 ' A' ' 12' ' ' LEU . 30.1 mt-30 -50.26 -12.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.638 -1.289 . . . . 0.0 108.542 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.523 ' N ' ' C ' ' A' ' 7' ' ' GLU . 3.2 t -79.14 -65.5 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -44.51 -45.58 9.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.634 -0.666 . . . . 0.0 109.325 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -62.29 -50.04 73.26 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -55.94 -55.1 36.77 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -50.22 -59.57 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -50.58 -27.86 7.59 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 108.981 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -99.78 -0.64 39.5 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.58 -0.7 . . . . 0.0 109.768 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -72.71 -10.71 60.11 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.367 -0.833 . . . . 0.0 110.132 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 p -50.11 -21.12 1.16 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -91.47 -68.31 0.8 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.492 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 95.1 mt -40.99 -28.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-O 121.731 0.777 . . . . 0.0 109.639 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 18' ' ' SER . 23.3 mt-10 -75.82 -47.72 24.53 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 18' ' ' SER . 5.4 mmt180 -60.2 -29.96 69.06 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -65.87 -67.89 0.41 Allowed 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.284 -0.885 . . . . 0.0 110.424 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.537 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.8 OUTLIER -54.83 -63.88 1.01 Allowed 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.035 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.621 ' NE2' ' N ' ' A' ' 24' ' ' GLN . 0.7 OUTLIER -43.96 -32.52 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.296 -0.877 . . . . 0.0 110.455 -179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -95.65 -70.16 0.72 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.91 -1.119 . . . . 0.0 110.924 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.479 ' HB2' HD12 ' A' ' 27' ' ' ILE . 48.1 m-85 -63.46 -69.77 0.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 111.101 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.496 ' H ' HD12 ' A' ' 27' ' ' ILE . 3.9 mp -92.26 -80.64 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.138 -0.976 . . . . 0.0 110.982 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 123.01 38.44 0.56 Allowed Glycine 0 N--CA 1.501 3.018 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.402 ' H ' ' HB2' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -137.16 91.4 2.62 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.441 -1.035 . . . . 0.0 109.107 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.1 m -139.43 69.7 39.35 Favored Pre-proline 0 N--CA 1.498 1.933 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 33' ' ' TRP . 79.8 Cg_endo -86.84 -21.69 2.07 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.099 2.533 . . . . 0.0 112.662 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -53.73 -7.27 0.11 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.078 -1.014 . . . . 0.0 109.038 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.508 ' H ' ' C ' ' A' ' 31' ' ' PRO . 8.4 m-90 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.552 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.478 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 56.5 t30 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 4' ' ' ASP . 18.6 mt-10 -84.07 93.33 8.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 109.83 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 5' ' ' VAL . 10.1 mp -75.2 19.91 0.15 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 108.689 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 2' ' ' GLU . 19.5 p-10 -65.98 40.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.0 110.167 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.622 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.7 t -76.43 -35.25 1.51 Allowed Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.242 -0.912 . . . . 0.0 110.281 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 41.2 Cg_exo -44.63 113.2 0.43 Allowed 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.395 2.063 . . . . 0.0 112.816 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.523 ' C ' ' N ' ' A' ' 9' ' ' VAL . 2.3 pm0 -88.99 -68.41 0.77 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.737 -0.602 . . . . 0.0 110.979 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.52 ' O ' HD23 ' A' ' 12' ' ' LEU . 4.2 mp0 -48.1 -16.64 0.1 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.611 -1.306 . . . . 0.0 108.264 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.523 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.2 t -73.08 -60.1 2.74 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -45.43 -45.28 12.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 0.0 109.127 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 15' ' ' GLN . 1.2 mptp? -61.64 -50.55 72.08 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.7 OUTLIER -55.78 -55.5 31.6 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 178.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -48.55 -57.64 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -53.42 -36.72 61.83 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 11' ' ' LYS . 18.7 mt-30 -87.27 -3.49 59.04 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.209 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -78.33 -7.58 57.42 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.486 -0.759 . . . . 0.0 109.84 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 16' ' ' ALA . 3.3 p -37.97 -25.78 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.9 0.857 . . . . 0.0 109.549 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.56 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 m -83.56 -70.38 0.57 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.9 mt -42.81 -34.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 121.709 0.766 . . . . 0.0 109.299 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.506 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 2.3 pt-20 -75.94 -38.02 58.04 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' SER . 2.5 mmp_? -66.62 -33.91 76.71 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 24' ' ' GLN . 8.9 mp -62.67 -61.6 2.31 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.843 0.83 . . . . 0.0 110.212 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 14.4 p -43.43 -16.4 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.59 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' LEU . 73.2 mt-30 -91.57 -37.71 12.93 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.993 -1.067 . . . . 0.0 109.873 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -92.75 -70.16 0.71 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.161 -0.962 . . . . 0.0 110.258 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -44.56 -63.98 0.79 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.89 . . . . 0.0 110.356 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.13 -80.13 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.278 -0.889 . . . . 0.0 110.061 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 145.6 -54.55 0.55 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.514 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 0.7 OUTLIER -73.01 165.01 25.85 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.335 -1.097 . . . . 0.0 108.571 179.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 70.7 m -155.63 118.6 2.37 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 108.383 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -39.48 -84.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.486 1.457 . . . . 0.0 112.908 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -172.65 66.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.414 -1.429 . . . . 0.0 110.164 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 120.528 -1.358 . . . . 0.0 108.845 178.661 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.476 ' C ' ' N ' ' A' ' 4' ' ' ASP . 4.3 pt-20 -48.25 103.91 0.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 109.701 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.3 mp -52.59 -12.38 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.476 ' N ' ' C ' ' A' ' 2' ' ' GLU . 4.6 p-10 -95.49 78.6 3.39 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.592 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 9.8 t -71.86 -35.22 3.45 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.332 -0.855 . . . . 0.0 110.599 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 72.8 Cg_exo -52.38 84.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.627 1.551 . . . . 0.0 112.493 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.477 ' C ' ' N ' ' A' ' 9' ' ' VAL . 64.3 mm-40 -94.59 -52.78 4.15 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.552 ' O ' HD23 ' A' ' 12' ' ' LEU . 20.4 mm-40 -57.85 -9.36 1.26 Allowed 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.477 ' N ' ' C ' ' A' ' 7' ' ' GLU . 44.4 t -84.43 -68.79 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.59 -37.9 8.78 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -68.0 -48.02 66.9 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.581 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -56.91 -56.39 22.28 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.486 ' O ' HG23 ' A' ' 17' ' ' THR . 9.1 mt -47.4 -58.71 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.45 ' O ' ' OG1' ' A' ' 17' ' ' THR . 39.0 mt-30 -50.06 -31.86 14.13 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 17' ' ' THR . 14.8 mm-40 -87.43 -66.55 0.9 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.236 -0.915 . . . . 0.0 109.267 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.581 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -48.96 -9.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.793 . . . . 0.0 109.867 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 15' ' ' GLN . 0.8 OUTLIER -76.25 -45.25 33.66 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.833 -1.167 . . . . 0.0 108.213 179.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.624 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.8 m -51.93 -28.93 18.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.355 -0.84 . . . . 0.0 109.316 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.409 ' C ' ' O ' ' A' ' 18' ' ' SER . 79.7 mt -45.92 -23.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 120.761 -1.212 . . . . 0.0 107.925 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.476 ' N ' ' C ' ' A' ' 18' ' ' SER . 42.1 mt-10 -77.1 -41.88 40.29 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.624 ' N ' ' O ' ' A' ' 18' ' ' SER . 2.2 mtm180 -66.46 -33.32 75.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -70.45 -69.72 0.34 Allowed 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.358 -0.838 . . . . 0.0 110.439 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.526 ' O ' ' N ' ' A' ' 28' ' ' GLY . 21.7 p -46.76 -61.46 1.83 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.738 -0.601 . . . . 0.0 110.118 -178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.491 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 75.8 mt-30 -47.9 -29.94 3.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 109.776 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -95.48 -67.92 0.83 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.238 -0.914 . . . . 0.0 110.554 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.516 ' HB2' HD12 ' A' ' 27' ' ' ILE . 61.0 m-85 -68.42 -65.97 0.63 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.186 -0.946 . . . . 0.0 111.213 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.516 HD12 ' HB2' ' A' ' 26' ' ' TYR . 4.2 mp -98.9 -81.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.147 -0.97 . . . . 0.0 111.511 -177.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 137.59 -5.13 3.43 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -86.14 118.51 25.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.203 -1.175 . . . . 0.0 109.613 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 m -160.21 101.36 1.4 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.477 -0.764 . . . . 0.0 108.957 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -41.81 -86.12 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.647 2.231 . . . . 0.0 113.864 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.407 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 53.2 t80 -178.5 74.21 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.854 -1.154 . . . . 0.0 109.327 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.403 179.661 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.473 HD22 ' C ' ' A' ' 1' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.535 ' C ' ' H ' ' A' ' 4' ' ' ASP . 7.9 tp10 -76.63 113.01 13.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.001 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 3' ' ' LEU . 9.2 mp -69.7 12.9 0.16 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.168 -0.958 . . . . 0.0 109.203 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' A' ' 2' ' ' GLU . 55.2 p30 -71.53 38.0 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.489 -0.757 . . . . 0.0 110.095 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.636 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.8 t -78.78 -34.85 1.02 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 110.351 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 78.0 Cg_exo -48.79 122.03 7.49 Favored 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 122.447 2.098 . . . . 0.0 112.08 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.481 ' C ' ' N ' ' A' ' 9' ' ' VAL . 33.9 tt0 -93.98 -71.24 0.67 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.286 -0.883 . . . . 0.0 111.665 -177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.51 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.6 pt20 -49.3 -19.67 0.53 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.674 -1.266 . . . . 0.0 108.004 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.7 t -71.76 -63.95 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.411 ' O ' ' N ' ' A' ' 14' ' ' GLN . 23.2 t70 -46.52 -48.25 19.36 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -55.21 -50.82 68.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -59.54 -56.62 19.69 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 8.2 mt -51.84 -56.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 10' ' ' ASP . 32.4 mm-40 -48.93 -41.34 33.52 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.605 0.717 . . . . 0.0 109.187 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -67.26 -11.14 56.71 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 13' ' ' ILE . . . -76.48 -9.85 58.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.49 -0.756 . . . . 0.0 108.994 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.7 p -52.99 -32.38 46.02 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -64.89 -70.05 0.25 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' SER . 96.8 mt -43.46 -29.1 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.841 0.829 . . . . 0.0 109.149 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.572 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 34.9 mt-10 -75.79 -46.31 31.37 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' SER . 0.8 OUTLIER -61.77 -38.23 87.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.85 -64.9 0.79 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.069 0.938 . . . . 0.0 109.051 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.4 ' O ' ' N ' ' A' ' 28' ' ' GLY . 13.7 p -55.51 -23.65 27.4 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.054 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -95.41 -29.54 14.37 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.981 -1.074 . . . . 0.0 110.588 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.486 ' N ' ' O ' ' A' ' 21' ' ' ARG . 23.8 t60 -91.66 -70.38 0.69 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.008 -1.058 . . . . 0.0 111.246 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -66.46 -45.92 78.11 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.128 -0.982 . . . . 0.0 110.783 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.5 mm -85.75 -72.0 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.017 -1.052 . . . . 0.0 109.79 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 103.58 42.94 1.91 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.45 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -170.04 120.2 0.63 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.221 -1.164 . . . . 0.0 108.941 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.45 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.8 m -147.7 72.58 11.56 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 120.982 -1.074 . . . . 0.0 109.889 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -83.36 29.91 0.54 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.666 2.244 . . . . 0.0 112.338 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -127.79 17.17 6.85 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.402 -0.811 . . . . 0.0 109.041 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.572 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 2.9 m-90 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.976 -1.012 . . . . 0.0 108.747 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.547 ' N ' HD22 ' A' ' 1' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 4' ' ' ASP . 27.1 mm-40 -69.35 104.5 2.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 109.43 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.475 ' O ' HD23 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -72.9 12.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.343 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 4' ' ' ASP . 46.7 p-10 -85.55 96.47 9.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.242 -0.911 . . . . 0.0 109.907 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.602 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.0 t -70.59 -36.86 5.99 Favored Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 120.962 -1.086 . . . . 0.0 110.024 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 79.8 Cg_exo -49.5 113.44 0.95 Allowed 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.327 2.018 . . . . 0.0 112.096 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.631 ' OE2' ' OE1' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -95.42 -56.04 2.84 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.413 -0.804 . . . . 0.0 111.135 -178.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.631 ' OE1' ' OE2' ' A' ' 7' ' ' GLU . 1.0 OUTLIER -57.35 -9.97 1.2 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 119.88 -1.763 . . . . 0.0 107.455 179.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.498 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -84.25 -65.93 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.408 ' N ' HG12 ' A' ' 9' ' ' VAL . 27.8 t70 -46.34 -43.67 16.19 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.633 -0.667 . . . . 0.0 109.21 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -62.51 -49.26 76.07 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.43 -57.06 14.33 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.525 ' O ' ' N ' ' A' ' 17' ' ' THR . 9.7 mt -48.98 -61.26 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 177.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.417 ' O ' ' OG1' ' A' ' 17' ' ' THR . 51.9 mt-30 -46.71 -38.26 9.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -79.15 -25.88 42.83 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.584 -0.698 . . . . 0.0 109.264 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -95.62 -9.65 31.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.323 -0.86 . . . . 0.0 110.227 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 13' ' ' ILE . 1.6 p -48.11 -40.77 24.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.088 -1.007 . . . . 0.0 108.874 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.444 ' C ' HD13 ' A' ' 22' ' ' LEU . 1.7 m -65.52 -67.72 0.42 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.619 -0.676 . . . . 0.0 109.27 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.497 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 98.0 mt -41.35 -28.43 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-O 121.891 0.853 . . . . 0.0 109.516 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.574 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 27.3 mt-10 -78.08 -57.99 3.5 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -51.85 -27.09 11.49 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.4 mp -70.11 -67.44 0.49 Allowed 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.341 -0.849 . . . . 0.0 110.983 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.554 ' CA ' ' H ' ' A' ' 28' ' ' GLY . 1.6 p -64.04 -57.14 10.54 Favored 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.564 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.489 ' OE1' ' SG ' ' A' ' 23' ' ' CYS . 7.5 mp0 -46.4 -33.62 4.03 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.872 -1.143 . . . . 0.0 109.348 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -95.53 -61.58 1.44 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -0.923 . . . . 0.0 110.279 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 22' ' ' LEU . 6.2 m-85 -81.66 -73.89 0.36 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 111.558 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.549 HD13 ' N ' ' A' ' 27' ' ' ILE . 1.9 mm -76.56 -79.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.535 -1.353 . . . . 0.0 110.616 -178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.554 ' H ' ' CA ' ' A' ' 23' ' ' CYS . . . 122.26 -9.23 9.54 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.479 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 75.2 t90 -84.86 100.16 11.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.628 -0.925 . . . . 0.0 109.459 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.479 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 10.3 m -160.17 73.3 3.03 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 109.059 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 33' ' ' TRP . 94.7 Cg_endo -85.38 -22.73 2.53 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 123.115 2.544 . . . . 0.0 112.892 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -56.61 -3.2 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.055 -1.028 . . . . 0.0 109.239 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.574 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 8.4 m-90 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.655 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 24.0 t30 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 4' ' ' ASP . 43.8 tt0 -97.9 146.37 25.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.296 -0.878 . . . . 0.0 109.387 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.1 tp -66.04 12.02 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.296 -0.877 . . . . 0.0 109.976 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 2' ' ' GLU . 50.0 p-10 -80.18 83.93 5.96 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.221 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 45.3 t -75.92 -33.08 1.23 Allowed Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.153 -0.967 . . . . 0.0 111.425 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 10.0 Cg_endo -89.53 116.49 0.7 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.464 2.109 . . . . 0.0 111.41 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.571 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 4.4 mp0 -81.41 -62.92 1.51 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.513 -176.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.58 ' O ' HD23 ' A' ' 12' ' ' LEU . 19.9 mp0 -49.77 -12.93 0.08 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.677 -1.264 . . . . 0.0 108.315 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 7' ' ' GLU . 2.3 t -82.22 -67.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.468 ' N ' HG12 ' A' ' 9' ' ' VAL . 26.3 t0 -46.92 -40.43 14.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 108.876 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 15' ' ' GLN . 38.7 mttt -63.94 -50.68 67.7 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -53.46 -54.74 32.69 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.0 mt -51.2 -58.95 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.43 ' O ' HG23 ' A' ' 17' ' ' THR . 32.1 mt-30 -55.78 -35.52 66.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.627 -0.671 . . . . 0.0 109.804 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 11' ' ' LYS . 45.1 mt-30 -76.0 -23.72 55.25 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 108.926 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -50.04 -12.93 0.09 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 109.42 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 15' ' ' GLN . 32.3 p -52.65 -32.87 44.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.154 -0.966 . . . . 0.0 108.44 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.492 ' C ' HD13 ' A' ' 22' ' ' LEU . 1.6 m -63.02 -70.1 0.23 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.482 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 84.1 mt -42.91 -27.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 121.943 0.878 . . . . 0.0 109.313 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.532 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 36.1 mt-10 -81.28 -47.91 12.71 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 18' ' ' SER . 13.1 mmm-85 -63.68 -28.81 70.15 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.9 mp -61.77 -66.21 0.57 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.867 0.841 . . . . 0.0 109.919 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.535 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.8 OUTLIER -58.04 -60.97 2.91 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.841 -179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -45.28 -33.49 2.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 110.267 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -95.32 -65.58 0.97 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.073 -1.017 . . . . 0.0 110.58 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.533 ' N ' ' O ' ' A' ' 22' ' ' LEU . 45.5 m-85 -68.14 -68.18 0.41 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.157 -0.965 . . . . 0.0 110.843 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.488 HD12 ' HB2' ' A' ' 26' ' ' TYR . 4.1 mp -97.22 -80.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.198 -0.939 . . . . 0.0 111.269 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 131.93 6.8 3.12 Favored Glycine 0 N--CA 1.502 3.089 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -98.12 99.46 10.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.271 -1.135 . . . . 0.0 109.804 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.4 m -155.11 69.48 5.57 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.205 -0.934 . . . . 0.0 108.898 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 33' ' ' TRP . 70.5 Cg_endo -86.54 -19.57 2.83 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 123.016 2.477 . . . . 0.0 112.651 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -60.02 1.01 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 109.663 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.532 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 7.1 m-90 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.504 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.481 ' C ' ' N ' ' A' ' 4' ' ' ASP . 80.3 mt-10 -49.92 120.43 4.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.587 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 30.6 tp -51.99 -12.99 0.25 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.481 ' N ' ' C ' ' A' ' 2' ' ' GLU . 7.3 p-10 -115.5 69.61 0.73 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 6' ' ' PRO . 8.0 t -51.48 -60.81 5.09 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 0.0 110.654 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.431 ' C ' ' O ' ' A' ' 5' ' ' VAL . 56.6 Cg_exo -28.46 106.39 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 122.972 2.448 . . . . 0.0 113.208 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 9' ' ' VAL . 31.1 mp0 -95.43 -70.2 0.72 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.576 -0.702 . . . . 0.0 109.949 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.552 ' O ' HD23 ' A' ' 12' ' ' LEU . 16.2 mp0 -50.98 -10.11 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.835 -1.166 . . . . 0.0 108.669 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 7' ' ' GLU . 28.2 t -82.32 -68.42 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.564 ' CG ' HE21 ' A' ' 14' ' ' GLN . 2.7 t70 -43.63 -40.35 4.06 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.22 -50.11 62.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -56.08 -54.17 48.23 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -49.37 -57.21 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.564 HE21 ' CG ' ' A' ' 10' ' ' ASP . 2.8 mp0 -53.41 -42.71 67.28 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -77.26 -9.73 58.98 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.313 -0.867 . . . . 0.0 109.048 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -90.33 -9.04 49.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.6 p -76.61 -29.99 56.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.453 -0.779 . . . . 0.0 110.649 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 21' ' ' ARG . 4.0 m -92.51 -14.87 27.78 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.967 -1.083 . . . . 0.0 110.627 -179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.491 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 43.1 mt -49.36 -23.33 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 O-C-N 120.446 -1.409 . . . . 0.0 107.399 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.524 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 16.2 pt-20 -78.08 -38.14 44.89 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 177.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' SER . 7.2 mmt-85 -69.83 -32.94 71.64 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.5 mp -66.48 -68.63 0.36 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.951 0.881 . . . . 0.0 110.499 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.524 ' SG ' ' NE2' ' A' ' 24' ' ' GLN . 2.5 p -48.57 -62.25 1.6 Allowed 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.738 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' N ' ' OE1' ' A' ' 24' ' ' GLN . 1.2 mp0 -43.28 -33.54 1.0 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.404 -0.81 . . . . 0.0 110.041 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.473 ' CD2' ' CE1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -95.79 -52.33 4.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.291 -0.881 . . . . 0.0 110.416 -179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.473 ' CE1' ' CD2' ' A' ' 25' ' ' HIS . 13.8 m-85 -92.94 -68.52 0.8 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 111.85 -178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.535 HD13 ' N ' ' A' ' 27' ' ' ILE . 2.1 mm -82.07 -80.58 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.432 -1.418 . . . . 0.0 110.301 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.503 ' H ' ' CB ' ' A' ' 23' ' ' CYS . . . 130.5 -14.31 5.59 Favored Glycine 0 N--CA 1.501 2.997 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -90.12 115.81 27.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.189 -1.183 . . . . 0.0 109.168 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.429 ' O ' ' O ' ' A' ' 31' ' ' PRO . 1.7 m -160.7 109.0 1.32 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.18 -0.95 . . . . 0.0 109.129 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.542 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 35.7 Cg_exo -38.31 -102.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.175 1.917 . . . . 0.0 113.493 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.542 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 51.8 m-85 -159.6 65.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.415 -1.428 . . . . 0.0 110.015 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.411 ' C ' ' O ' ' A' ' 32' ' ' PHE . 3.1 m-90 . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.644 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -53.31 124.51 14.85 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.522 ' N ' ' OE1' ' A' ' 2' ' ' GLU . 1.4 tp -50.33 -9.62 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.432 -0.792 . . . . 0.0 109.144 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 2' ' ' GLU . 0.8 OUTLIER -94.14 124.75 38.35 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.617 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.2 t -91.5 -33.65 0.35 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.155 -0.966 . . . . 0.0 111.566 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 72.7 Cg_exo -50.74 82.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.89 1.726 . . . . 0.0 112.946 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 5' ' ' VAL . 15.7 tt0 -95.47 -54.08 3.52 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.556 ' O ' HD23 ' A' ' 12' ' ' LEU . 4.0 mp0 -56.4 -9.44 0.7 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.471 ' N ' ' C ' ' A' ' 7' ' ' GLU . 37.4 t -82.05 -66.73 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -46.1 -43.88 15.12 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.51 -49.55 74.9 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -56.01 -56.17 24.03 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.43 ' O ' ' N ' ' A' ' 17' ' ' THR . 9.1 mt -49.78 -60.7 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -48.62 -33.0 9.06 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.2 mm-40 -82.0 -49.56 10.11 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.354 -0.841 . . . . 0.0 109.878 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -71.69 -16.25 62.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.975 . . . . 0.0 109.665 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 20' ' ' GLU . 1.1 p -66.53 -48.03 71.01 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -39.33 -57.6 1.35 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.692 0.758 . . . . 0.0 110.005 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.495 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 79.6 mt -45.18 -25.9 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.5 0.667 . . . . 0.0 109.337 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.514 ' OE1' ' NE2' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -84.83 -34.16 22.76 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 179.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 18' ' ' SER . 34.7 mtm180 -73.33 -36.44 66.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.9 mp -51.9 -61.07 2.49 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.025 0.917 . . . . 0.0 109.713 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.7 OUTLIER -63.45 -62.24 1.81 Allowed 'General case' 0 C--N 1.283 -2.287 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.383 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.514 ' NE2' ' OE1' ' A' ' 20' ' ' GLU . 73.9 mt-30 -48.48 -29.7 4.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.176 -0.953 . . . . 0.0 110.036 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.426 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 50.4 t60 -95.1 -62.24 1.34 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.05 -1.031 . . . . 0.0 110.367 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' HB2' HD12 ' A' ' 27' ' ' ILE . 38.3 m-85 -75.64 -65.14 0.94 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.13 -0.981 . . . . 0.0 110.936 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 26' ' ' TYR . 3.9 mp -99.49 -81.04 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.101 -0.999 . . . . 0.0 111.58 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 126.95 32.96 0.66 Allowed Glycine 0 N--CA 1.505 3.238 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -116.33 78.19 1.17 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.55 -0.971 . . . . 0.0 109.176 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.4 m -150.51 69.21 8.7 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 121.143 -0.973 . . . . 0.0 109.766 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -81.19 60.04 7.64 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.634 2.222 . . . . 0.0 111.698 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.53 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 71.2 t80 -162.2 29.36 0.11 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.029 -1.044 . . . . 0.0 110.336 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 3.8 m-90 . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 118.018 -0.991 . . . . 0.0 108.766 179.34 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.564 0.697 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.518 ' C ' ' H ' ' A' ' 4' ' ' ASP . 29.6 tt0 -48.71 167.8 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.419 -0.801 . . . . 0.0 109.358 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.2 tp -71.99 16.25 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.48 -0.762 . . . . 0.0 109.63 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 2' ' ' GLU . 37.2 p-10 -83.64 105.36 14.5 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.561 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 1.7 t -72.21 -39.12 6.19 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 120.954 -1.092 . . . . 0.0 110.009 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 11.9 Cg_exo -71.78 92.6 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.246 0 C-N-CA 121.983 1.789 . . . . 0.0 111.521 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' C ' ' N ' ' A' ' 9' ' ' VAL . 65.5 tt0 -94.87 -55.4 3.12 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.531 ' O ' HD23 ' A' ' 12' ' ' LEU . 79.2 mt-30 -52.8 -12.02 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.527 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -77.6 -70.04 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.513 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -44.81 -42.25 7.69 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.3 OUTLIER -60.88 -52.51 64.76 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -55.65 -55.4 32.54 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.8 mt -52.21 -56.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -54.61 -38.67 67.07 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.395 0.617 . . . . 0.0 109.812 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 11' ' ' LYS . 17.9 mt-30 -65.05 -24.64 67.53 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.326 -0.859 . . . . 0.0 109.465 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.41 -15.84 1.91 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.293 -0.879 . . . . 0.0 109.125 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 p -55.51 -32.92 63.3 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -62.63 -70.25 0.21 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.429 ' C ' ' O ' ' A' ' 18' ' ' SER . 72.8 mt -40.32 -33.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 122.063 0.935 . . . . 0.0 109.051 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.408 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 19.2 mt-10 -73.21 -54.14 9.19 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 18' ' ' SER . 31.6 mmt-85 -52.52 -39.13 60.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 24' ' ' GLN . 9.5 mp -63.52 -66.06 0.59 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.975 0.893 . . . . 0.0 109.299 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 6.9 p -46.06 -18.83 0.05 Allowed 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.319 0.58 . . . . 0.0 109.937 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 22' ' ' LEU . 70.6 mt-30 -95.27 -27.18 15.62 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -96.07 -69.66 0.75 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.049 -1.032 . . . . 0.0 110.827 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -58.85 -58.92 6.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.459 -0.776 . . . . 0.0 111.66 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.449 ' H ' HD12 ' A' ' 27' ' ' ILE . 3.3 mp -94.12 -27.47 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.234 -0.916 . . . . 0.0 111.114 -177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.31 -45.17 2.78 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.499 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 4.1 m95 -69.8 151.6 45.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -1.121 . . . . 0.0 109.127 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 82.4 m -156.04 108.41 2.1 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -36.78 -92.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.919 1.746 . . . . 0.0 113.093 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 65.4 t80 -174.26 69.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.518 -1.364 . . . . 0.0 109.76 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.078 -1.014 . . . . 0.0 109.36 179.274 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.577 ' ND2' ' N ' ' A' ' 2' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.577 ' N ' ' ND2' ' A' ' 1' ' ' ASN . 2.8 pt-20 -47.27 107.24 0.11 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.865 . . . . 0.0 109.696 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.7 tp -59.23 -4.45 0.54 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.07 -1.019 . . . . 0.0 108.4 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 2' ' ' GLU . 4.5 p-10 -108.35 118.59 37.18 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.0 t -78.66 -35.17 1.08 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.232 -0.918 . . . . 0.0 111.071 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 80.9 Cg_exo -47.67 110.54 0.32 Allowed 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.384 2.056 . . . . 0.0 113.088 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.491 ' C ' ' N ' ' A' ' 9' ' ' VAL . 8.7 pt-20 -95.54 -55.92 2.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.573 -0.704 . . . . 0.0 110.338 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.551 ' O ' HD23 ' A' ' 12' ' ' LEU . 1.0 OUTLIER -56.72 -9.83 0.87 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.414 -1.429 . . . . 0.0 107.596 179.269 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.491 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -82.22 -65.85 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.417 ' N ' HG12 ' A' ' 9' ' ' VAL . 9.1 t70 -46.02 -43.29 14.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.472 -0.767 . . . . 0.0 109.123 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -62.17 -50.22 72.69 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.1 -56.15 25.46 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.8 mt -49.49 -57.04 2.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -48.81 -34.63 12.77 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -87.66 -11.12 49.35 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -75.33 -11.91 60.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.088 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.3 p -77.05 -9.47 58.74 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -94.36 -70.72 0.69 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.78 -0.575 . . . . 0.0 110.007 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 53.1 mt -38.79 -31.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-O 121.602 0.715 . . . . 0.0 109.921 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.48 ' CG ' ' N ' ' A' ' 21' ' ' ARG . 11.9 pt-20 -75.83 -46.4 30.69 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' SER . 1.5 mmm180 -58.91 -40.85 85.75 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.9 mp -56.12 -60.6 3.26 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.964 0.888 . . . . 0.0 109.93 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.653 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 7.0 p -51.25 -52.32 45.86 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.428 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.653 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 79.4 mt-30 -62.02 -24.52 67.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.783 -1.198 . . . . 0.0 110.09 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -95.49 -49.02 5.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -0.944 . . . . 0.0 110.538 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -97.81 -76.84 0.51 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.076 -1.015 . . . . 0.0 111.672 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 27' ' ' ILE . 3.6 mm -59.19 -80.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.834 -1.166 . . . . 0.0 110.323 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 135.53 -60.24 0.64 Allowed Glycine 0 N--CA 1.497 2.725 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.472 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 8.5 t90 -64.42 142.03 58.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.371 -1.076 . . . . 0.0 108.901 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.472 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 3.1 m -155.01 120.61 2.63 Favored Pre-proline 0 N--CA 1.488 1.45 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.546 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 60.9 Cg_exo -37.66 -94.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 121.567 1.512 . . . . 0.0 113.039 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 86.2 m-85 -158.2 59.21 0.46 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.325 -1.485 . . . . 0.0 110.723 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.436 ' HE1' ' HB1' ' A' ' 16' ' ' ALA . 1.1 m-90 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 120.693 -1.254 . . . . 0.0 108.84 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 4' ' ' ASP . 3.9 pt-20 -61.66 98.06 0.09 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.134 -0.979 . . . . 0.0 109.474 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -73.17 13.92 0.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.196 -0.94 . . . . 0.0 108.662 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 2' ' ' GLU . 38.5 p-10 -44.3 91.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.603 -0.686 . . . . 0.0 110.141 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.626 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.2 t -76.15 -35.23 1.58 Allowed Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 121.248 -0.908 . . . . 0.0 110.479 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 81.4 Cg_exo -49.97 108.0 0.19 Allowed 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.472 2.115 . . . . 0.0 113.113 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' C ' ' N ' ' A' ' 9' ' ' VAL . 28.2 mm-40 -95.63 -59.48 1.86 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.747 -0.595 . . . . 0.0 109.449 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.574 ' O ' HD23 ' A' ' 12' ' ' LEU . 17.3 mp0 -54.23 -9.9 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.885 -1.134 . . . . 0.0 108.081 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.509 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -82.54 -67.36 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.42 ' N ' HG12 ' A' ' 9' ' ' VAL . 1.5 t70 -44.84 -33.86 2.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.616 -0.677 . . . . 0.0 109.614 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' A' ' 15' ' ' GLN . 14.8 tttt -73.76 -49.14 26.89 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -54.23 -53.44 53.59 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.344 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.2 mt -50.01 -58.32 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -56.95 -27.42 61.1 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.415 0.626 . . . . 0.0 109.714 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' LYS . 75.8 mt-30 -99.73 0.09 41.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.193 -0.942 . . . . 0.0 110.176 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -67.59 -9.81 46.24 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.29 -0.881 . . . . 0.0 110.189 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.0 p -70.6 -15.15 62.72 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -93.28 -58.4 2.32 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.506 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 77.5 mt -39.59 -26.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-O 121.866 0.841 . . . . 0.0 109.346 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 18' ' ' SER . 3.5 mm-40 -74.49 -50.26 18.91 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.572 ' N ' ' O ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -55.74 -31.86 62.89 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.1 mp -69.81 -69.45 0.35 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.463 -0.773 . . . . 0.0 110.724 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.542 ' O ' ' N ' ' A' ' 28' ' ' GLY . 1.5 p -54.58 -57.03 13.03 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.192 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -46.33 -33.11 3.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.082 -1.011 . . . . 0.0 109.779 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -95.62 -65.6 0.96 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.159 -0.963 . . . . 0.0 110.153 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 22' ' ' LEU . 50.2 m-85 -67.25 -72.02 0.18 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 110.912 -178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.432 ' H ' HD12 ' A' ' 27' ' ' ILE . 4.1 mp -93.14 -81.17 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.054 -1.029 . . . . 0.0 111.16 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 129.53 0.82 5.7 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -92.51 98.92 11.76 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.271 -1.135 . . . . 0.0 109.258 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.8 m -153.44 77.22 6.03 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.218 -0.926 . . . . 0.0 109.068 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 33' ' ' TRP . 65.6 Cg_endo -87.98 -26.05 0.75 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 123.015 2.477 . . . . 0.0 112.572 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.424 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 86.9 t80 -55.86 -3.9 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.659 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.505 ' H ' ' C ' ' A' ' 31' ' ' PRO . 13.8 m-90 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.607 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.487 ' ND2' ' OE2' ' A' ' 7' ' ' GLU . 1.1 m120 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.339 0.59 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 4' ' ' ASP . 6.0 tt0 -154.34 -165.42 2.08 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.1 mt -75.98 16.84 0.38 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.103 -0.998 . . . . 0.0 108.751 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 2' ' ' GLU . 28.4 p-10 -114.4 109.7 18.73 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.624 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.1 t -71.62 -36.32 4.44 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 120.944 -1.098 . . . . 0.0 110.27 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 32.3 Cg_exo -60.06 100.16 0.14 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.21 1.94 . . . . 0.0 112.413 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.489 ' C ' ' N ' ' A' ' 9' ' ' VAL . 49.1 mt-10 -95.68 -63.4 1.16 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.501 -0.749 . . . . 0.0 109.357 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.56 ' O ' HD23 ' A' ' 12' ' ' LEU . 19.5 mt-30 -54.71 -9.24 0.31 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.956 -1.09 . . . . 0.0 108.347 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.489 ' N ' ' C ' ' A' ' 7' ' ' GLU . 54.2 t -85.7 -70.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 178.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.426 ' OD1' ' OE1' ' A' ' 14' ' ' GLN . 4.7 t70 -45.85 -31.77 2.27 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.618 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 tttm -74.53 -48.63 25.89 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.56 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.66 -55.89 29.0 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.5 mt -49.32 -54.56 5.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.426 ' OE1' ' OD1' ' A' ' 10' ' ' ASP . 8.2 mt-30 -50.29 -42.64 52.72 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -77.14 -6.57 53.42 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -95.26 -43.41 8.07 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.537 -0.727 . . . . 0.0 110.192 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.424 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 10.5 p -34.5 -30.12 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 120.975 0.417 . . . . 0.0 111.521 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.6 m -89.32 -71.37 0.61 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.007 -1.058 . . . . 0.0 109.572 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 90.9 mt -47.58 -29.11 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.809 ' OE2' ' CG ' ' A' ' 33' ' ' TRP . 17.9 mm-40 -75.49 -53.16 9.11 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 17' ' ' THR . 13.4 mmm-85 -49.63 -32.17 12.42 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 18' ' ' SER . 8.7 mp -68.38 -68.19 0.41 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.719 0.771 . . . . 0.0 110.351 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.513 ' O ' ' N ' ' A' ' 28' ' ' GLY . 28.0 p -60.29 -16.14 31.65 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.652 -0.655 . . . . 0.0 109.584 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -93.13 -31.08 14.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.298 -0.876 . . . . 0.0 109.442 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -95.55 -56.85 2.56 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.298 -0.876 . . . . 0.0 110.527 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -63.52 -57.41 10.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 110.853 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.8 mp -100.51 -80.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.017 -1.052 . . . . 0.0 110.764 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 131.34 39.9 0.24 Allowed Glycine 0 N--CA 1.502 3.084 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.423 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 2.0 t90 -162.67 124.46 2.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.054 -1.262 . . . . 0.0 108.849 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.423 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.6 m -144.93 94.13 5.44 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.146 -0.971 . . . . 0.0 109.448 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 33' ' ' TRP . 94.3 Cg_endo -84.51 -27.8 1.27 Allowed 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 122.097 1.865 . . . . 0.0 112.437 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -62.54 -0.16 0.57 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.051 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.809 ' CG ' ' OE2' ' A' ' 20' ' ' GLU . 21.2 m-90 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.282 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 51.0 t30 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 4' ' ' ASP . 0.0 OUTLIER -78.35 87.41 4.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -0.901 . . . . 0.0 109.007 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.47 ' O ' HD23 ' A' ' 3' ' ' LEU . 0.9 OUTLIER -66.07 6.01 0.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.089 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 2' ' ' GLU . 1.0 OUTLIER -86.12 102.95 14.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 0.0 109.292 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.619 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 2.2 t -74.48 -35.35 2.15 Favored Pre-proline 0 C--N 1.306 -1.321 0 O-C-N 121.23 -0.919 . . . . 0.0 110.801 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 74.3 Cg_exo -47.14 114.84 1.1 Allowed 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.234 1.956 . . . . 0.0 112.532 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.526 ' C ' ' N ' ' A' ' 9' ' ' VAL . 39.4 tt0 -93.75 -67.63 0.85 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.669 -0.645 . . . . 0.0 110.441 -178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.545 ' O ' HD23 ' A' ' 12' ' ' LEU . 36.0 mm-40 -50.14 -12.47 0.08 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.631 -1.293 . . . . 0.0 108.465 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.5 t -78.68 -64.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 177.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.547 ' CG ' HE21 ' A' ' 14' ' ' GLN . 6.0 t70 -43.93 -47.58 8.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 11' ' ' LYS . 4.4 mptp? -59.49 -52.58 64.96 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.562 ' O ' ' N ' ' A' ' 16' ' ' ALA . 0.6 OUTLIER -54.17 -50.97 65.81 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.567 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 16' ' ' ALA . 8.0 mt -56.79 -62.02 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.547 HE21 ' CG ' ' A' ' 10' ' ' ASP . 2.4 mp0 -47.51 -20.08 0.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.117 -0.99 . . . . 0.0 109.024 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.443 ' N ' ' C ' ' A' ' 13' ' ' ILE . 46.7 mt-30 -102.08 -16.42 16.42 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.556 0.694 . . . . 0.0 109.347 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -52.98 -9.55 0.13 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.406 -0.809 . . . . 0.0 110.295 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.402 ' N ' ' C ' ' A' ' 15' ' ' GLN . 14.3 p -78.89 -21.66 47.11 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.829 -1.17 . . . . 0.0 109.195 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -95.8 -71.88 0.65 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.368 -0.832 . . . . 0.0 110.969 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 18' ' ' SER . 97.8 mt -42.92 -30.66 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-O 121.643 0.735 . . . . 0.0 110.073 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -73.85 -48.42 31.34 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 18' ' ' SER . 6.0 mmm180 -53.91 -35.27 61.46 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 26' ' ' TYR . 9.6 mp -67.8 -67.51 0.45 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 121.718 0.771 . . . . 0.0 109.975 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 14.3 p -51.05 -58.58 5.72 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.295 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.639 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 78.8 mt-30 -47.88 -31.49 5.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.783 -1.198 . . . . 0.0 109.797 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -95.9 -59.09 1.93 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.259 -0.901 . . . . 0.0 111.304 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.481 ' N ' ' O ' ' A' ' 22' ' ' LEU . 22.9 m-85 -87.34 -80.32 0.26 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.986 -1.071 . . . . 0.0 112.245 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.532 HD13 ' N ' ' A' ' 27' ' ' ILE . 2.3 mm -56.16 -65.31 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.805 -1.184 . . . . 0.0 110.412 -177.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 107.28 -20.37 32.94 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -96.53 122.08 39.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.504 -0.998 . . . . 0.0 108.728 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.7 m -135.22 94.15 16.1 Favored Pre-proline 0 N--CA 1.495 1.811 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -34.24 -98.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.444 2.096 . . . . 0.0 113.819 -177.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.43 ' CD2' ' O ' ' A' ' 32' ' ' PHE . 62.0 t80 -172.08 70.29 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.502 -1.374 . . . . 0.0 109.597 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.77 179.447 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.454 ' OD1' ' N ' ' A' ' 1' ' ' ASN . 2.0 p30 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.378 0.608 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.545 ' C ' ' H ' ' A' ' 4' ' ' ASP . 6.2 tp10 -67.08 131.44 45.83 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 tp -66.19 11.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.382 -0.824 . . . . 0.0 109.842 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.545 ' H ' ' C ' ' A' ' 2' ' ' GLU . 57.7 p30 -83.46 63.79 7.51 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.372 -0.83 . . . . 0.0 109.006 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 6' ' ' PRO . 21.5 t -43.34 -60.66 2.32 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.419 -0.801 . . . . 0.0 110.527 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.41 ' C ' ' O ' ' A' ' 5' ' ' VAL . 16.6 Cg_exo -36.41 97.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 122.106 1.871 . . . . 0.0 112.215 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.499 ' C ' ' N ' ' A' ' 9' ' ' VAL . 1.4 tm-20 -95.97 -65.44 0.97 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.446 -0.784 . . . . 0.0 109.439 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.508 ' O ' HD23 ' A' ' 12' ' ' LEU . 2.9 mp0 -51.55 -13.04 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.786 -1.196 . . . . 0.0 108.232 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' N ' ' C ' ' A' ' 7' ' ' GLU . 18.0 t -76.22 -65.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.572 ' CG ' HE21 ' A' ' 14' ' ' GLN . 3.1 t70 -43.4 -45.81 6.36 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -61.41 -51.26 69.49 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -56.51 -55.22 36.53 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 16' ' ' ALA . 10.3 mt -49.77 -55.53 4.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.572 HE21 ' CG ' ' A' ' 10' ' ' ASP . 2.8 mp0 -50.93 -41.18 58.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -75.1 -13.3 60.47 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.531 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -88.27 -25.92 22.58 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 14' ' ' GLN . 47.8 p -61.7 -31.76 71.93 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.7 m -69.05 -70.9 0.24 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.436 -0.79 . . . . 0.0 109.474 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 79.3 mt -46.41 -28.45 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -78.28 -54.24 6.43 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -51.27 -37.2 45.93 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mp -65.79 -69.93 0.27 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.877 0.846 . . . . 0.0 109.438 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.525 ' O ' ' N ' ' A' ' 28' ' ' GLY . 9.0 p -52.64 -38.58 60.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.208 0.528 . . . . 0.0 109.638 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.505 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 37.3 mm-40 -67.15 -36.71 82.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.814 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.0 t-160 -90.05 -38.85 13.3 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.201 -0.937 . . . . 0.0 110.076 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -75.95 -65.56 0.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.905 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.77 -68.64 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.251 -0.906 . . . . 0.0 110.158 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 119.68 -2.48 13.63 Favored Glycine 0 N--CA 1.501 3.029 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.451 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -131.97 123.39 27.25 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.539 -0.977 . . . . 0.0 108.496 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.451 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.3 m -147.59 69.63 11.33 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 108.943 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.67 8.96 3.12 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.385 2.056 . . . . 0.0 112.59 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -84.87 -1.21 56.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.14 -0.975 . . . . 0.0 109.035 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.049 179.852 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.4 m120 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' A' ' 4' ' ' ASP . 0.7 OUTLIER -70.53 124.44 24.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.955 . . . . 0.0 109.723 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.604 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.7 mm? -73.14 12.77 0.5 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.206 -0.934 . . . . 0.0 108.784 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 2' ' ' GLU . 38.0 p-10 -72.59 77.79 1.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.543 -0.723 . . . . 0.0 109.873 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.63 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.2 t -76.73 -33.15 1.11 Allowed Pre-proline 0 N--CA 1.487 1.383 0 O-C-N 121.253 -0.904 . . . . 0.0 110.905 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 1.3 Cg_endo -93.41 110.55 0.2 Allowed 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 122.953 2.436 . . . . 0.0 111.234 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.541 ' C ' ' N ' ' A' ' 9' ' ' VAL . 31.8 tt0 -85.02 -62.2 1.59 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.353 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.538 ' O ' HD23 ' A' ' 12' ' ' LEU . 24.4 mm100 -48.84 -14.08 0.06 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.706 -1.246 . . . . 0.0 108.249 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.541 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.2 t -77.92 -63.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.552 ' CG ' HE21 ' A' ' 14' ' ' GLN . 5.5 t70 -46.82 -47.6 21.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.361 -0.837 . . . . 0.0 108.833 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -57.42 -50.5 72.8 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -57.7 -55.44 34.77 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 16' ' ' ALA . 9.8 mt -51.33 -53.49 15.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.053 -1.03 . . . . 0.0 108.353 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.552 HE21 ' CG ' ' A' ' 10' ' ' ASP . 2.3 mp0 -52.98 -37.74 61.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -72.39 -15.63 61.85 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -95.6 -13.37 24.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 14' ' ' GLN . 30.7 p -71.03 -31.64 68.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.116 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.452 ' O ' HD13 ' A' ' 22' ' ' LEU . 1.7 m -65.75 -71.0 0.2 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.414 -0.804 . . . . 0.0 109.802 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 77.7 mt -46.79 -28.88 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.465 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 32.0 mt-10 -77.93 -49.29 14.45 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 25' ' ' HIS . 11.5 mmm180 -55.93 -34.32 65.52 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.452 HD13 ' O ' ' A' ' 18' ' ' SER . 8.4 mp -62.69 -65.84 0.63 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.982 0.896 . . . . 0.0 109.815 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 28' ' ' GLY . 20.2 p -60.87 -18.4 55.96 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.87 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -95.2 -28.31 15.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 0.0 109.76 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 21' ' ' ARG . 46.9 t60 -95.24 -69.09 0.77 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.168 -0.958 . . . . 0.0 110.395 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -52.71 -54.76 29.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.242 -0.911 . . . . 0.0 110.784 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.9 mp -98.84 -80.84 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.154 -0.966 . . . . 0.0 110.798 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.47 42.57 0.24 Allowed Glycine 0 N--CA 1.501 2.988 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.442 ' C ' ' SG ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -170.29 130.37 0.92 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -1.195 . . . . 0.0 109.089 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.442 ' SG ' ' C ' ' A' ' 29' ' ' TRP . 1.6 m -146.74 89.52 5.72 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.208 -0.932 . . . . 0.0 109.523 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 96.6 Cg_endo -84.83 51.73 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.196 1.93 . . . . 0.0 112.364 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.503 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 63.8 m-85 -158.52 28.11 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.974 -1.079 . . . . 0.0 109.74 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.465 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 2.9 m-90 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.017 -0.992 . . . . 0.0 108.767 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.552 0.692 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.601 ' C ' ' H ' ' A' ' 4' ' ' ASP . 26.8 tt0 -44.4 136.38 4.16 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.495 0.664 . . . . 0.0 109.946 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 5' ' ' VAL . 6.0 tp -67.42 19.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.51 0.672 . . . . 0.0 109.71 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.601 ' H ' ' C ' ' A' ' 2' ' ' GLU . 25.0 p30 -67.01 58.08 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.375 -0.828 . . . . 0.0 109.2 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 3' ' ' LEU . 71.2 t -41.24 -54.54 5.86 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.623 -0.673 . . . . 0.0 111.185 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 5' ' ' VAL . 88.0 Cg_exo -22.04 100.15 0.01 OUTLIER 'Trans proline' 0 N--CA 1.483 0.875 0 C-N-CA 123.547 2.832 . . . . 0.0 113.825 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.494 ' C ' ' N ' ' A' ' 9' ' ' VAL . 28.5 tt0 -95.21 -53.12 3.9 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.608 ' CD ' ' H ' ' A' ' 8' ' ' GLN . 3.8 mp0 -56.78 -10.17 0.97 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.494 ' N ' ' C ' ' A' ' 7' ' ' GLU . 3.4 t -82.39 -64.88 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -46.27 -43.93 16.03 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -60.62 -50.2 74.47 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.6 OUTLIER -58.48 -56.5 21.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 16' ' ' ALA . 10.1 mt -49.29 -52.28 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -51.2 -42.35 60.84 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -71.83 -13.91 61.81 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 13' ' ' ILE . . . -86.42 -24.24 25.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.444 -0.785 . . . . 0.0 109.23 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -94.49 -12.55 27.45 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -95.54 -67.83 0.83 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 18' ' ' SER . 95.5 mt -38.11 -28.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.836 0.826 . . . . 0.0 109.876 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.531 ' O ' ' NE2' ' A' ' 24' ' ' GLN . 15.7 pt-20 -82.55 -46.56 13.21 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' A' ' 18' ' ' SER . 11.9 mtt85 -69.6 -30.18 67.88 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' A' ' 26' ' ' TYR . 4.3 mp -65.28 -68.74 0.34 Allowed 'General case' 0 C--O 1.204 -1.309 0 O-C-N 121.224 -0.923 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.58 ' O ' ' N ' ' A' ' 28' ' ' GLY . 3.2 p -41.56 -54.52 3.16 Favored 'General case' 0 N--CA 1.504 2.248 0 C-N-CA 120.136 -0.625 . . . . 0.0 109.673 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.535 ' N ' ' OE1' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -45.99 -42.88 13.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 109.56 179.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -95.44 -54.86 3.24 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.119 -0.988 . . . . 0.0 109.682 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.626 ' N ' ' O ' ' A' ' 22' ' ' LEU . 13.8 m-85 -61.68 -77.46 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.452 -0.78 . . . . 0.0 109.826 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' A' ' 26' ' ' TYR . 5.3 mp -99.15 -80.78 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.584 -0.697 . . . . 0.0 110.512 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 139.98 -7.89 2.97 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -88.17 115.25 25.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.319 -1.106 . . . . 0.0 109.494 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.6 m -160.3 108.55 1.38 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 108.923 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -40.12 -83.08 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.305 2.003 . . . . 0.0 113.642 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.49 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 53.3 t80 -176.23 71.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.798 -1.189 . . . . 0.0 110.093 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.091 -1.005 . . . . 0.0 109.553 178.85 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 4' ' ' ASP . 51.0 mt-10 -68.81 117.06 10.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.45 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.0 tp -71.99 13.78 0.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.461 -0.774 . . . . 0.0 109.618 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 2' ' ' GLU . 12.9 p30 -72.02 78.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.377 -0.827 . . . . 0.0 109.555 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.543 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 18.6 t -102.95 -33.83 0.21 Allowed Pre-proline 0 N--CA 1.496 1.862 0 O-C-N 121.318 -0.864 . . . . 0.0 113.168 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 35.6 Cg_exo -53.52 161.26 4.3 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 121.248 1.298 . . . . 0.0 114.53 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.514 ' C ' ' N ' ' A' ' 9' ' ' VAL . 42.7 mm-40 -76.22 -59.99 2.53 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.417 -0.802 . . . . 0.0 109.532 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.758 ' NE2' ' H ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -54.65 -9.62 0.35 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.867 -1.133 . . . . 0.0 107.95 178.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.514 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.8 t -88.07 -67.44 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -49.62 -39.63 36.46 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.949 -1.094 . . . . 0.0 108.819 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 15' ' ' GLN . 37.2 mttp -63.46 -49.42 73.74 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.574 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -54.52 -54.37 41.97 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.366 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 mt -54.04 -56.51 9.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -56.74 -32.74 65.86 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.49 -0.756 . . . . 0.0 109.505 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 11' ' ' LYS . 49.3 mt-30 -69.32 -26.33 64.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.193 -0.942 . . . . 0.0 109.048 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.15 -13.09 0.74 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.298 -0.876 . . . . 0.0 109.131 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.413 ' N ' ' C ' ' A' ' 15' ' ' GLN . 8.6 p -51.56 -36.68 46.26 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -60.17 -69.27 0.23 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.447 -0.783 . . . . 0.0 109.105 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 97.3 mt -42.73 -29.6 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-O 121.883 0.849 . . . . 0.0 109.334 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.568 ' CG ' ' NE1' ' A' ' 33' ' ' TRP . 29.6 mt-10 -79.52 -48.88 13.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 18' ' ' SER . 16.6 mmt85 -60.61 -33.32 72.59 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.8 mp -63.99 -66.97 0.47 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 122.022 0.915 . . . . 0.0 109.699 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 28' ' ' GLY . 18.7 p -57.37 -16.69 9.72 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.767 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -95.48 -29.58 14.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.174 -0.954 . . . . 0.0 109.844 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -95.3 -68.53 0.8 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.208 -0.933 . . . . 0.0 110.635 -179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -52.49 -54.29 34.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.179 -0.951 . . . . 0.0 110.966 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.01 -80.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.078 -1.014 . . . . 0.0 111.192 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.95 37.91 0.37 Allowed Glycine 0 N--CA 1.502 3.04 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -163.69 128.97 2.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.179 -1.189 . . . . 0.0 109.246 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.6 m -144.12 105.19 4.79 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.14 -0.975 . . . . 0.0 109.022 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 33' ' ' TRP . 89.6 Cg_endo -82.56 -29.22 1.49 Allowed 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.836 1.69 . . . . 0.0 112.992 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.08 11.15 0.33 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.07 -1.019 . . . . 0.0 109.159 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.568 ' NE1' ' CG ' ' A' ' 20' ' ' GLU . 16.8 m-90 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.627 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.685 ' N ' HD22 ' A' ' 1' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.235 0.541 . . . . 0.0 109.543 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.463 ' CD ' ' H ' ' A' ' 2' ' ' GLU . 1.0 OUTLIER -50.05 90.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.612 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 1' ' ' ASN . 5.6 mt -65.03 -0.14 1.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.271 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 2' ' ' GLU . 0.9 OUTLIER -83.46 47.53 1.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.298 -0.876 . . . . 0.0 109.53 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 38.2 t -73.59 -34.88 2.34 Favored Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 121.329 -0.857 . . . . 0.0 110.622 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 89.1 Cg_exo -50.98 106.03 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.207 1.938 . . . . 0.0 112.845 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.499 ' C ' ' N ' ' A' ' 9' ' ' VAL . 64.7 tt0 -95.46 -58.34 2.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.763 -0.586 . . . . 0.0 109.478 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.595 ' O ' HD23 ' A' ' 12' ' ' LEU . 26.0 mm-40 -54.89 -9.52 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' N ' ' C ' ' A' ' 7' ' ' GLU . 3.9 t -84.74 -68.03 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 178.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -46.37 -33.81 4.15 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.595 -0.691 . . . . 0.0 109.569 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -73.03 -48.12 38.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.595 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -56.23 -55.13 36.96 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -49.16 -56.81 2.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 17' ' ' THR . 34.5 mt-30 -53.37 -42.76 67.19 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -72.46 -18.78 61.66 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.312 -0.868 . . . . 0.0 108.885 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 12' ' ' LEU . . . -72.38 -9.36 58.41 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.321 -0.862 . . . . 0.0 109.078 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 20' ' ' GLU . 6.5 p -46.16 -65.54 0.54 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.445 -0.785 . . . . 0.0 109.423 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.6 m -36.21 -66.59 0.2 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.618 0.723 . . . . 0.0 110.763 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 96.5 mt -45.01 -27.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 109.914 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.518 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 0.3 OUTLIER -83.85 -35.78 23.93 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' SER . 10.7 mmt180 -72.21 -25.53 61.69 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 26' ' ' TYR . 7.7 mp -64.21 -65.63 0.65 Allowed 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.636 0.731 . . . . 0.0 110.009 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.555 ' O ' ' N ' ' A' ' 28' ' ' GLY . 5.0 p -47.09 -58.15 4.32 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -47.36 -34.56 7.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.152 -0.968 . . . . 0.0 109.99 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -95.49 -70.4 0.71 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.03 -1.044 . . . . 0.0 111.294 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 22' ' ' LEU . 52.5 m-85 -53.21 -67.68 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.126 -0.984 . . . . 0.0 110.672 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.74 -81.02 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.118 -0.989 . . . . 0.0 110.697 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 134.32 42.56 0.14 Allowed Glycine 0 N--CA 1.498 2.833 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -165.95 116.74 1.03 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -1.15 . . . . 0.0 109.201 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.5 m -130.24 90.04 43.02 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -83.76 41.09 0.99 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.974 1.783 . . . . 0.0 112.89 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.494 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 71.9 t80 -160.19 27.8 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.709 -1.245 . . . . 0.0 110.121 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.163 179.639 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.6 m120 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.292 0.568 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.481 ' C ' ' N ' ' A' ' 4' ' ' ASP . 63.6 mm-40 -46.54 109.87 0.23 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.0 109.762 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.8 tp -50.54 -13.32 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 108.772 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.481 ' N ' ' C ' ' A' ' 2' ' ' GLU . 3.5 p30 -100.44 56.73 0.91 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.51 -0.744 . . . . 0.0 109.333 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.624 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 3.0 t -73.55 -34.06 2.08 Favored Pre-proline 0 N--CA 1.486 1.333 0 O-C-N 121.084 -1.01 . . . . 0.0 110.837 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 48.8 Cg_exo -57.79 55.47 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.486 2.124 . . . . 0.0 113.455 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 5' ' ' VAL . 52.0 mt-10 -82.4 -66.26 0.91 Allowed 'General case' 0 C--N 1.286 -2.182 0 O-C-N 121.233 -0.917 . . . . 0.0 108.589 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.516 ' O ' HD23 ' A' ' 12' ' ' LEU . 19.0 mm-40 -55.62 -9.73 0.57 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.856 -1.152 . . . . 0.0 108.041 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.487 ' N ' ' C ' ' A' ' 7' ' ' GLU . 42.1 t -81.3 -67.04 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 14' ' ' GLN . 2.2 t0 -45.09 -44.17 10.2 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -62.64 -50.24 72.01 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.329 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.4 OUTLIER -55.09 -54.99 36.13 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.395 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -50.26 -58.04 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -56.39 -36.6 69.06 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.557 -0.714 . . . . 0.0 109.812 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 11' ' ' LYS . 13.3 mt-30 -76.89 -49.9 14.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.947 -1.095 . . . . 0.0 109.42 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 18' ' ' SER . . . -53.02 -9.05 0.12 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 108.949 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 14' ' ' GLN . 6.5 p -42.98 -23.88 0.05 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.072 0.939 . . . . 0.0 108.864 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 16' ' ' ALA . 1.5 m -79.32 -70.81 0.48 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 10.9 mt -43.74 -37.57 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-O 122.027 0.918 . . . . 0.0 109.298 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.507 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 1.6 pt-20 -73.63 -45.51 52.4 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' NE ' ' OE1' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -58.0 -41.24 82.63 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.3 mp -55.9 -59.25 5.15 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.154 0.978 . . . . 0.0 109.132 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 20' ' ' GLU . 5.3 p -55.75 -32.6 63.54 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.19 -178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.542 ' OE1' ' NE ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -95.5 -25.42 16.22 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.763 -1.211 . . . . 0.0 110.968 -178.098 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 21' ' ' ARG . 3.6 t60 -87.82 -68.68 0.74 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.042 -1.036 . . . . 0.0 110.971 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -76.91 -47.92 19.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.149 -0.969 . . . . 0.0 111.408 -178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.9 mm -76.34 -76.05 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.89 -1.131 . . . . 0.0 109.898 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 128.41 -36.95 2.36 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.508 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 4.1 t90 -90.84 151.36 21.19 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.4 -1.059 . . . . 0.0 109.4 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 29' ' ' TRP . 60.1 m -156.99 150.47 19.0 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 32' ' ' PHE . 56.2 Cg_endo -70.28 -89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 121.353 1.369 . . . . 0.0 111.949 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.528 ' CD1' ' O ' ' A' ' 31' ' ' PRO . 19.8 m-85 -155.4 47.12 0.51 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.844 -1.16 . . . . 0.0 111.164 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 O-C-N 120.563 -1.336 . . . . 0.0 108.718 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.484 ' C ' ' H ' ' A' ' 4' ' ' ASP . 1.2 pm0 -159.07 84.62 0.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 109.688 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.621 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.4 mm? -76.73 18.56 0.33 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.0 108.45 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 4' ' ' ASP . 20.8 p-10 -66.62 99.1 0.56 Allowed 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.352 0.596 . . . . 0.0 110.331 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.603 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 53.1 t -80.29 -32.86 0.72 Allowed Pre-proline 0 N--CA 1.484 1.261 0 O-C-N 121.222 -0.924 . . . . 0.0 110.91 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 5' ' ' VAL . 9.2 Cg_exo -40.27 119.68 0.74 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.307 2.005 . . . . 0.0 112.087 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.521 ' C ' ' N ' ' A' ' 9' ' ' VAL . 69.1 tt0 -85.33 -70.88 0.56 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.567 -0.708 . . . . 0.0 112.498 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.642 ' H ' ' NE2' ' A' ' 8' ' ' GLN . 4.1 mp0 -51.43 -12.28 0.15 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.425 -1.422 . . . . 0.0 108.329 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.521 ' N ' ' C ' ' A' ' 7' ' ' GLU . 2.3 t -81.35 -64.39 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.506 ' OD1' ' NE2' ' A' ' 14' ' ' GLN . 5.6 t70 -46.05 -45.63 16.21 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' NZ ' ' CG ' ' A' ' 7' ' ' GLU . 27.2 mttp -59.28 -51.96 67.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.584 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -54.34 -53.45 53.67 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 8.0 mt -54.42 -59.75 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.506 ' NE2' ' OD1' ' A' ' 10' ' ' ASP . 37.0 mt-30 -51.47 -38.09 52.1 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.553 -0.717 . . . . 0.0 109.329 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 17' ' ' THR . 42.9 mt-30 -64.19 -28.25 69.62 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.244 -0.91 . . . . 0.0 108.683 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 13' ' ' ILE . . . -46.33 -13.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.592 -0.693 . . . . 0.0 109.702 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' GLN . 5.9 p -52.17 -31.93 33.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 108.472 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 21' ' ' ARG . 1.7 m -65.02 -70.63 0.22 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.051 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 18' ' ' SER . 94.6 mt -38.38 -30.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.864 0.84 . . . . 0.0 109.591 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 18' ' ' SER . 16.1 mt-10 -75.47 -53.01 9.37 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' SER . 5.3 mmt-85 -52.57 -43.74 65.46 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 25' ' ' HIS . 7.8 mp -59.9 -62.39 1.91 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.029 0.919 . . . . 0.0 109.443 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 24' ' ' GLN . 1.7 p -44.13 -49.29 9.04 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.456 -178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.612 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 58.9 mt-30 -62.86 -24.19 67.67 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.887 -1.133 . . . . 0.0 108.71 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.506 ' N ' ' O ' ' A' ' 22' ' ' LEU . 46.8 t-80 -96.13 -58.78 1.99 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.458 -0.776 . . . . 0.0 111.193 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.481 ' N ' ' O ' ' A' ' 22' ' ' LEU . 73.6 m-85 -88.93 -80.91 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 0.0 112.037 -177.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 29' ' ' TRP . 3.8 mm -48.62 -19.72 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.03 -1.044 . . . . 0.0 109.74 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 23' ' ' CYS . . . 68.07 -55.44 0.41 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.471 ' N ' ' O ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -76.68 159.08 30.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -1.191 . . . . 0.0 108.856 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 31' ' ' PRO . 52.8 m -154.55 106.22 2.37 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.555 ' O ' ' CG ' ' A' ' 32' ' ' PHE . 24.6 Cg_exo -37.08 -105.65 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.346 2.03 . . . . 0.0 113.58 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 31' ' ' PRO . 68.5 m-85 -158.99 63.43 0.41 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.352 -1.468 . . . . 0.0 110.069 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.8 m-90 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.395 179.169 . . . . . . . . 0 0 . 1 stop_ save_